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The main objectives of this thesis were to investigate whether dysfunctions of the frontal-
striatal and limbic circuits are basic to the emotional and cognitive processes underlying the 
symptomatology of obsessive-compulsive disorder (OCD) and to determine the disorder-
specificity of these abnormalities. To address these issues, task related changes in regional 
cerebral blood flow (rCBF) and blood oxygenation level dependent (BOLD) signal were 
measured using positron emission tomography (PET) and functional magnetic resonance 
imaging (fMRI), respectively. In order to investigate the psychopathological processes of 
the disorder, three experimental paradigms were designed addressing three different mental 
states: 1) emotional perception during provoked contamination fear, 2) higher-order 
cognitive function during executive performance, and 3) the interaction between emotional 
and cognitive processes during a paradigm addressing attentional bias. Brain activation 
patterns in unmedicated OCD patients were compared with those in both healthy control 
subjects and patients with related disorders, such as panic disorder (PD) and 
hypochondriasis. 
 
As will be described in part I, chapters 2 and 3, various neuroimaging techniques are 
available for investigating neuropsychiatric disorders. Each modality has its own specific 
applicability in the search for the underlying mechanisms of the various mental processes of 
interest. Both strengths and limitations of these techniques should be taken into account in 
choosing a modality for a specific experiment. As in most symptom provocation 
experiments, in the present thesis, oxygen-15 labeled water (H2
15O) and PET were used to 
visualize the neuronal correlates of contamination fear. Due to the radioactive half-life of 2 
minutes, the interscan interval must be at least 8 to 10 minutes. Acquisition of subsequent 
PET scans (each of about 90 seconds) in this typical on-off schedule is useful to capture 
relatively slow processes such as induced symptomatic states. Also, the obligatory interscan 
intervals enable recovery from the provoked emotional response between experimental 
conditions.  
In contrast to symptom provocation studies, most neuropsychological paradigms 
require the higher temporal resolution of fMRI. Functional MRI enables separate analysis 
of a large amount of subsequent events, i.e. short mental states in a specific experimental 
condition. A whole brain echo-planar imaging (EPI) acquisition generally takes 2 to 3 
seconds. During a neuropsychological task of about 15 minutes, usually 200 to 450 images 
can be acquired. In this way, fMRI is a powerful technique to compare relatively fast task 
related changes in BOLD signal, both within and between study groups of interest. 
 Chapters 2 and 3 provide recent overviews of the existing neuroimaging 
literature in OCD and PD, respectively. These reviews contain both early studies and recent 
findings, incorporating the experimental results that are described more extensively in part 
III of this thesis. Therefore, these chapters should be seen as state-of-the-art presentations 
of the field at the present time rather than at the start of the experimental work described in 
this thesis (2000). These reviews clearly show the rapid developments within this field and 
they further illustrate the frontal-striatal and limbic hypothesis. 
 
Before describing OCD specific experiments, part II of this thesis addresses two 


















During the analyses of the PET data, it became clear that subject motion could introduce 
significant artifacts. In fact, in a first-pass analysis, inaccurate attenuation correction due to 
motion induced misalignment between transmission and emission scans appeared to be 
responsible for (erroneous) task related changes in regional activity concentrations. To 
further investigate this issue an alternative method for attenuation correction, the image 
registration (IR) method, was implemented and evaluated. Both in phantoms and in 
humans, the accuracy of the IR method was compared with that of other methods for 
attenuation correction. The results are given in chapter 4. 
 In case of fMRI an almost infinite reservoir of neuropsychological tasks can be 
used for investigating various emotional and/or cognitive processes. Most of these tasks 
have been developed for application in healthy control subjects. An important 
methodological issue is to adjust these neuropsychological paradigms to psychiatric study 
populations. Comparison of task-related activation patterns between different groups 
requires a sensitive paradigm that specifically addresses the function of interest and 
incorporates a correction for differences in task performance. A self-paced, event-related 
and parametric design allows for flexibility in response, separate analysis of false and 
correct events, and comparisons between subjects or groups at each task level. This results 
in increased comparability across groups. In chapter 5, the design of a parametric self-
paced pseudo-randomized event-related version of a planning task is presented.  
 
Part III of this thesis describes the background and results of the experiments performed in 
OCD patients. This part addresses the neuronal correlates of normal and pathological, 
emotional and cognitive processes during three induced mental states. Task related 
activation patterns in medication-free OCD patients are compared with those in both 
healthy and psychiatric control groups.  
In order to visualize the neural correlates of the symptomatic state in OCD patients 
with contamination fear, a H2
15O PET symptom provocation experiment was performed. 
This study, as a replication of earlier provocation designs, was meant to contribute to a 
better understanding of previous findings that were inconsistent due to various 
methodological concerns. A randomized block design with standardized visual 
presentations of ‘dirty’ and ‘clean’ surroundings was used to compare the task-related 
changes in rCBF in a homogeneous group of medication-free OCD patients with those in 
healthy control subjects. The results are given in chapter 6. 
 Although dysfunctions in the frontal-striatal system seemed to be implicated in the 
symptomatic state of OCD, little was known about its role in the accompanying cognitive 
impairments. Therefore, one objective was to investigate the flexibility of the frontal-
striatal system in OCD during a higher-order executive, but emotionally neutral, task. A 
parametric fMRI version of a planning task was used to increase the specificity of the 
experimental effects of interest and to control for differences in task performance between 
groups. Task-related changes in BOLD signal were measured in medication-free OCD 
patients, and compared with those in healthy control subjects. In chapter 7, findings and 
implications are presented and discussed. 
A third experimental approach to unravel the altered functioning of the frontal-
striatal and limbic systems in OCD is through the investigation of emotional interference 



















pathogenetically important in anxiety disorders. The critical process of ‘gating’ (i.e. 
selectively attend to relevant stimuli, whilst simultaneously ignoring irrelevant competing 
stimuli) has been linked to frontal-striatal function. The other element, emotional appraisal 
of information, has been linked to limbic function. Using an fMRI version of the cognitive 
and emotional Stroop task, the neuronal correlates of attentional bias in OCD, PD and 
hypochondriasis were investigated. This comparison between related disorders might 
contribute to a better understanding of the disorder-specificity of the abnormalities. The 
results are described in chapter 8.  
 
The last chapter of this thesis (chapter 9) discusses strengths and limitations of the present 
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Obsessive-compulsive disorder (OCD) is a neuropsychiatric condition that is characterized 
by intrusive anxiety-provoking thoughts (obsessions) and subsequent repetitive behaviors 
(compulsions). Neurobiological models of OCD have emphasized the mediation of clinical 
symptoms by aberrant frontal-striatal circuits in addition to dysfunctional neurotransmitter 
interactions, i.e. serotonergic-dopaminergic and glutamatergic-serotonergic. These models 
were mainly based on preclinical animal and laboratory reports as well as lesion studies and 
early imaging paradigms. Recently, a neurobiological model for normal human emotion 
perception has been described, proposing distinct ventral and dorsal processing systems 
corresponding with differential levels of emotion perception. This construct appears 
relevant for elucidating the pathophysiology of OCD, as OCD is classified as an anxiety 
disorder.  
In the present paper we present a comprehensive review of the neuroimaging 
literature in OCD with the aim of critically appraising the support provided for current 
pathophysiological models, as well as relating these findings to constructs of normal 
emotion perception. Traditionally, neuroimaging designs in OCD included structural 
studies in search of morphological abnormalities, resting state measurements of cerebral 
blood flow and metabolism, and symptom provocation designs. Over the last few years, 
sophisticated functional neuroimaging paradigms have been introduced using cognitive 
and/or emotional paradigms; also, radioligands have become available to assess receptor 
distribution and affinity. These recent study designs are more hypothesis-driven and better 
respect the heterogeneity of OCD, increasing their sensitivity and specificity for elucidating 
the pathophysiological substrate of this disorder. 
Results of imaging studies point to the need for adjustments in current models with 
respect to the involvement of frontal-striatal circuits in OCD. In line with recent insights 
into the neurobiology of emotion processing, a ventral-dorsal dissociation may be 
distinguished. Moreover, data from pediatric OCD patient samples have commenced to 
shed light on developmental characteristics of OCD. Furthermore, longitudinal designs 
from early into later life, in combination with pre-post treatment comparisons, are of great 
value for assessing the state-trait duality. Finally, the use of multimodal study designs holds 
great promise for the near future. 






















Obsessive-compulsive disorder (OCD) is a neuropsychiatric condition that is characterized 
by intrusive anxiety-provoking thoughts (obsessions) and subsequent repetitive behaviors 
(compulsions)1. Lifetime prevalence rates of this often debilitating disorder as found in 
recent epidemiological studies range from 0.5%2 to 2.9%3 in the general population.  
The role of neurobiological factors in the etiology of OCD was first suggested by 
descriptions of obsessive-compulsive behavior in patients with subcortical disorders, e.g. 
Huntington’s disease4, Sydenham’s chorea5, and pallidal lesions6, and in patients with 
frontal lobe lesions7. Based on such observations, as well as on more recent functional 
neuroimaging data, several neurobiological models for OCD have been proposed8-10. 
Although differing on details, all these models emphasize the mediation of OCD symptoms 
by hyperactivity of frontal-striatal circuitry. In brief, cortical regions, mainly the 
orbitofrontal cortex (OFC) and anterior cingulate cortex (ACC), and striatal structures are 
presumed to be captured in a hyperfunctional, self-perpetuating loop9. In this hyperactive 
circuit, the prefrontal regions putatively subserve enhanced ‘error detection’, corresponding 
to the patients’ characteristic sense that ‘something is wrong’. The striatum is supposedly 
engaged in abnormal ‘gating’, relating to the selection and generation of aberrant 
behavioral patterns on the basis of erroneous information from cortical areas. Moreover, the 
dysfunctional striatum may allow the emergence of repetitive behavioral patterns that have 
a reinforcing function in alleviating distress caused by obsessional thoughts. Possibly, the 
striatum exerts this pathological function due to overactive dopaminergic projections to this 
structure8;10. Other neurotransmitters hypothesized to be involved in the pathophysiology of 
OCD are serotonin through its inhibitory interactions with dopamine, and glutamate by 
means of its excitatory role in frontal-striatal connections and its interactions with 
serotonin11. 
Although these models stress the involvement of para-limbic regions such as OFC 
and ACC in the pathophysiology of OCD, they do not attribute a role to key limbic 
structures, i.e. the insula and amygdala. This is surprising given the fact that OCD is 
considered an anxiety disorder and the amygdala is assumed to be the central component of 
fear processing12. A recent neurobiological model for human emotion processing13;14 
proposed several levels of emotion perception with corresponding neuronal correlates: first, 
the identification of the emotional significance of a stimulus and, subsequently, the 
production of an affective state. These subprocesses were assumed to be associated with a 
ventral neuronal system consisting of the amygdala, insula, ventral striatum and ventral 
regions of the prefrontal and cingulate cortices. Second, the regulation of the affective state 
was hypothesized to be represented by a dorsal neuronal pathway, i.e. hippocampus and 
dorsal regions of prefrontal and cingulate cortices. The authors used this model to describe 
affective symptoms in four main psychiatric disorders14. However, OCD was not among 
these disorders, leaving a lacuna to be filled.  
 
In this article, we intend to contribute to the existing literature on the pathophysiology of 
OCD by reviewing all available neuroimaging papers in OCD, categorized according to the 
applied technique or paradigm. First, we summarize the results of structural studies, after 




















designs are discussed followed by cognitive paradigms and, finally, ligand and magnetic 
resonance spectroscopy (MRS) studies. In each paragraph, we aim to not only review the 
results but also critically appraise methodological issues, and discuss the possibilities and 
limitations of the imaging technique or paradigm at stake for unraveling the neurobiology 
of OCD. A final discussion will integrate the findings, discuss the implications for the 
above-mentioned emotion processing model13 and neurobiological models of OCD, and 
provide some directions for future research. 
 
 
Structural imaging studies 
 
Findings of structural imaging studies in OCD are summarized in Table 2.1. The first 
studies suggesting brain abnormalities in OCD were based on either qualitative evaluation 
of computed tomography (CT) scans, or measurements of whole brain volume and 
ventricle-to-brain ratios VBR15;16. Some years later, Luxenberg et al.17 used CT for 
measurements of the striatum in a small sample of early-onset male OCD patients and 
healthy controls, reporting decreased bilateral caudate volumes in OCD. Subsequent 
volumetric studies in OCD, which were mainly based on magnetic resonance imaging 
(MRI) data, restricted their data analysis to the striatum. Variability of neuroanatomical 
criteria for delineation of regions of interest (ROIs), used in most of these studies18-26, may 
partly explain inconsistent results obtained in these studies. Whereas results of Robinson et 
al.21 supported the finding of decreased striatal volumes, also normal18;20;22-26 or even 
increased19;27 striatal volumes have been reported.   
 More recent MRI studies expanded the number of ROIs or performed whole brain 
data acquisition and analysis. These studies, however, revealed similarly inconclusive 
results. Concerning the ventral regions of the prefrontal cortex, including the ACC, 
increased26;28;29 as well as decreased27;30;31 volumes have been reported. Thalamic volumes 
were increased in medication-naïve pediatric OCD patients, normalizing after paroxetine 
treatment32, as well as in adult OCD29. Both enlarged and diminished volumes were also 
found for temporal lobe structures such as the amygdala and hippocampus28;30;33;34.   
An alternative method of volumetric analysis of MR images is voxel-based 
morphometry (VBM)35. In VBM, structural images are segmented on a voxel-by-voxel 
basis and subsequently warped to anatomical standard space, so that individual volumetric 
differences will appear as differences in gray matter density.  Potential confounds in VBM 
include differences in white matter/gray matter contrast between groups, and 
misclassification of voxels due to partial volume effects36. On the other hand, time-
consuming drawing of ROIs, with its often low interrater reliability, can be avoided; 
moreover, VBM is a useful technique to assess subtle differences in gray matter 
concentrations at a microstructural level. So far, only 2 studies have used VBM in 
OCD29;37. Comparing 25 OCD patients with 25 healthy control subjects, Kim et al.29 found 
increased gray matter densities in left OFC, left thalamus and bilateral hypothalamus in 
OCD patients. Gilbert et al.37 investigated the relationship between age and gray matter 
concentrations in 21 children with OCD and 15 control subjects. A negative correlation was 














































































age-related decrease in gray matter density. This correlation was absent in OCD patients, 
suggesting a neurodevelopmental abnormality.  
During normal development of the brain neurons, dendrites, axons and synapses 
are first produced in excess, after which some are maintained while others are eliminated. 
This process of normally programmed cell death during brain development yields a 
decreasing ratio of gray to white matter. Increased gray matter density in specific regions of 
the frontal-striatal circuits in OCD patients compared with healthy control subjects may 
reflect a failure in synaptic proliferation or a defect in pruning processes. In 1996, Jenike 
and colleagues38 were the first to report that cortex-to-white matter ratio was larger in OCD 
compared with controls. In addition to the search for subtle gray matter abnormalities, 
VBM might be used to detect white matter changes in the frontal-striatal pathways39. The 
investigation of normal and abnormal brain maturation in very young children with and 
without OCD may contribute to a better understanding of the role of neurodevelopmental 
processes in the pathophysiology of OCD. Longitudinal follow-up of these children into 
adolescence and adulthood enables visualization of natural history as well as the evaluation 
of long-term effects of treatment strategies.  
 
To conclude, so far results of structural imaging studies in OCD have shown that 
morphological abnormalities, if present, are subtle. More refined analysis of whole brain 
images, including measurements of gray as well as white matter densities, is needed in 
homogeneous large samples. Accumulating evidence suggests that structural changes in 
OCD occur early in life, necessitating longitudinal follow-up of pediatric cohorts. 
Moreover, to understand the functional implications of structural changes, multi-modal 
imaging investigations are warranted. For instance, altered morphology may be related to 
an imbalance of interacting neurotransmitter systems28. Study designs combining MRS and 
VBM in pediatric OCD appear promising to investigate this issue. In addition, 
neuropsychological dysfunction and altered responsiveness of frontal-striatal circuits during 
functional MRI paradigms might be explained, at least partly, by subtle gray and/or white 
matter changes in frontal-striatal pathways. Therefore, results of functional imaging studies 
need to be corrected for possible morphological differences. Moreover, comparisons 
between OCD patients, their first-degree relatives and non-related control subjects may 
elucidate an underlying genetic predisposition. Finally, morphological characteristics, 
suggestive for neurodevelopmental abnormalities, may be used as endophenotypes for 





Resting-state studies aim to acquire data of basal brain metabolism or regional cerebral 
blood flow (rCBF) in patients while being in a neutral state. Resting-state studies have 
mainly been performed with the use of 18F-fluorodeoxyglucose (FDG) positron emission 
tomography (PET) or Technetium-99m hexamethyl propyleneamine-oxime (99mTc-
HMPAO) single photon emission computed tomography (SPECT), or inhalation of xenon-




















Compared with healthy controls, these studies have frequently shown increased metabolism 
or rCBF for OCD patients in the OFC, either bilaterally40-42, left-lateralized43;44 or right-
lateralized45;46, and in bilateral47;48 or left44 ACC, left frontotemporal cortex42, left insula45 
and right dorsal parietal cortex41. Also, elevated metabolism and rCBF have often been 
found in subcortical structures, such as bilateral46;48-50 or right42;44 thalamus, bilateral40;43 or 
right50 head of caudate nucleus, and bilateral putamen/pallidum48;51. These findings point 
toward hyperactive frontal-striatal circuitry in mediating OCD symptoms. This assumption 
is supported by frequently observed positive correlations between these metabolic 
alterations and symptom severity in OCD patients41;45;46;52. Also in line with this hypothesis 
is that functional correlations between these areas tend to diminish after successful 
treatment, as has been repeatedly demonstrated53-55.  
Conflicting findings have also been reported: decreased metabolism and rCBF 
have been found in the above mentioned structures as well, for the right OFC52;56, left 
ACC52, left lateral temporal cortex56, left parietal cortex45;56, bilateral41 or right56-58 caudate 
nucleus, bilateral putamen57 and right56 thalamus. Some of these functional abnormalities in 
this opposite direction were also correlated with clinical OCD rating scores52;56. However, 
metabolism and rCBF have been consistently found to be decreased in the bilateral 
dorsolateral/superior prefrontal cortex56;58;59. 
 
Differences between these studies with respect to the identified structures and to the 
direction of aberrant activity in OCD subjects may be due to several methodological issues, 
concerning both patient characteristics and technical (imaging) aspects. With regard to the 
former, the inclusion of OCD patients that used antiobsessional medication in some studies 
may have presented a confound43;56;57;59. Notably, in a recent pre-treatment to post-
treatment functional neuroimaging study in OCD, the use of medication itself was found to 
induce brain metabolic alterations over time60. This implies that the concomitant use of 
medication in the above mentioned early resting-state studies might have confounded the 
results on cerebral metabolism or rCBF. Indeed, in several of these studies additional 
analyses were performed excluding medicated patients, which sometimes led to (slightly) 
different outcomes. 
Another confounder in differentiating OCD and healthy subjects may have been 
the use of patient samples with concurrent major depression43;50. The exclusion of major 
depression in OCD for the comparison with controls is important, as depression rating 
scores in OCD patients have been found to be strongly correlated with decreased 
metabolism in right caudate, bilateral thalamus, bilateral amygdala and left hippocampus49. 
In support of this finding, Busatto et al.52 demonstrated that diminished rCBF in right 
lateral OFC in OCD subjects relative to controls disappeared after excluding patients with 
concomitant major depression. 
A final factor with regard to patient characteristics that may have skewed findings 
between patients and controls across resting-state studies is the inclusion of OCD groups 
differing on clinical subdimensions. These subdimensions are likely to be associated with 
distinct neurophysiological correlates50;61;62. However, most resting-state studies do not 
provide information on the composition of their patient samples in this respect, so that 
differences in patients’ symptom dimensions across studies may have accounted for 

































































































Next to patient inclusion factors, imaging methodologies differ across resting-state studies 
and thus may also explain divergent findings. Such differences are the reporting of absolute 
versus relative metabolic or rCBF rates, the use of ROIs versus voxel-by-voxel analysis, the 
various ways of outlining neuroanatomical structures, and the determination of sites, sizes 
and shapes of the applied ROIs. A clear example of how such factors may influence 
comparability of results between studies has been provided by Aylward and colleagues22. 
These authors investigated if previously reported differences between OCD and healthy 
subjects in caudate metabolism40;43;48;59 merely reflected the use of absolute versus relative 
metabolic rates. They concluded that differences between OCD and normal subjects 
disappeared after correcting caudate metabolic rates for differences in whole brain glucose 
uptake.  
 
Changes in activity after treatment 
Apart from cross-sectional designs, resting-state studies have been conducted longitudinally 
in OCD patients, i.e. at baseline and following treatment, either with antidepressant 
medication or cognitive behavioral therapy (CBT). These studies point towards a decrease 
in baseline-elevated metabolism or rCBF in the OFC55;60;63-67, ACC48;66;68, caudate 
nuclei51;53;54;60;63;65;67, putamen60;67 and thalamus60. These changes were found both after 
medication and CBT. Importantly, these neuronal differences at follow-up were 
significantly greater in responders compared with non-responders60;65;66 and/or were 
associated with decreases in OCD symptom severity48;53-55;63;64;68 or in general 
functioning51. However, discrepant findings with regard to post-treatment metabolic rates in 
OCD patients have also been reported, such as a further increase in pretreatment elevated 
right caudate metabolism after trazodone43, an increase in right putamen metabolism63 and a 
decrease in bilateral caudate glucose uptake55 both before and after clomipramine 
treatment.  
Despite these few discordant findings, the overall impression is that improvement 
of OCD symptoms is accompanied by a normalization of frontal-striatal circuit activity. 
Two methodological issues need to be pointed out, however. First, except for two 
studies53;60, in these longitudinal designs the control group was not rescanned, so that 
treatment effects were potentially confounded with time (order) effects. However, session 
to session variability for metabolic or rCBF alterations is likely to be small, as shown for 
HMPAO SPECT69 and FDG PET53 in healthy subjects. Second, in some of these 
longitudinal studies, the use of medication55;67 or the improvement in comorbid depression66 
cannot be excluded as a confounder for post-treatment brain activity alterations.  
 Finally, resting-state studies have been used to predict treatment response. Swedo 
et al.64 found that lower pre-treatment metabolism in right OFC and right ACC predicted 
better short-term outcome on clomipramine (2 months later), whereas lower left caudate 
activity predicted better long-term response outcome (over 1 year). Based on analyses from 
previously published data53;54, Brody and colleagues70 demonstrated that higher pre-
treatment activity in left OFC was associated with more improvement in the CBT group, 
yet less improvement in the fluoxetine-treated group. Similarly, Saxena et al.65 found 
bilateral lower OFC pretreatment metabolism to be a good predictor for paroxetine 
response. Thus, remarkably consistent findings show that decreased activity in OCD-




















treatment, whereas the opposite (i.e. increased activity at baseline) may be true for CBT. 
An exception is the study of Hoehn-Saric and colleagues66 in which higher pre-treatment 
rCBF in OFC, basal ganglia and cingulate areas was associated with better clinical outcome 
after medication. This discrepant finding may be attributed to the use of an OCD patient 
sample with comorbid depression. 
 
In summary, resting-state studies have indicated that OCD pathophysiology is mediated by 
hyperactivity in frontal-striatal circuits, involving the OFC, caudate nucleus, putamen and 
thalamus. Interestingly, a recent meta-analysis that weighed effect sizes for regional CBF 
and metabolism differences between OCD and control groups across resting-state 
functional studies, showed that significant hyperactivity in OCD was actually limited to the 
orbital gyrus and the head of the caudate nucleus71. Although the importance of such 
quantitative assessments of functional abnormalities in OCD cannot be underestimated, the 
very nature of such analyses restricts the inclusion to comparable paradigms, thereby 
leaving out a substantial number of valid yet incompatible studies. The functional 
abnormalities described in the current review appear to be state-related, as brain activity in 
these structures tends to normalize upon successful treatment with medication or CBT. The 
finding of elevated resting-state activity in various brain regions in OCD may have 
implications for other functional neuroimaging designs in this disorder, in particular 
symptom provocation or cognitive activation paradigms. In such designs, brain activity 
during a baseline condition is often subtracted from an experimental condition, and these 
differences are subsequently compared between OCD and control groups. However, if 
baseline activity differs between groups as indicated by resting-state studies, these 
interaction effects are more difficult to interpret.  
A related issue when considering these resting-state imaging data, is what 
constitutes the actual nature of ‘rest’ in OCD. It may be incorrect to regard this state as an 
asymptomatic one, since OCD is characterized by tonic rather than phasic symptomatology, 
as opposed to other anxiety disorders, e.g. panic disorder. If indeed ‘resting-state’ is not 
equivalent to ‘symptom-free’ in OCD, again this has implications for the interpretation of 
abnormalities found in other functional imaging paradigms (e.g. symptom provocation or 
cognitive activation), as determining the exact nature of ‘mind states’ in each of these 
paradigms is currently impossible.  
 
 
Symptom provocation studies 
 
Another strategy to differentiate between state and trait aspects of OCD is represented by 
symptom provocation designs. By alternating rest and symptom states within a session, the 
role of time (order) effects, as discussed in the previous paragraph, can be ruled out. 
However, studies using symptom provocation in OCD have yielded mixed results, as 
summarized in Table 2.3. Overall, the most consistent finding is provocation-induced 
increased activation of various frontal-striatal regions, such as the OFC61;72-79, ACC73;75, 
striatum72-74;78;79, and thalamus72;78;79. In contrast to the increased activation in ventral 
prefrontal regions, OCD patients showed decreased dorsal prefrontal activation during the 




















temporal lobe structures, such as the amygdala, also has been demonstrated during the 
provoked state72;74;75;80. Moreover, OCD patients with predominant contamination fear 
showed increased activation in the insular cortex, implicated in disgust perception61;74;77. 
Inconsistencies in results may again be explained by methodological issues, 
concerning technical aspects of imaging (e.g. imaging modality, ROIs versus whole brain 
data acquisition and analyses, correction for motion artifacts), patient selection (i.e. 
medication status, comorbidity, disorder sub-dimensions and sample size), and stimulus 
paradigms (i.e. randomized versus off-on design, tactile versus visual, and idiosyncratic 
versus standardized stimuli). Many provocation studies used tactile stimuli (‘dirty’ vs. 
‘clean’), which necessitated ritual behavior (i.e. hand washing), interrupting the scan 
sessions. Since in these studies subjects, once provoked, remained symptomatic for up to 
several hours, a balanced order paradigm (intended to control for order effects) was 
precluded73-76;81.  
 
In contrast to most OCD symptom provocation studies investigating contamination fear in 
‘washers’, Cottraux and colleagues82 included OCD patients with prominent checking 
rituals. OCD patients as well as controls showed increased orbitofrontal perfusion during 
the provoked compared with the neutral state. In addition, provocation-induced rCBF in the 
basal ganglia was higher in controls compared with OCD patients. Our own results, based 
on a comparison between eleven medication-free contamination-feared OCD patients and 
ten healthy control subjects, also showed decreased caudate activation in OCD patients 
compared with controls, during provocation of contamination fear80. Since most studies, 
which report increased provocation-induced caudate activation, lack a healthy control 
group72;73;79, it cannot be excluded that activation of the basal ganglia reflects normal 
processing of emotional information or ritualistic behavior, also present in healthy 
volunteers. Moreover, in OCD patients, the recruitment of the frontal-striatal circuit seems 
to be even sub-optimal compared with controls80;82. Therefore, it seems likely that the 
failure of the frontal-striatal circuit in OCD patients to control the processing of negative 
disease related stimuli results in an inadequate fear response.  
This fear response involves limbic activation, which was reflected by the 
activation of the amygdala in our study80. Whereas we found that left amygdala activation 
was stable over time during the provoked states, right amygdala showed a sensitization 
effect, positively correlated with scores of subjective distress and obsessionality. In contrast 
to our PET results, many provocation experiments in OCD have observed amygdala 
involvement only in small subgroups and/or at lower statistical thresholds74;75, or not at 
all61;73;77-79;82. This inconsistency may be explained partly by the use of ROIs excluding the 
amygdala79;82, limited statistical power of small sample off-on designs73;74, use of 
medication61;78, and differences in stimulus paradigm. Although the amygdala receives 
multimodal sensory information, projections from visual processing areas are particularly 
prominent83. Therefore, salient visual stimuli may give rise to amygdala activation more 
easily than tactile or auditory stimuli. The use of antidepressants is likely to suppress 
amygdala function84. Amygdala involvement in OCD during the symptomatic state is in 
agreement with studies using fear paradigms in normal controls85-90, supporting the role of 
the amygdala as a key structure in evaluating the behavioral significance of external stimuli 




















provocation in patients with posttraumatic stress disorder92 as well as during CCK 
challenge in healthy volunteers93, activation of limbic structures during symptom 
provocation in OCD may reflect an inadequate, but nonspecific, fear response. As 
mentioned before, this fear response seems to be secondary to a failure of the frontal-striatal 
circuit to control the processing of negative (e.g. contamination-related) stimuli. 
 
OCD is a clinically heterogeneous disorder. Factor-analytic studies have consistently 
identified at least 4 stable symptom dimensions: contamination/washing, 
aggressive/checking, hoarding, and symmetry/ordering94;95. As mentioned in the previous 
paragraph, different neuronal mechanisms may underlie the heterogeneous symptoms of the 
various OCD dimensions. In two symptom provocation studies, differentiation between 
OCD subcategories has been investigated61;78. Phillips and colleagues61 compared 
‘checkers’ and ‘washers’ using standardized visual stimuli. Similar to the results of 
Cottraux et al.82, ‘checkers’ as well as normal control subjects showed increased activation 
of the frontal-striatal regions during the provoked versus neutral state. In contrast, insular 
activity was observed in ‘washers’. A methodological drawback of this study, restricting 
the between-subtype comparison, is the fact that only washing-relevant, no checking-
relevant stimuli, were presented during the provocation.  
Recently, Mataix-Cols and colleagues78 also investigated the neuronal 
differentiation between OCD dimensions, using general aversive, washing-related, 
checking-related, hoarding-related, and neutral visual stimuli in a heterogeneous group of 
OCD patients. In contrast to Phillips et al.61 who allocated their patients to mutually 
exclusive subgroups, Mataix-Cols and colleagues compared different stimulus sub-types 
within one heterogeneous group of OCD patients. Whereas ventral regions of the frontal-
striatal circuits were activated during washing-related provocation, checking-related stimuli 
induced recruitment of dorsal regions of these circuits. Unfortunately, no symptom subtype 
by stimulus subtype interaction analysis was described. In future research, it would be 
interesting to combine the two strategies, thus comparing both patient symptom dimensions 
(e.g. using the Padua Inventory-Revised96) and stimulus sub-type within the same study 
design. 
 
Two studies have been performed to investigate the correlation between pre-treatment 
response during symptom provocation and the efficacy of treatment with selective serotonin 
reuptake inhibitors (SSRIs). Rauch and colleagues76 found in a small sample of 
contamination-feared OCD patients lower bilateral orbitofrontal and higher bilateral 
posterior cingulate activation to be predictive of a better response to fluvoxamine. Hendler 
et al.97, using SPECT, investigated a larger group of OCD patients with mixed symptoms. 
Before treatment, responders showed less provocation-induced activation in the dorsal ACC 
than non-responders, although these results might have been biased by differences in 
comorbid depressive symptoms. An additional post-hoc ROI analysis showed that 
prospective responders also had significantly more pre-treatment provocation-induced 
activation in the right caudate nucleus than non-responders. Following 6 months of 
sertraline treatment, symptom provocation led to increased activation in left anterior 
temporal cortex in responders, but not in non-responders. Whether the results reflect 



























































in pre-treatment symptom severity or comorbid depressive symptomatology awaits further 
investigation. In addition, since no placebo control group was included, it cannot be 
excluded that these neurophysiological changes reflect spontaneous improvement. 
Moreover, it would be interesting to know, if a therapeutic response to CBT may also be 
predicted by pre-treatment neuronal responses to symptom provocation. 
 
Taken together, symptom provocation studies have implicated a number of regions in the 
pathophysiology of OCD. The results so far have provided evidence that frontal-striatal 
involvement reflects ritualistic behavior, even in normal subjects, whereas increased medial 
temporal activity (including the amygdala) has been associated with (pathological) anxiety. 
Provocation-induced anxiety may be associated with non-specific rCBF changes due to 
increases in vigilance and/or arousal that obscure the functional circuitry changes specific 
to the disease. For this reason, symptom induction in a scanning environment needs to be 
refined by the use of standardized, symptom- and dimension-specific stimuli, controlling 
for general emotional effects by including a generally aversive control condition. Although 
some evidence exists that different neuronal correlates underlie different OCD symptom 
dimensions, more research is warranted to further address the issue of heterogeneity, 
including analyses of covariance with scores of dimensional symptom subscales. In 
addition, to better understand the temporal order of neuronal effects during symptom 
provocation, region-specific changes in time have to be investigated, for example by 
simultaneous fMRI/EEG registration. Moreover, longitudinal designs and pre-post 
treatment measurements may provide more insight in the trait-state question. Finally, to 
enable correction for differences in morphology and resting state metabolism, combined 
data acquisition within the same subjects is needed.  
 
 
Cognitive activation paradigms 
 
The use of cognitive probes during functional neuroimaging is a highly promising tool for 
the study of neuropsychiatric disorders. These paradigms are sensitive and specific for 
unraveling their neuronal correlates, in that they allow the induction of hypothesis-driven 
and disorder-associated functional brain states of interest. OCD is associated with a number 
of cognitive deficits, as indicated by neuropsychological studies. Although results are far 
from consistent, impairments appear to stand out in the field of executive functioning and 
(nonverbal) memory, especially in the context of the need to apply organizational strategies 
to effectively complete such tasks98;99. 
So far, cognitive paradigms during functional neuroimaging in OCD have been 
relatively sparse and have been used to investigate different, often unrelated cognitive 
domains (see Table 2.4). In one of the first of such designs, Rauch and colleagues100, using 
H2
15O PET, showed a lack of bilateral striatal activation during successful implicit learning 
in OCD patients, in contrast to healthy subjects. Instead, patients recruited 
(para)hippocampal regions that normally serve the processing of explicit learning and 
memory. This finding was replicated in a small (N=6) OCD sample during fMRI instead of 
PET scanning101. It was argued that (para)hippocampal brain areas are engaged during task 








































confirmed in a neuropsychological study that showed a failure of implicit learning in OCD 
when subjects had to simultaneously perform an explicit memory task102. However, the 
reported differential activations between OCD subjects and controls by Rauch et al.100;101 
were only partly replicated in a recent, similar experiment during fMRI scanning103.  
Employing a verbal fluency paradigm, Pujol and colleagues104 investigated left 
DLPFC function during fMRI. They noticed increased activation in this region for OCD 
subjects while performing the task, as well as elevated residual activation during a 
subsequent resting period. According to the authors, these functional alterations indicated 
enhanced responsiveness to cognitive challenge in the DLPFC, and diminished ability to 
suppress activation during rest in the same area. Differential activations in the DLPFC 
between OCD and healthy controls was also found in a recent study on planning capacity 
using the Tower of London task, conducted in our laboratory. In this experiment, we 
demonstrated that dorsal frontal-striatal circuitry was recruited to a lesser extent in OCD 
patients compared with controls105. Instead, patients activated the ACC, VLPFC, 
parahippocampal gyrus and dorsal brain stem. Results appear to reflect an inadequacy to 
appropriately engage the dorsal frontal-striatal circuit for planning in OCD, together with 
compensatory engagement of structures involved in maintenance of task rules in working 
memory (VLPFC), performance monitoring (ACC), intermediate-term memory capacity 
(parahippocampal gyrus) and arousal/effort (dorsal brain stem). The hypothesis of a 
compensatory increased effort in OCD patients compared with normal controls during task 
performance has received additional support from another recent cognitive activation study 
by our group 106. Using a classical Stroop task, we found that posterior regions (fusiform 
area, parahippocampal gyrus, insula, brain stem, precuneus and parietal cortex) were 
increasingly activated in patients during cognitive interference (i.e. incongruent vs. 
congruent color naming). Moreover, in an emotional variant of this task, processing of 
OCD related versus neutral words during color naming was associated with enhanced 
activation of VLPFC, dorsal ACC, putamen and amygdala in OCD compared with controls. 
In comparison with other anxiety patients suffering from hypochondriasis and panic 
disorder, OCD subjects were unique in two ways. First, they exhibited neuronal effects 
during emotional interference (i.e. emotional versus neutral words) only for OCD related 
words, whereas hypochondriasis and PD patients reacted on both OCD- and panic related 
words. Second, patients with OCD recruited a predominantly ventral neuronal system for 
processing this disease-specific emotional material, as opposed to the other patient groups 
that also used a dorsal system for processing emotional cues. As noted in the introduction, 
these two activation pathways, i.e. a ventral and dorsal one, have recently been 
distinguished in human emotion processing. The former corresponds to amygdala, insula 
and ventral regions of the striatum, ACC and OFC, whereas the latter is composed of the 
hippocampus and dorsal regions of the ACC and PFC13. 
In a spatial working memory paradigm using the n-back task, van der Wee et al.107 
found diminished performance at the highest task load level although activity in regions 
normally found in spatial working memory, i.e. bilateral DLPFC and parietal cortex, was 
similar to control subjects in OCD at all load levels. However, in OCD subjects, the ACC 
was engaged to a greater extent at all load levels. The authors concluded that spatial 
working memory capacity is normal in OCD, but performance is impaired at the highest 




















activity, not related to performance is in line with the results of Ursu et al.108, who used a 
response conflict (continuous performance) task in OCD and normal subjects during fMRI. 
They found increased ACC activity both during errors and during correct trials 
encompassing high-conflict situations. Previously, increased error-related ACC activity 
had been found as heightened and prolonged error-negativity responses during false trials in 
an ERP paradigm, using a variant of the Stroop task109. However, the results of van der 
Wee et al.107 and Ursu et al.108 extend these findings by showing that increased ACC 
activity is also present during correct responses, across task paradigms. This may reflect an 
enhanced and dysfunctional action monitoring in OCD subjects, regardless of actual task 
performance. It may represent the neuronal substrate of the subjective feelings of doubt 
despite correct task performance that are so characteristic of this disorder.    
 
In summary, the number of cognitive paradigms during functional neuroimaging in OCD 
up to this date is small. It can be expected, however, to increase rapidly over the next few 
years due to the opportunities these paradigms provide for elucidating the neuronal 
substrate of this disorder. The few experiments conducted so far have begun to shed light 
on various neurophysiological mechanisms involved in OCD. First, during cognitive 
challenge (both explicit and implicit), dorsal frontal-striatal responsiveness appears to be 
diminished in OCD, which is presumably compensated for by recruitment of posterior (e.g. 
medial temporal) brain regions. Second, OCD related emotional material may be processed 
primarily by ventral but not dorsal prefrontal pathways. This may indicate a lack of 
effortful regulation of affective states in OCD13. Third, increased and performance-
unrelated ACC activity appears to be present across cognitive paradigms, putatively 
corresponding to enhanced, inadequate action monitoring in OCD. Further research is 
needed to investigate the neuronal substrate of cognitive deficits in OCD and the 
interactions between emotional and cognitive processing systems in OCD, i.e. between the 
limbic and dorsal frontal-striatal systems. In the selection of cognitive tasks, it is important 
that specific abnormalities in OCD as identified in recent or ongoing neuropsychological 
research be respected. For the interpretation of results from such designs, it is important to 
take into account findings from related imaging paradigms; for instance, the increased 
resting-state activity in brain regions such as the striatum in OCD may be responsible for a 
failure to recruit these areas with cognitive probes, i.e. may cause a ‘ceiling effect’.  
 
 
MRS and ligand studies 
 
MRS enables direct and non-invasive measurements of brain chemistry in vivo, and 
therefore this tool is specifically useful for child- en adolescent psychiatric research and 
longitudinal follow-up by repeated measurements without the possible risks involved when 
using ionizing radiation. Most MRS studies in OCD have been performed by Rosenberg 
and coworkers, investigating early-onset OCD in children and adolescents 110-117. 
Compounds that can be measured by 1H MRS include myoinositol (mI), choline (Cho), 
(phospho)creatine (Cr), glutamatergic compounds (Glx), and N-acetyl-aspartate (NAA). 
Increased Cho signal reflects increased levels of choline-containing compounds, such as 




















excitatory neurotransmission118. NAA is a marker for neuronal viability119 and declines in 
neuronal tissue before neuronal loss is detectable by conventional MRI methods120.  
So far, MRS results concerning neurochemical changes in OCD have been 
inconsistent (see Table 2.5). An important methodological limitation of MRS is that data 
acquisition in most studies is limited to a single voxel or small volume in the striatum, 
thalamus or prefrontal cortex, restricting comparisons between studies. Decreased NAA 
signal in left25 and right striatum121 has been found in adult OCD, whereas striatal volumes 
were unchanged. This finding supports the idea that MRS enables early detection of 
decreasing cell density. In contrast to these studies, the results of Ohara and colleagues122, 
based on medicated OCD patients, suggested normal viability of the neuronal cells in the 
putamen and pallidum. The caudate nucleus, however, was not included in the analysis. 
Differences in medication status cannot explain this inconsistency since Rosenberg and 
colleagues also found normal thalamic113 and striatal NAA signal111 in their medication-
naive pediatric OCD patients. In addition, even increased NAA concentrations have been 
found in the DLPFC114 of children with OCD. Moreover, absolute measures of the 
compounds showed that the reported reductions in right and left medial thalamic 
NAA/(Cho+Cr) and NAA/Cho ratios in pediatric OCD actually reflected an increase in Cho 
levels110 rather than a decrease in NAA113. Therefore, the possible role of cholinergic 
dysfunction in the pathophysiology of OCD needs further elaboration. 
 Dysfunctional glutamatergic neurotransmission and altered serotonergic 
modulation of glutamatergic transmission at the level of the caudate nucleus may also be 
involved in the pathogenesis and maintenance of OCD symptoms28;123. Glutamate is the 
primary excitatory neurotransmitter in the frontal-striatal circuits and increased 
glutamatergic neurotransmission in specific regions of these circuits may contribute to 
obsessive-compulsive symptoms123. Glutamate receptor antagonists have been shown to 
reduce OCD-like behavior in mice124. Moreover, in a family-based association study, 
variants of the glutamate subunit receptor gene were associated with the susceptibility to 
develop OCD125. MRS results have provided additional evidence for a dysfunctional 
glutamatergic neurotransmission in OCD. Comparing 11 medication-naive pediatric OCD 
patients to 11 healthy control children, Rosenberg et al.111 reported increased left caudate 
Glx concentrations in OCD. After 12 weeks of paroxetine treatment, Glx levels had 
normalized. Interestingly, adequate cognitive behavioral therapy did not induce a reduction 
in striatal Glx116. The disease-specificity of glutamatergic dysfunction in OCD still has to 
be addressed, since altered Glx concentrations in the ACC were found in OCD as well as in 
MDD117.  
 
In contrast to MRS studies, PET and SPECT ligand designs require radiolabeled high-
affinity ligands to detect neurochemical differences between experimental groups. These 
techniques enable in vivo measurements of global and regional receptor density and affinity 
of the various interacting neurotransmitter systems. Although only a small number of ligand 
studies have been performed in OCD so far, future use of these techniques is promising. 
However, some important methodological issues have to be considered. First, the radiation 
risk limits its use in child and adolescent research, and in longitudinal follow-up designs. 
Second, since the spatial resolution of PET and SPECT is moderate at best, MRI co-




















differences between groups. Third, the functional mechanisms underlying decreased or 
increased ligand binding are not yet fully understood. Altered ligand binding can be 
explained by a number of factors, including 1) changes in endogenous neurotransmitter 
concentrations, 2) genetic modification of the receptor proteins, 3) morphological changes 
of specific brain regions and 4) altered receptor density due to up or down-regulation of the 
postsynaptic receptors. Moreover, changes in one neurotransmitter might be secondary to 
primary changes in another neurotransmitter system. 
So far, ligand studies in OCD have mainly focused on 5-HT and DA. A possible 
role of dysfunctional brain serotonergic and dopaminergic neurotransmitter systems in the 
pathophysiology of OCD has been suggested a long time ago. The hypothesis that OCD 
involves a disturbance in 5-HT transmission was initially based on the clinical observation 
that the tricyclic antidepressant clomipramine is an effective psychopharmacological agent 
in OCD126-128. Since other tricyclic antidepressants are ineffective in OCD, it has been 
concluded that the efficacy of clomipramine is due to its potent serotonin reuptake 
inhibiting properties, similar to SSRIs. However, a substantial fraction of patients with 
OCD show no significant improvement in response to SSRIs alone, suggesting that an 
isolated disturbance in 5-HT function cannot fully account for the pathophysiology of 
OCD129. Clinical studies showed that the combination of a SSRI with an antipsychotic drug, 
antagonizing the DA receptor, is successful in a considerable amount of these SSRI-
refractory cases130;131.  
 Concerning the role of the monoaminergic systems in OCD, recent ligand SPECT 
and PET studies have given additional support for the hypothesis that both DA and 5-HT 
are involved in the modulation of obsessive-compulsive symptoms. Iodine-labeled [123I]-
2β-carbomethoxy-3β-(4-iodophenyl)tropane ([123I] β-CIT) is a SPECT radiotracer with high 
affinity to monoamine transporters132 and thus can be used to visualize the human central 
dopamine (DAT) and serotonin transporters (SERT) in vivo133. Although β-CIT lacks 
specificity within the monoamine transporter family, distinct brain regions were found to be 
related to DA and 5-HT binding: whereas striatal β-CIT uptake mainly reflects binding to 
DAT, in the other regions comprising the hypothalamus, thalamus, midbrain and pons, β-
CIT uptake has been predominantly associated with SERT availability134. Alternative 
radiotracers used to visualize DAT and SERT are the SPECT-ligand iodine-labeled N-(3-
iodopropen-2-yl)-2β-carbomethoxy-3β-(4-chlorophenyl)tropane ([123I] IPT) and the PET-
ligand C-11 labeled trans-1,2,3,5,6,10 β-hexahydro-6-[4-9methylthio)phenyl]pyrrolo-[2,1-
a]-isoquinoline ([11C] McN 5652), respectively.  
So far, ligand studies focusing on SERT and DAT in OCD have produced 
conflicting results (see Table 2.5), probably due to methodological issues concerning 
differences in age, gender, medication history, comorbidity and/or genetic predisposition. 
Moreover, the sample sizes of these studies were limited. Pogarell et al.135, using [123I] β-
CIT SPECT, found increased β-CIT binding in the midbrain and pons of medication-naive 
OCD patients, reflecting increased SERT availability. Midbrain β-CIT binding was highest 
in patients with childhood or adolescence onset of symptomatology, suggesting a more 
pronounced serotonergic dysfunction in early compared with late-onset OCD. In contrast to 
Pogarell et al.135, other studies reported unchanged136 or reduced137 SERT availability, using 
[11C] McN5652 PET and [123I] β-CIT SPECT, respectively. Since SSRI treatment may lead 



























































that most OCD patients in the study of Pogarell et al. were medication-naive, in contrast to 
the patients in other studies.  
Very recently, Denys and colleagues138 performed a radiolabeled iodobenzamide 
([123I] IBZM) SPECT study, investigating D2 receptor binding in 10 OCD patients and 10 
healthy control subjects. Decreased D2 receptor binding in the left caudate nucleus and a 
reduced left compared with right caudate volume was found in OCD. Decreased [123I] 
IBZM binding might be explained by several underlying mechanisms. First, structural 
changes of striatal cells due to developmental abnormalities or degeneration processes 
might be present. Since left caudate volume was smaller in OCD patients compared with 
control subjects, this explanation cannot be ruled out. Second, reduced dopamine D2 
densities in OCD could also be the result of genetic variability, although this seems a less 
likely explanation for the observed hemispheric asymmetry. The authors suggested that the 
decreased [123I] IBZM binding reflects postsynaptic dopamine D2 receptor down-regulation 
by competition with high concentrations of endogenous dopamine. This third explanation is 
in agreement with the hypothesis of an imbalance between the direct and indirect pathways 
of the frontal-striatal circuits in OCD, due to increased inhibition of the indirect pathway by 
dopamine D2
139. Increased secretion and higher synaptic concentrations of endogenous 
dopamine may result from decreased inhibition of dopamine due to serotonergic 
dysfunction. The presence of increased endogenous dopamine concentrations in the 
striatum is supported by the [123I] IPT SPECT results of Kim et al.140, who found an 
increased DAT binding in the right basal ganglia and a tendency toward an increased DAT 
binding in the left basal ganglia. In contrast, Pogarell et al.135 reported normal striatal ß-CIT 
binding in a smaller sample of mostly medication-naive OCD patients.  
Future ligand studies in OCD should attempt to distinguish between changes in 
endogenous ligand concentrations and altered receptor density and/or affinity, for example 
by using double infusion protocols with high and low specific activity radiotracers. In 
addition, dopaminergic reactivity in OCD could be investigated with the aid of 
amphetamine pretreatment, similar to studies in schizophrenia141.    
 
In conclusion, results from MRS and ligand studies have revealed some evidence for 
changes in various interacting neurotransmitter systems in OCD, including serotonin, 
dopamine, glutamate and acetylcholine. The exact mechanism of the neurochemical 
imbalance and the interactions between different neurotransmitters needs further 
elaboration. The use of MRS in the follow-up of early-onset OCD patients to investigate 
glutamatergic and cholinergic changes, in combination with ligand serotonin and dopamine 
measurements in their later life, is likely to contribute to a better understanding of 
dysfunctions at a neurochemical level in OCD. 
 
 
Summary and conclusions 
 
In the present paper, we intended to critically review the neuroimaging literature in OCD. 
The most consistent finding emanating from various imaging modalities and paradigms is 
the role of frontal-striatal and limbic circuits in the pathogenesis and maintenance of the 




















remains uncertain. The term ‘frontal-striatal’ appears to be too broad to capture the subtle 
alterations of brain functioning in OCD during the various emotional and/or cognitive 
paradigms investigated thus far. In addition, although OCD is classified in the DSM-IV as 
an anxiety disorder, the role of limbic regions such as the amygdala in the pathophysiology 
of OCD has received little attention in the neuroimaging literature. Moreover, the 
interactions between frontal-striatal and anterior medial temporal regions are still poorly 
understood.  
A second general finding emerging from the data is the functional differentiation, 
which appears to be present between ventral and dorsal frontal-striatal regions. Resting 
state in OCD patients is associated with increased activity of the ventral parts of frontal-
striatal circuitry - probably reflecting ongoing emotional and cognitive processing due to 
tonic symptomatology.  During symptom provocation, activation of limbic structures 
(mainly the amygdala) and additional recruitment of ventral frontal-striatal regions may 
reflect the processing of salient information together with emotional responding. 
Furthermore, exaggerated responses (anxiety and/or distress) may, at least in part, be the 
result of insufficient suppression or top-down control by the dorsal frontal-striatal circuit. 
These neuroimaging results can now be related to the model of Phillips et al.13. As 
discussed in the introduction section, this model distinguishes three levels of emotion 
perception, relying on different parts of ventral and dorsal (prefrontal and temporal) 
regions: 1) the identification of the emotional significance of an external stimulus, 2) the 
generation of an affective state in response to the stimulus, and 3) the regulation of the 
affective state. At present it is insufficiently clear which processing subsystem is 
dysfunctional, or how abnormalities at these distinct levels interact in OCD; do these 
patients attribute exaggerated affective significance to disease related stimuli in the 
environment (level 1) or do they identify these cues appropriately, but subsequently 
develop a disproportional fear response due to a hypersensitive limbic system (level 2)? Or, 
alternatively, do these patients lack an adequate modulation of this initial fear response as a 
result of a dorsal dysfunction (level 3)? These questions will need to be addressed in future 
neurobiological research in OCD. Dysfunction of dorsal frontal-striatal circuitry might be 
secondary to abnormal maturation of gray and white matter during early childhood. 
Moreover, glutamatergic, serotonergic and/or dopaminergic dysfunction, resulting in an 
altered balance between these various neurotransmitter systems, are likely to interact with 
cerebral maturation processes. Therefore, more insight in normal brain maturation and its 
role in the characteristic, temporary compulsive-like behaviors in normal young children 
might contribute to OCD research 142. Investigation of normal development might also 
provide an answer to the question whether OCD symptomatology primarily results from a 
cortical abnormality or primarily emanates from a subcortical dysfunction. The decreased 
responsiveness of the dorsal frontal-striatal circuit not only modulates emotional 
processing, but also has implications for cognitive, mainly executive, functioning. OCD 
patients show impaired performance on executive tasks, correlated with decreased dorsal 
frontal-striatal responsiveness and increased activation of posterior cortical and subcortical 
regions reflecting both compensatory mechanisms (e.g. effort) and heightened arousal. 
Cognitive function in OCD patients is also characterized by enhanced performance 




















Although the OFC and VLPFC have been implicated in decision making143, so far no 
imaging studies using such a paradigm (e.g. a gambling task) have been performed in OCD. 
Moreover, fMRI paradigms might be useful to further investigate emotion-cognition 
interactions. 
 
So far, almost all neuroimaging results in OCD have been based on comparisons between 
OCD patients and healthy control subjects. Concerning the issue of disorder-specificity, 
two questions arise: 1) is a neurophysiological differentiation possible between OCD 
subcategories, and 2) are the frontal-striatal and limbic activation patterns observed in 
functional imaging studies specific for OCD or is there an overlap with other anxiety 
disorders, mood disorders or even psychotic disorders? To answer these questions, two 
opposite approaches are needed: ‘splitting’, i.e. contrasting subcategories within OCD, and 
‘lumping‘, or grouping together of OCD patients with patients suffering from other 
neuropsychiatric disorders, by changing the focus to functional dimensions instead of 
DSM-categories.  
 
Over the last two decades, imaging techniques have proven to be very useful in elucidating 
underlying neurophysiological and neurochemical mechanisms in a number of psychiatric 
disorders, including OCD, and the ongoing progress in technology makes these techniques 
even more promising in the near future. However, several issues related to important 
general methodological aspects in functional imaging, have to be considered. Probably the 
most urgent questions in this respect that still need to be addressed are: in which state is the 
patient at the moment of data acquisition and to what extent do researchers succeed in 
inducing and maintaining the intended emotional and/or cognitive state in subjects within 
an experimental setting? Functional MRI is blind to baseline differences, which may 
confound group-by-task comparisons, although a few studies have attempted to control for 
this problem by the use of parametric designs. In general, it is questionable whether 
customary subtraction designs really succeed in isolating only the neuropsychological 
function of interest, even with a carefully matched baseline condition (e.g. for stimulus 
complexity and motor demands). Moreover, assessment of task related effects in patient 
groups, as well as group-by-task interaction effects, may be problematic due to aspecific 
factors, such as increased arousal or distress. Next to these issues that are to be resolved, 
future designs will need to optimize methodological aspects such as sufficiently large 
sample sizes, adequate matching between patients and controls (for age, gender, education 
level, among others), and homogeneous patient groups with regard to medication history, 
illness duration and severity, and comorbid diagnoses.  
Even in the ideal situation of no methodological drawbacks, the interpretation of 
data still remains a challenge as well. We need to reconsider the functional significance of 
hypoperfusion or hyperactivation in a specific brain region and what it tells us about the 
underlying neuronal response. Altered state-related oxygenation levels might be secondary 
to structural and/or neurochemical abnormalities and the specificity of the findings for 
OCD is yet to be assessed. There is an obvious need for designs adopting an integrated 
approach, for example by comparing multiple tasks within the same subject sample and 
using multimodal imaging. Also, most imaging studies in OCD published to date have been 




















biochemical (PET or MRS) imaging techniques in sufficiently large, homogeneous cohorts 
are likely to hold the greatest promise for unraveling the pathogenesis of psychiatric 
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The neuroanatomical correlates of panic disorder (PD) can be investigated with the aid of 
several complementary neuroimaging study designs. These include structural studies 
detecting morphological abnormalities, resting state measurements of cerebral blood flow 
and metabolism, provocation designs using pharmacological challenge agents, functional 
imaging designs during the performance of cognitive and/or emotional tasks, and ligand 
studies measuring receptor distribution and affinity. Results of most of these studies 
support the involvement of structures in the temporal lobe, specifically the amygdala, the 
hippocampus and the parahippocampal gyrus, and several subregions of the prefrontal 
cortex in panic disorder symptomatology. In addition, a number of different 
neurotransmitter systems have been implicated in the hypersensitivity of the fear network. 
Although the spontaneous panic attack is the most prominent characteristic of the disorder, 
results of imaging studies seem to reflect mainly other manifestations in these patients, such 
as anticipatory and generalized anxiety, avoidance behavior and conditioned fear responses. 
Theoretical models in PD are based on the assumption that each component of the disorder 
is linked to a distinct neuroanatomical system in the brain. Since a clear description of the 
emotional state at the time of data acquisition is lacking in most studies, proper 
neuroanatomical differentiation between panic attacks, anticipatory anxiety and other 
related symptoms in PD is not yet possible. In addition, various anxious states, including 
panic attacks, are not specific for panic disorder, but rather characterize anxiety disorders in 
general as well as ‘physiologic’ anxiety and fear responses. This necessitates between-
diagnosis comparisons. Moreover, to investigate whether the observed neuroanatomical and 
neurophysiological abnormalities predispose to panic disorder, or are secondary to chronic 
symptomatology or medication, longitudinal follow-up measurements should be performed. 
Considering the fast development and innovation of imaging technology, increasing the 
























Panic disorder (PD) is characterized by recurrent, spontaneous panic attacks, i.e. acute 
episodes of intense fear, accompanied by physical as well as cognitive symptoms. Several 
theoretical models have been proposed to explain the pathophysiology of PD. In this 
context, a wide range of disparate issues have been addressed, including dysfunctional 
serotonergic and/or noradrenergic systems1-5, aberrant responsivity to CO2 at the level of the 
brainstem6, hyperresponsivity of the amygdala and associated limbic structures7;8, and 
abnormal functioning of the GABA-benzodiazepine receptor complex9 or cholecystokinin-
B (CCKB) receptor
10. However, the extensive literature addressing the neuroanatomical 
structures and neurotransmitter systems assumed to be implicated in PD, and the 
inconsistencies between findings, show the complexity of the topic. 
An alternative approach to investigate the pathophysiology of PD is 
neuroanatomical differentiation between symptom dimensions11;12. Gorman and 
colleagues11 brought together biological-pharmacological and cognitive-behavioral findings 
in PD and linked the three main components of the illness, anticipatory anxiety, panic 
attacks and phobic avoidance, to three distinct neuroanatomical systems in the brain: the 
brainstem, the limbic circuit and the prefrontal cortex, respectively. In a revised version of 
their hypothesis7, the amygdala was introduced on the basis of its role in conditioned fear13 
and the suggested overlap between conditioned fear and PD. Daekin and Graeff1;5, in 
contrast, suggested PD to be mainly associated with unconditioned fear. Their theory was 
based on the dual role of serotonin (5-HT), a neurotransmitter which, on the one hand, 
facilitates conditioned fear responses via activation of limbic structures, such as the 
temporal cortex, amygdala and hippocampus and, on the other hand, inhibits unconditioned 
fear responses via brainstem structures, specifically the dorsal periaqueductal grey (PAG). 
They suggested that conditioned fear relates to generalized and anticipatory anxiety, while 
unconditioned fear is akin to panic. Tests in healthy volunteers supported this dual role of 
5-HT: administration of the 5-HT agonist fenfluramine attenuated (in a dose-dependent 
way) anxiety, induced by a simulated public speaking test (reflecting decreased 
unconditioned fear), whereas fenfluramine did not significantly change the amplitude of 
skin conductance during the conditioned fear test14. Considering that PD involves not only 
spontaneous panic attacks, but also anticipatory anxiety, avoidant behavior and even 
situation-based panic attacks, conciliation between the models of Gorman et al.7;11 and 
Daekin and Graeff1;5 is possible. Both theories assume neuroanatomical differentiation 
between different aspects of anxiety, irrespective of the diagnosis.  
 
The development and sophistication of various structural and functional neuroimaging 
techniques have provided the opportunity for a further exploration of the neuroanatomical 
correlates of PD symptomatology, and future research using these techniques is promising. 
Thus, up till now several different imaging modalities and experimental paradigms have 
been employed in an effort to delineate the pathophysiology of PD and associated anxiety 
states. A brief overview of these structural and functional neuroimaging modalities will be 
provided in order to stipulate their possibilities and limitations.  
Magnetic resonance imaging (MRI) can be used to detect morphological (or 




















structures of interest, enabling calculation of volumes or detection of focal abnormalities in 
feature or density. Computerized tomography (CT) represents another structural imaging 
technique, providing less contrast between tissue classes than MRI, however. Both 
structural imaging techniques enable visualization of morphological abnormalities 
independent of the actual state.  
Functional imaging studies, in contrast, measuring blood flow or glucose 
metabolism, are dependent on state or trait anxiety levels at the time of tracer distribution or 
image acquisition. Positron emission tomography (PET), single photon emission computer 
tomography (SPECT) and functional MRI have been used to investigate resting state 
characteristics as well as provoked anxious conditions. In addition, cognitive paradigms 
enable specific activation of brain systems of interest. In contrast to the considerable 
temporal and spatial limitations of PET and SPECT techniques, functional MRI, measuring 
regional blood oxygenation level dependent (BOLD) signal changes, is suitable to 
investigate flow changes during experimental conditions in relatively smaller regions. 
However, the most frequently used 1.5 Tesla MRI scanners also cannot distinguish 
anatomical regions smaller than 10-15 mm, such as individual brainstem nuclei. Since 
functional MRI is a non-invasive tool and does not require radiolabeled tracers, it enables 
multiple measurements.  
One other domain in neuroimaging research focuses on neurochemical 
characteristics. Using radiolabeled high-affinity ligands, PET and SPECT methods enable 
in vivo measurements of global and regional receptor density and affinity. An alternative 
approach includes magnetic resonance spectroscopy (MRS), measuring changes in regional 
relative concentrations of specific compounds, such as neurotransmitters or their 
metabolites. Similar to functional imaging studies that measure changes in perfusion and 
metabolism, these ligand and MRS studies are influenced by state variables. 
  
On the basis of this brief overview, we may conclude that two major streams in 
neuroimaging research exist: one focusing on structural and functional abnormalities of 
specific neuroanatomical structures and functional brain circuits during different cognitive 
and/or emotional states, and another focusing on distinct and interacting neurotransmitter 
systems. What can they tell us in PD research? Results of resting state studies are supposed 
to reflect baseline differences between PD patients and healthy controls, consisting of 
anticipatory anxiety or phobic avoidance, reflected by altered activation patterns of 
temporal cortex and limbic structures. Challenge studies, in contrast, if these succeed in 
capturing the actual panic attack, are expected to visualize changes at the level of brainstem 
structures, thalamus and basal ganglia. Cognitive paradigms, with or without emotional 
manipulation, may further contribute to our understanding of specific brain regions 
involved in PD. Interestingly, ligand and MRS studies, as well as some challenge designs 
investigate altered neurotransmitter functioning and the interactions between different 
neurotransmitter systems. Neither the structural and functional approach of 
neuroanatomical circuitries nor the neurochemical approach can provide full insight in the 
pathophysiology of PD. Instead, integration of both approaches is needed. 
 In the present chapter, we critically discuss the results of various neuroimaging 
studies, keeping in mind their possibilities and limitations in probing the neuroanatomical 




















neuroimaging literature on PD according to the technique or paradigm used. First, we 
summarize the results of structural and resting state studies. Then, we describe studies using 
challenge agents, focusing on both neuroanatomical as well as neurochemical 
characteristics of PD. Next, abnormalities in neurotransmitter functioning, as addressed by 
ligand and MRS studies, are discussed. Since adrenergic ligand studies are lacking and 
there is only one serotonergic ligand study in PD, most results concern the benzodiazepine 
receptor complex and the associated gamma-aminobutyric (GABA)-ergic system. Finally, 
the results of some recent fMRI studies will be discussed. Although many fMRI paradigms 
contain a psychological challenge, we discuss these studies separately from those studies 
using pharmacological challenge. 
 
 
Structural imaging studies 
 
As mentioned before, structural abnormalities are assumed not to be dependent on the 
actual psychological or neurophysiological state of the subjects at the time of image 
acquisition, but rather seem to reflect static or slow-developing processes. Structural 
changes may be the result of vascular or neurochemical changes due to long-term 
symptomatology or chronic use of psychotropic medication. Alternatively, these 
morphological abnormalities may be due to genetically based, early developmental 
disturbances that predispose to PD. Since prospective follow-up studies are lacking, no 
conclusions can be drawn so far concerning the time of onset and mechanisms underlying 
the structural changes in PD.  
 
Findings of structural imaging studies in PD are summarized in Table 3.1. Early MRI 
studies investigating neuroanatomical changes in lactate-sensitive PD patients reported 
increased focal abnormalities in the medial temporal cortices, mainly involving the right 
hemisphere15;16. These changes were correlated with illness duration and total number of 
lifetime panic attacks. Moreover, a trend was found between the incidence of structural 
abnormalities and the age of onset of the illness, suggesting a prognostic value15. A 
considerable methodological drawback of these studies was the inclusion of PD patients 
using benzodiazepines before and during the measurements. 
 Using qualitative CT and electroencephalography (EEG), Lepola et al.17 
investigated 45 unmedicated PD patients and found non-specific abnormalities with both 
techniques in some patients, while the vast majority exhibited normal EEG and CT 
findings. Since no control group was included, results are difficult to interpret. In contrast, 
another study combining EEG with structural imaging, found EEG-screening, similar to the 
lactate-provocation test, useful in identifying PD patients with a high probability of MRI 
brain abnormalities18. PD patients with non-epileptic EEG abnormalities compared with PD 
patients without EEG abnormalities and healthy control subjects showed increased 
morphologic brain abnormalities. These abnormalities mainly concerned the septo-
hippocampal region.  
 Later studies, using quantitative volumetric MRI methods, confirmed the 
involvement of temporal regions in panic disorder, as suggested by the results of these early 




















showed decreased volumes of left and right temporal lobes in PD patients compared with 
healthy control subjects. Also a trend to whole brain volume reduction was found, but this 
finding may be partly gender biased. Another methodological drawback of this study was 
the presence of comorbid psychiatric disorders. Contrary to their expectations, no 
significant difference in hippocampal volume was found between patients and controls.  
Inconsistent with the results of Vythilingam et al.19, later quantitative structural 
MRI studies have found volumetric changes of specific subregions of the temporal lobes, 
such as the amygdala20;21, hippocampus20 and parahippocampal gyrus22. Amygdaloid 
involvement in PD has been supported by preclinical evidence for its role in conditioned 
fear and the evaluation of emotionally relevant information13. Although one would expect 
the amygdala to be larger23;24, not smaller, decreased bilateral amygdaloid volumes were 
found in PD compared with controls20;21. It has been suggested that the structural regional 
atrophy within the amygdala might be accompanied by functional increased sensitivity or 
hyperexcitability. Whether volume reduction of the amygdala predisposes to PD or rather 
reflects a neurodegenerative process secondary to the disorder is unclear. However, no 
significant correlation was found between volumetric changes of the amygdala on the one 
hand, and duration of the symptoms, number of panic attacks and demographic variables on 
the other hand. Although these correlational results, which have not yet been replicated, are 
inconsistent with those concerning temporal lobe measurements15;16, they suggest a primary 
rather than a secondary process21.  
Uchida et al.20 reported a trend for decreased mean volume of the left 
hippocampus in PD compared with healthy controls. They found a positive correlation 
between left hippocampal volume and illness duration, with recent cases showing smaller 
hippocampal regions than prolonged cases20. Left-to-right asymmetry of hippocampal 
absolute mean volumes (left < right) was found both in PD patients and in healthy control 
subjects21. However, when comparing normalized mean volumes, the hippocampal 
asymmetry remained in PD patients, but only reached near-significance in healthy controls. 
Voxel-based morphometry (VBM) analysis in PD revealed grey matter deficits in left 
parahippocampal gyrus22. This structural hippocampal and parahippocampal asymmetry is 
consistent with asymmetric left-to-right functional differences in these regions as found in 
resting state FDG- and H2
15O PET studies25-28. Massana et al.22 suggested that the metabolic 
asymmetry in the (para)hippocampal region, attributed to increased right-sided metabolism, 
might reflect compensation for left-sided structural deficits in this region. Since a reduced 
left-sided hippocampal volume was also found in patients with posttraumatic stress disorder 
related to childhood physical and sexual abuse29, this abnormality seems not to be restricted 
to PD but may constitute a general characteristic of anxiety disorders. 
  
Considering the results of studies addressing structural differences in PD patients compared 
with control subjects, abnormalities and volume reductions mainly concern the temporal 
cortex or specific structures in the temporal lobe, such as hippocampus, parahippocampal 
gyrus and amygdala. Correlational analyses with clinical characteristics were found to be 
inconclusive. Inconsistencies in results may be explained by methodological issues: the use 
of non- or semi-quantitative MRI techniques15;16;18, non-uniformity in the definition of 
regions of interest (ROI), gender bias19, limited sample sizes20;21, the presence of comorbid 








































abnormalities in temporal structures are consistent with the results of metabolic changes in 
this region as reported by resting state functional imaging studies. Since no prospective 
longitudinal measurements have been performed, it is unclear whether structural changes 
predispose to the development of panic disorder or rather occur secondary to panic 
symptomatology or chronic use of psychotropic medication. Moreover, future research will 
need to investigate disorder-specificity of the findings, by comparing PD patients to 
subjects with other anxiety disorders. 
 
 
Resting state imaging 
 
Resting state studies assume PD patients to be at a baseline state at the time of data 
acquisition. Although study paradigms indeed try to create an atmosphere of ‘rest’ or 
neutral state (e.g. by a continuous performance task), the possibility exists that the scanning 
procedure has more emotional impact on PD patients than on healthy volunteers, inducing 
considerable anxiety or distress. Nazemi and Dager30 investigated the psychological 
reactions and coping strategies, used in response to confinement in a MRI scanner, in 13 
PD patients and 11 control subjects. Whereas the coping strategies of PD patients and 
healthy volunteers to general stress were dissimilar, they tended to converge in response to 
the stress induced by the experimental procedure. Prolonged MRI confinement resulted in a 
significant reduction in the fear of restriction, but not in the fear of suffocation.  
 
The results of studies revealing baseline changes in PD are shown in Table 3.2. Using 
radiolabeled water (H2
15O) PET, Reiman et al.25;26 demonstrated abnormally low ratios of 
left-to-right parahippocampal blood flow and increased whole brain metabolism in PD 
patients who were vulnerable to lactate-induced panic attacks, compared with PD patients 
with a negative response on lactate challenge and healthy controls. They suggested, 
although could not prove yet, that the described asymmetry reflected increased right-sided 
metabolism. Although PET emission scans were acquired during resting state, preceding 
lactate-induced anxiety states may have influenced the results. For instance, Drevets et al.31 
showed that part of the results could be explained by vascular or muscular changes due to 
teeth clenching. In addition, vasoconstrictive effects of hyperventilation-induced 
hypocapnia following lactate-provocation may complicate the interpretation of the cerebral 
blood flow changes7. Another methodological drawback was the use of psychotropic 
medication during the experiment in some PD patients.  
In subsequent studies, Nordahl and colleagues27;28 examined cerebral glucose 
metabolism using 18F-fluorodeoxyglucose (18FDG) PET in unmedicated PD patients, 
irrespective of lactate-sensitiveness, during an auditory discrimination task. Although their 
results did not confirm whole brain hypermetabolism as reported by Reiman et al.26, 
metabolic asymmetry in the (para)hippocampal region was replicated. This left-to-right 
asymmetry remained after imipramine treatment28. In addition, PD patients showed 
decreased metabolism in left inferior parietal and anterior cingulate cortices and increased 
metabolism in the medial orbitofrontal cortex compared with healthy controls27. Post-
treatment metabolic measurements showed a decrease in the posterior orbitofrontal cortex 








































Bisaga et al.32 in six female lactate-sensitive medication-free PD patients and 6 female 
healthy control subjects. Instead of a decreased left-to-right ratio, they reported increased 
left-sided hippocampal and parahippocampal metabolic rates in the PD patients compared 
with the normal subjects. In addition, relatively decreased metabolic flow was reported for 
right inferior parietal and superior temporal cortices. No correlations were found between 
clinical variables and the PET findings. 
An alternative technique to measure metabolic changes is Tc99m-
hexamethylpropyleneamine oxime (Tc99mHMPAO) SPECT. Comparing 7 lactate-sensitive 
drug-naive PD patients with 5 normal subjects, De Cristofaro et al.33 found significant left-
to-right asymmetry in the inferior prefrontal cortices, considered to be due to increased 
right-sided cerebral blood flow. In contrast to repeatedly reported right-sided 
hypermetabolism in the (para)hippocampal regions, hypoperfusion was found bilaterally in 
the hippocampal regions of these PD patients. Recently, Eren et al.34 used the same 
technique, although without lactate provocation prior to SPECT measurement. They found 
a significant decrease in perfusion bilaterally in the inferior frontal cortex. Correlation 
analyses with disease severity scores did not reach significance after correction for multiple 
comparisons. In contrast to other studies, Lucey et al.35;36 did not find any difference 
between PD patients and controls, but instead reported reduced metabolism in the caudate 
nucleus and the prefrontal cortex in OCD and PTSD patients compared with controls and 
PD patients. 
  
Summarizing, the main findings of resting state measurements in PD show involvement of 
(para)hippocampal and prefrontal regions, presumably reflecting chronic anticipatory 
anxiety and cognitive modulation processes. Inconsistencies exist concerning lateralization 
and direction of effect, e.g. decreased or increased cerebral flow and metabolism compared 
with controls. Resting state differences may be confounded by underlying structural 
changes, prolonged effects of pre-test lactate challenge, vascular and muscular artifacts, as 





Several methodological and physiological issues have to be considered when imaging the 
neurophysiological correlates of panic attacks. Since natural panic attacks occur at random 
intervals, challenge agents are necessary to induce and capture an attack. Many of these 
panicogenic agents have been used, such as sodium lactate37, CO2
38;39, the cholecystokinin 
B (CCK-B) receptor agonist cholecystokinin tetrapeptide (CCK4) and its synthetic analogue 
pentagastrin40;41, the noradrenergic alpha2-antagonist yohimbine42;43 and the 5-HT-agonist 
fenfluramine44. Challenge agents should meet several criteria45. First, the agent should 
mimic closely naturally occurring anxiety, rather than induce a ‘cold’ or ‘as-if’ anxious 
emotion. This implies both physical and psychological, and peripheral as well as central 
characteristics of anxiety. Second, it should be replicable in order to be a useful research 
tool. Third, the induced symptoms should be short-lived or readily reversible. Finally, the 
agent should be able to reflect both trait and state responses, i.e. differentiate between 




















responses to treatment, respectively.  
Since panic attacks, occurring naturally as well as agent-induced, are brief, 
radiotracers with a temporal resolution compatible with this short time frame, such as 
H2
15O, are used. However, the H2
15O PET technique visualizes changes in regional CBF, 
not metabolism. Although it is assumed that increased neuronal activity in a given region is 
accompanied by increased blood flow in that region, the possibility exists that the 
uncoupling of CBF and metabolism may occur under circumstances of heightened stress, 
such as a panic attack7.  
Another issue of consideration are the hemodynamic consequences of 
hyperventilation during the panic attacks. Hyperventilation-induced hypocapnia causes 
vasoconstriction. Subsequent diminished CBF then counteracts the expected increases in 
perfusion, as found in the study of Stewart et al.46. To correct for the vasoconstrictive 
effects of hyperventilation, pCO2-adjusted CBF values can be used
47. However, even after 
correction for differences in pCO2, PD patients were found to be more sensitive to the 
vasoconstrictive effects of hyperventilation than comparison subjects48. The implied 
hypersensitivity was confirmed by the results of Dager et al.49, using magnetic resonance 
spectroscopy (MRS) to measure brain-lactate levels during voluntary hyperventilation. 
Despite a comparable stable level of pCO2, PD patients exhibited significantly greater rises 
in brain lactate than comparison subjects. Additional mechanisms have been suggested to 
underlie this hypersensitivity in PD, such as fear-associated stimulation of the locus 
coeruleus causing noradrenergic-mediated vasoconstriction4 or of the parabrachial nucleus 
leading to global cerebral vasoconstriction50. 
 Based on theoretical models of neuroanatomical differentiation between 
anticipatory anxiety and panic attacks, results of challenge studies, in case they succeed in 
inducing a panic attack at the time of data acquisition, are presumed to reflect the 
neuroanatomical correlates of the attack. Since the brainstem and ventral hypothalamus are 
assumed to play a crucial role in panic, it is important to realize that small brainstem nuclei, 
such as locus coeruleus, PAG and raphe nuclei, and hypothalamic nuclei cannot be 
distinguished using current imaging techniques. Table 3.3 summarizes the results of 
different challenge paradigms performed in PD. 
 
CO2-challenge 
During an explorative study addressing the role of hyperventilation in panic, the 
panicogenic effect of 20 minutes continuous inhalation of a 5%/95% CO2/O2 mixture was 
detected accidentally39. At the same time, another group reported panic attacks in anxious 
subjects following a single vital-capacity inhalation of a mixture of 35%/65% CO2/O2
38. 
Both procedures are still frequently used in panic research (see for a review Rassovsky & 
Kushner51). However, as mentioned before, an increase in pCO2 levels alters CBF, thereby 
potentially confounding and/or masking CBF changes produced by the panic attack. 
Therefore, in neuroimaging studies using CO2 challenge, residual pCO2 increases or 
decreases are used to mathematically correct the global CBF values26;47. In normal subjects, 
increased pCO2 levels result in vasodilatation and enhancement of global CBF. Levels of 
pCO2 and global CBF have been found to return to normal within 50 seconds post-initiation 
of CO2 inhalation
52.  




















and stable pCO2-adjusted CBF, in response to hypocapnia and vasoconstriction induced by 
hyperventilation. Whereas normal controls returned to baseline levels soon after CO2-
challenge, PD patients exhibited a prolonged abnormal pattern of CBF response to 
provocation52. In contrast to their hypothesis, Mathew and Wilson53 found no differences in 
perfusion between normal controls and anxious patients after CO2 challenge. However, 
subjects, both controls and anxious patients, who experienced challenge-induced anxiety 
showed a more modest increase in CBF than subjects who did not experience anxiety. The 
finding that the panicogenic effects are not exclusively found in PD patients, but also in 
other anxiety disorders, such as specific phobias54, as well as in healthy controls 
subjects54;55, limits the use of CO2 challenge for diagnostic purposes in PD.   
 
Lactate-challenge 
Since the classic experiment of Pitts & McClure37, lactate-challenge is considered to be of 
diagnostic significance for panic disorder. Based on earlier studies reporting higher 
physical exercise-induced serum lactate levels in subjects with anxiety disorders compared 
with controls56;57, these authors hypothesized lactate to be anxiogenic. To test this 
hypothesis, they infused 14 anxious patients and 10 healthy control subjects with sodium 
lactate and placebo. All anxious patients, except for one, and only two healthy control 
subjects, experienced severe anxiety following lactate infusion. These results have been 
replicated in several studies58-63. Successful treatment of the panic with antidepressants or 
benzodiazepines has been shown to block this lactate-induced anxiety58;59;61;63. Lactate 
comes close to fulfilling the requirements of an ideal challenge agent, as defined by 
Guttmacher et al.45. Although the exact mechanism underlying the anxiogenic properties of 
lactate remains unclear, hypersensitivity of central chemoreceptors has been suggested11;64.  
Stewart et al.46 used dynamic SPECT with Xenon-133 to measure regional CBF 
changes in 10 drug-free PD patients and 5 healthy controls subjects before and during 
lactate-challenge. Six of the 10 PD patients and none of the control subjects experienced 
lactate-induced panic attacks. Whereas lactate infusion markedly raised whole brain 
perfusion in controls and those PD patients who did not panic, a minimal increase or even 
decrease in CBF was found in PD patients experiencing an attack. Although pCO2 was not 
monitored during the experiment, this effect has been attributed to a large extent to lowered 
pCO2 and vasoconstriction secondary to hyperventilation. During the panic attack, 
increased perfusion was found in the right occipital cortex.  
 In their H2
15O PET study, Reiman et al.65 found that lactate-induced panic attacks 
correlated with increased perfusion in several regions of the brain, mainly in the bilateral 
temporal lobe. Although the involvement of these temporal regions was not found in 
lactate-challenge in non-panicking PD patients and controls, activation of the same 
temporal regions was also found to be involved during normal anticipatory anxiety in 
healthy volunteers66.  
 
Cholecystokinin (CCK4) and pentagastrin challenge 
CCK4, as well as its analogue pentagastrin, has a high affinity for CCKB-receptors. This 
subtype of CCK receptors is especially abundant in several brain regions implicated in fear 
responses, such as the rostral brainstem, hippocampus, amygdala and several parts of the 




















CCK has been found in rodents; benzodiazepines have been shown to antagonize CCK-
induced activation of hippocampal neurons70 and CCK significantly enhanced GABA 
release in striatum, frontal cortex and hippocampus71. CCKB-receptor agonists induced 
panic attacks and anxiety, in a dose-dependent manner, in healthy controls as well as in PD 
patients40;72, although the sensitivity for this challenge is enhanced in PD [41]. The CCKB-
antagonist L-365,260 antagonized CCK4-induced anxiety
73. In addition, pretreatment with 
the serotonin-noradrenalin reuptake inhibitor imipramine or the selective serotonin reuptake 
inhibitor fluvoxamine decreased the vulnerability for CCKB-agonists in PD patients, 
suggesting an interaction between CCK and other neurotransmitter systems74;75. 
In search of neuroanatomical correlates of anxiety in healthy volunteers, using 
CCK4 as a panicogenic agent, Benkelfat et al.
76 reported increased regional CBF in the 
claustrum-insular-amygdalar region, the anterior cingulate cortex and the cerebellar vermis. 
Javanmard et al.77 extended these findings by showing specific regional CBF changes as a 
function of time. Whereas early effects of CCK were accompanied by increases in regional 
CBF in the hypothalamic region, subsequent measurements showed increased regional CBF 
in the claustrum-insular region. In addition, decreased regional CBF was found in the 
medial frontal cortex.  
So far, only one imaging study in PD has been performed using pentagastrin as 
panicogenic agent. Boshuisen et al.78 compared brain perfusion before pentagastrin 
challenge (“anticipatory anxiety”) and after subsiding the challenge-induced panic 
symptoms (“rest”), in 17 PD patients and 21 healthy volunteers. Both before and after 
pentagastrin challenge, differences between PD patients and healthy control subjects were 
found in virtually the same fear-related brain regions, although these activation patterns 
clearly differed in intensity. Thus, increased activation was found in the parahippocampal 
gyrus, superior temporal cortex, hypothalamus, anterior cingulate cortex and midbrain; 
decreased activation was reported for the precentral gyrus, inferior frontal cortex, right 
amygdala and anterior insular cortex. Unpublished data of this group showed a high panic 
incidence in PD patients during pentagastrin challenge, although control subjects 
experienced anxious arousal as well. Panic in PD patients as well as anxious arousal in 
controls was correlated with increased regional CBF in the parahippocampal gyrus, basal 
ganglia and parts of the prefrontal cortex, and decreased perfusion in the precentral gyrus, 
thalamus and other parts of the prefrontal cortex. Interestingly, in controls but not in PD 
patients, activation of the hypothalamus and bilateral amygdala was found during 
pentagastrin-induced anxiety. In addition, in PD partial normalization of the regional CBF 
patterns was found after successful pharmacological treatment79. Thus, the results of 
Boshuisen et al.78;79 failed to demonstrate clear-cut neuroanatomical differentiation between 
different anxious states in PD as proposed by theoretical models.  
 
Yohimbine challenge 
Yohimbine, an α2-adrenergic receptor antagonist, enhances synaptic availability of 
noradrenalin (NA) and increases sympathetic activity by blocking pre-synaptic α2-
autoreceptors. The locus coeruleus (LC) plays a central role in noradrenergic mediation of 
stress and anxiety. A comprehensive review addressing the LC-NA system in pathological 
anxiety has been published by Sullivan et al.4. Yohimbine, as a challenge agent, has some 




















without the full emotional impact of the naturally occurring panic attacks45. Second, the 
specificity of yohimbine-challenge is limited, since also patients with PTSD were found to 
experience yohimbine-induced anxiety80. Also, adrenalin itself has been used as 
pharmacological agent in PD81. Since adrenalin is known to produce peripheral symptoms 
of arousal without penetrating the blood-brain barrier, anxiety during adrenalin provocation 
is therefore unlikely to result from a central neurochemical mechanism, as has been 
proposed for lactate and CO2
11. 
Compared with control subjects, PD patients show more yohimbine-induced 
subjective anxiety and increased cardiovascular biochemical responses, despite similar 
increases in NA levels42;43;82. Also, levels of 3-methoxy-4-hydroxyphenylglycol (MHPG), 
the peripheral marker of central NA turnover, are increased in PD patients following 
administration of yohimbine42. Drugs that reduce the locus coeruleus firing rate, such as the 
α2-adrenergic agonist clonidine, have been shown to possess antipanic properties83. Acute 
clonidine administration also produced a greater decrease in anxiety and plasma MHPG 
levels of PD patients compared with normal volunteers, supporting the hypothesis of 
noradrenergic dysregulation in PD84;85. Moreover, treatment with the serotonin reuptake 
inhibitor fluvoxamine reduced yohimbine-induced anxiety in PD patients86, illustrating the 
interaction between the noradrenergic and serotonergic system.  
Neuroanatomical correlates of yohimbine challenge were investigated in healthy 
volunteers by Cameron et al.87, using H2
15O PET. Compared with placebo, yohimbine 
produced a significant decrease in global perfusion and increased regional CBF in the 
medial frontal and insular cortices, as well as the thalamus and cerebellum. Since all 
subjects hyperventilated after yohimbine challenge, part of the decreased global perfusion 
may be explained by hyperventilation-induced hypocapnia. One subject, experiencing a 
yohimbine-induced panic attack, showed increased instead of decreased whole brain CBF. 
Increased activation of medial frontal cortex was correlated with increases in anxiety 
ratings. 
 An early, and so far the only, imaging study with yohimbine-challenge in PD 
patients has been done by Woods et al.88. Using 99mTcHMPAO SPECT, they measured 
regional CBF changes after bolus injection of yohimbine and saline in 6 medication-free 
PD patients and 6 healthy control subjects. All PD patients and only one control subject 
experienced higher anxiety levels in response to yohimbine. Yohimbine decreased frontal 
cortical flow in PD patients, but not in controls.  
  
Fenfluramine challenge 
The serotonin (5-HT) agonist fenfluramine facilitates 5-HT release and inhibits 5-HT 
reuptake, in this way increasing serotonergic function. As mentioned before, serotonin is 
considered to play a dual role in anxiety. Animal experiments as well as clinical studies 
have given evidence for anxiogenic as well as anxiolytic characteristics of this 
neurotransmitter. Serotonergic projections to the brainstem and forebrain arise from the 
dorsal raphe nucleus (DRN) and the medial raphe nucleus (MRN), both modulating parallel 
functioning systems1-3;5. The MRN mainly projects to the lateral hypothalamus, temporal 
cortex, amygdala and hippocampus. The DRN, on the other hand, projects largely to 
brainstem structures such as the PAG and LC, as well as to the ventral hypothalamus, 








































locus coeruleus. Serotonergic projections from the DRN inhibit firing of LC neurons; 
noradrenergic innervation from the LC excites DRN neurons. In contrast, afferent 
noradrenergic projections from the LC inhibit the MRN. Serotonergic inhibition of the PAG 
is assumed to be crucial in preventing unconditioned fear responses such as panic attacks1;5. 
This inhibitory effect is strengthened by noradrenergic inhibitory innervation of the PAG 
from the LC and the presence of GABA-ergic receptors at the level of the PAG. In contrast 
to the inhibiting effect of 5-HT in unconditioned fear responses, 5-HT facilitates 
conditioned fear responses (e.g. generalized and anticipatory anxiety) via activation of the 
limbic structures such as the amygdala and hippocampus. 
The differentiation between the anxiolytic and anxiogenic properties of 5-HT is 
important for  interpreting the results of fenfluramine challenge in panic disorder patients. 
Increased fenfluramine-induced anxiety was found in PD patients44;89. Since described 
anxiety symptoms were different from the classic characteristics of panic, these results 
suggest that fenfluramine enhanced anticipatory anxiety, rather than triggering a panic 
attack. This idea is supported by the results of Mortimore & Anderson90, who investigated 
the effect of fenfluramine in resting state anxiety and CO2-induced panic attacks in 13 
medication-free PD patients during a double-blind placebo-controlled crossover design. 
Compared with placebo, fenfluramine increased anxiety prior to CO2-challenge but 
attenuated CO2-induced panic.  
 So far, only one imaging study using fenfluramine-challenge in PD has been 
published91. To compare regional CBF changes 20 and 5 minutes before and 20 and 35 
minutes after fenfluramine challenge, H2
15O PET was used in 9 PD patients and 18 healthy 
volunteers. The study design lacked a placebo control condition. Compared with controls, 
PD patients showed a decreased regional CBF in the left posterior parietal-superior 
temporal cortex. Following fenfluramine challenge a greater increase in perfusion in the 
same region was found in PD patients compared with control subjects. No correlation was 
found between the presence of a fenfluramine-induced panic attack and peak voxel activity. 
Moreover, since fenfluramine-induced panic attacks, when present, subsided within 5 
minutes of fenfluramine administration and the post-fenfluramine PET scans were acquired 
at 20 and 35 minutes after challenge, fenfluramine-induced activation of the left posterior 
parietal-superior temporal cortex in PD patients is unlikely to reflect the panic attack. More 
research on the relationship between serotonin and neuroanatomical correlates of baseline 
anxiety and panic attacks in PD patients is required. 
 
Combining the results of challenge studies in PD, no clear conclusion concerning the 
neuroanatomical correlates of panic attacks can be drawn. Although many studies support 
the involvement of temporal and limbic structures (e.g. the amygdala, hippocampus and 
parahippocampal gyrus) in non-panic anxious states of PD, results with regard to the 
neuroanatomical correlates of panic attacks are inconsistent. Several explanations may be 
put forward for this. The first problem is capturing the attack in an experimental setting. 
The second problem is that the results of many challenge studies lack proper differentiation 
of the anxious states during data acquisition. Third, rapid habituation of the amygdala 
response may explain the inconsistencies concerning amygdaloid involvement in challenge-
induced anxiety in PD. Finally, since the amygdala is only 15 mm of size and brainstem 




















due to the limited spatial resolution of PET and SPECT, favoring the use of functional MRI 
techniques in future research. 
 Concerning the role of the monoaminergic systems in PD, challenge studies have 
shown that both NA and 5-HT are involved in the modulation of anxious states. Moreover, 
complex reciprocal interactions between the neurotransmitters exist. In addition to these 
monoamines, the GABA-ergic system has been investigated indirectly by the use of CCK 
and pentagastrin. As will be discussed below, more insight in the role of GABA has been 





The GABA-benzodiazepine receptor complex 
Based on the anxiolytic effects of benzodiazepines, most ligand studies in PD have 
addressed the benzodiazepine receptor function and its influence on GABAa transmission. 
Modulation of the GABA-benzodiazepine receptor complex is assumed to underlie the 
pharmacological actions of benzodiazepines as well as to mediate the anxious emotion 
itself. Conventional benzodiazepines act as benzodiazepine receptor agonists and facilitate 
the inhibitory effects of GABA, resulting in their sedative, anxiolytic and anticonvulsant 
effects. Inverse agonists, such as FG7142, in contrast, were found to produce opposite 
effects, i.e. increased anxiety and arousal92. Flumazenil and its synthetic analogue 
iomazenil are antagonists. They block the effects of both agonists and inverse agonists, but 
have few intrinsic effects themselves93. Although this spectrum of agonist activities at the 
benzodiazepines receptor may explain pharmacological effects in human anxiety, aberrant 
patterns have been found in PD. Panic disorder patients, compared with healthy controls, 
were found to be less sensitive to the conventional benzodiazepine diazepam using saccadic 
eye movement velocity as a dependent measure, suggesting a functional subsensitivity of 
the GABA-benzodiazepine complex in brainstem regions controlling saccadic eye 
movements94. Whereas conventional benzodiazepines are able to reduce anticipatory 
anxiety in PD patients, high-potency benzodiazepines are necessary to attenuate anxiety 
levels during a panic attack.  
Abnormal benzodiazepine receptor functioning in PD may be explained by 
different mechanisms95. First, PD patients may have an overproduction of an endogenous 
inverse agonist. Second, it is possible that PD patients have a deficiency in a naturally 
occurring benzodiazepine full agonist. Very little is known about endogenous 
benzodiazepines ligands. The third hypothesis implies a shift in benzodiazepines receptor 
‘set-point’ towards the inverse agonist direction. This theoretical hypothesis predicts 
reduced efficacy of benzodiazepines agonists, increased efficacy of inverse agonists and the 
emergence of partial inverse agonist actions for antagonists, such as flumazenil. 
Administration of flumazenil to PD patients resulted in an increase of panic attacks and 
subjective anxiety in comparison to controls95;96. This anxiogenic effect of flumazenil 
argues against the presence of endogenous anxiogenic (inverse agonist) ligands.  
 Several studies have investigated the benzodiazepine receptor function in PD 
using 123I-iomazenil SPECT97-101 or 11C-flumazenil PET102;103, as summarized in Table 3.4. 




















receptor binding97-99. Other methodological caveats, limiting comparison of results, were 
the inclusion of diseased control subjects97-99, the existence of comorbid diagnoses99, the 
use of antidepressants99;100 and limited group size102. In addition, timing of the paradigm 
seems to be of importance: whereas most studies reported baseline differences, Bremner et 
al.101 were able to compare PD patients who panicked during the scan with PD patients who 
did not. The panickers, compared with the non-panickers, showed a decreased 
benzodiazepine receptor binding in the prefrontal cortex. In contrast to the results of 
Bremner et al. 101, who reported decreased binding in frontal cortex to be correlated with 
panic severity, Abadie et al.103 did not find an effect of symptom severity.  
Baseline differences in benzodiazepine receptor binding have been reported for 
several brain regions, mainly the prefrontal97;98;100;102 and temporal cortices97-102. In contrast, 
no differences have been found by Abadie et al.103, which may be explained by the 
inclusion of patients with different anxiety disorders instead of only PD. Whereas Malizia 
et al.102 reported a global reduction in benzodiazepine receptor binding, with the greatest 
significance in the right orbitofrontal cortex and insula, no whole brain differences were 
found by Bremner et al.101. Concerning frontal involvement, some studies reported 
increased98;100 and some decreased97;102 benzodiazepine receptor binding in this region. In 
the temporal cortex, benzodiazepine receptor binding has been found to be 
reduced97;99;101;102, specifically in the hippocampus101, although increased binding in the 
temporal lobe was reported by Brandt et al.100. Altered benzodiazepine receptor binding has 
also been found in the occipital cortex97, precuneus101 and caudate nucleus101. 
 To summarize, SPECT and PET studies investigating benzodiazepine receptor 
binding in PD have generated inconsistent results. However, decreased binding (global as 
well as regional) compared with control subjects, seems to be the main finding at the 
baseline state in PD. Decreased global and/or regional benzodiazepine receptor binding at 
baseline may be explained by different mechanisms102. First, modification of GABAA-
subunit composition, for instance by increased expression of α6 subunits to which 
flumazenil does not bind, may be the result of genetic polymorphisms or environmentally 
induced modification of receptor configuration. Second, increased concentration of brain 
GABA may induce down-regulation of the GABA-benzodiazepine receptor complex104. 
However, instead of increased GABA concentrations, Goddard et al.105, using MRS, found 
a 20% decrease in occipital cortex GABA levels in PD patients compared with controls. 
Also, serotonergic and noradrenergic changes influence benzodiazepine receptor binding9. 
Finally, structural brain abnormalities, such as temporal lobe atrophy, may explain 
decreased flumazenil binding. 
 
Other ligand studies 
So far, most ligand studies in PD focused on the GABA-ergic system. However, the use of 
other radiolabeled ligands, e.g. to measure changes in the adrenergic and serotonergic 
systems, is desirous and promising. Very recently, Neumeister et al.106 reported the results 
of the first serotonergic ligand study in PD. Binding of the very selective 5-HT1A receptor 
radioligands 18F-trans-4-fluoro-N-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-(2-pyri-
dyl)cyclohexanecarboxamide (FCWAY) was determined in 16 unmedicated PD patients 
and 15 healthy volunteers using quantitative PET measurements. PD patients, compared 








































cortices and in the raphe nuclei. No significant differences were found between PD patients 
with or without a comorbid depressive disorder.  
 
 
Functional MRI experiments 
 
Notwithstanding the advantage of increased spatial and temporal resolution and non-
invasive visualization of cerebral blood flow changes, functional MRI studies are sparse in 
PD. The first functional MRI study in PD was done by Bystritsky et al.107, using imagery 
exposure. Six PD patients and 6 healthy control subjects performed directed imagery of 
neutral, moderate and high anxiety-related situations based on an individually determined 
behavioral hierarchy. Increased activation during high anxiety blocks compared with 
neutral blocks was found in the right inferior frontal cortex, the right hippocampus, bilateral 
anterior cingulate cortex extending into the anterior prefrontal gyrus, and the posterior 
cingulate cortex extending into the precuneus. Although anxiety ratings were significantly 
higher in PD patients compared with controls, no panic attack occurred during the 
experiment. Increased activation in the amygdala could not be visualized, due to signal drop 
out in that region of the MRI images. Moreover, since the small sample size did not permit 
between-group statistical comparisons, replication of the findings in a more extended 
sample is needed.  
Maddock et al.108 compared 6 PD patients with 8 control subjects while making 
valence judgments of threat-related and neutral words using functional MRI. Compared 
with the healthy volunteers, the PD patients showed increased activation of the left 
posterior cingulate and dorsolateral prefrontal cortices in response to threat-related words. 
In addition, PD patients had significantly more right greater than left asymmetry in the 
parahippocampal region. Although PD patients reported more anxiety during the test than 
the controls, no amygdaloid response was found.  
In a recent study, we investigated the disease-specificity and neuroanatomical 
correlates of cognitive and emotional Stroop interference effects across different anxiety 
disorders109. In contrast to the results of Maddock et al. 108, increased right-sided 
amygdaloid and hippocampal activation was found in PD patients, correlating with 
increased interference in response to panic related threat words109. Activation patterns in 
PD patients were compared with those in OCD and hypochondriasis patients and healthy 
volunteers. Whereas in OCD patients emotional interference was restricted to disease-
specific (OCD related) words, in PD patients frontal-striatal activation was found during 
color naming of both OCD and panic related words. However, color naming of panic 
related words was significantly slowed and was correlated with additional activation of the 
right amygdala and hippocampus. Although PD patients did not panic during the 
experiment, they showed increased activation of the rostral brainstem during color naming 
of panic related threat words. Hypochondriasis patients showed a similar activation pattern 
as PD patients, but without the amygdaloid response. In contrast to the robust emotional 
interference effects, PD patients showed minimal interference on color naming of 
incongruent color words, i.e. the cognitive variant of the task. 
 




















neuroanatomical differentiation between panic and non-panic anxiety as supposed by 
Gorman et al.11 and Deakin & Graeff1. Although these fMRI paradigms have shown to 
provoke considerable non-panic anxiety and distress in PD patients, no panic attacks during 
MRI image acquisition have been reported. However, increased activation during these 
non-panic anxious states has been found in brain regions assumed to be related to both 
anticipatory anxiety and panic. Provocation experiments using fMRI, enabling visualization 
of brain activation changes during panic attacks with good temporal and spatial resolution, 
are needed to further investigate this issue.  
Another domain of fMRI research, desirable but not yet addressed in PD so far, 
consists of cognitive paradigms with or without emotional manipulation, e.g. memory 
tasks. PD patients show an explicit memory bias for threat stimuli, compared with neutral 
stimuli110. Although the hippocampus has been implicated in PD, no imaging studies have 
been performed to investigate if altered hippocampal functioning is responsible for the 
impaired memory function. Moreover, to differentiate between global anxiety traits and 





Structural and resting state studies have been performed to investigate the neuroanatomical 
and neurophysiological characteristics of PD patients at rest. Focal abnormalities and 
volume reductions have been found mainly in the temporal lobe, specifically in the 
amygdala, hippocampus and parahippocampal gyrus. Resting state results mainly support 
involvement of the (para)hippocampal regions and the prefrontal cortex. Since prospective 
follow-up designs are lacking, it is not clear whether these abnormalities predispose to 
panic disorder or rather reflect secondary processes due to long-term symptomatology or 
chronic use of medication. Moreover, the specificity of these findings for PD still has to be 
established by comparing different anxiety disorders or different symptom dimensions. 
Based on the assumption of the limbic system to be involved in anticipatory anxiety, it 
might be argued that these baseline studies have visualized anticipatory anxiety or 
experiment-induced distress rather than a baseline state characteristic of PD. The scanning 
environment may induce claustrophobia more easily in PD patients than in healthy 
volunteers, confounding the results. Probably the most important and most difficult 
question in imaging PD seems to be: at what (anxious) state is the subject at the time of 
image acquisition? 
The same issue is relevant with respect to challenge studies. Challenge studies do 
not always succeed in capturing the panic attack. Therefore, challenge-induced anxiety in 
PD varies from anxious baseline states to near-panic anxiety or real panic attacks. Other 
important methodological issues are differences in time frames of the experimental 
paradigms, limited temporal resolution of PET and SPECT techniques (missing 
visualization of rapidly habituating structures), limited spatial resolution (missing 
activations of small regions of interest, e.g. nuclei in brainstem and hypothalamus) and 
hemodynamic changes due to hyperventilation-induced hypocapnia.  
Ligand studies in PD have mainly investigated the GABA-benzodiazepine 




















binding, both increased and decreased, in temporal and frontal brain regions. Panic 
symptomatology has been correlated with decreased benzodiazepine receptor binding in 
prefrontal regions, although this finding still needs to be replicated. So far, only one study 
has used a serotonergic radioligand, showing decreased 5-HT1A-receptor binding in 
cingulate cortex and raphe nucleus. No ligand studies have been performed in PD to 
investigate the pharmacokinetics of (nor)adrenergic receptors. Considering the complexity 
of interacting neurotransmitter systems and their differential roles in the mediation of 
normal as well as pathological anxiety, future research should incorporate paradigms 
suitable to compare well-described anxious states before and after pharmacological and 
cognitive-behavioral treatment.  
Although functional MRI paradigms have been used to investigate cognitive 
functions in many psychiatric disorders, these studies are limited in PD research. Results 
from fMRI studies using cognitive paradigms, e.g. memory tasks, may contribute to a better 
understanding of the brain regions involved in PD and the mechanism behind the increased 
attentional bias and explicit memory bias to threat stimuli in these patients. 
 
Theoretical models in PD are based on the assumption that each component of the disorder 
is linked to a distinct neuroanatomical system in the brain. However, since a clear 
description of the emotional state at the time of data acquisition is lacking in most imaging 
studies, proper neuroanatomical differentiation between panic attacks, anticipatory anxiety 
and other related symptoms in PD is not yet possible. To better establish the 
neuroanatomical correlates of different anxious states, in PD patients as well as in patients 
with other anxiety disorders and healthy controls, different neuroimaging modalities should 
be combined. For instance, a promising design would be a combination of an adrenergic or 
serotonergic ligand study and a cognitive fMRI paradigm during a controlled emotional 
state, with subsequent volumetric measurements of those brain regions identified during 
functional imaging. In addition, longitudinal follow-up measurements are needed to 
investigate the effects of medication, psychotherapy, long-term symptomatology and 
comorbidity. Moreover, comparison between PD patients, their first-degree relatives and 
non-related control subjects may elucidate underlying genetic predisposition. Also, 
neuroanatomical correlates as revealed by imaging studies, can be used as phenotypes in 
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Attenuation correction of PET activation studies in 
the presence of task related motion. 
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Motion induced misalignment between transmission and emission scans can result in 
erroneous estimation of regional tissue activity concentrations. If this motion is of a random 
nature, mismatch between transmission and emission scans is likely to result in diminished 
signal-to-noise ratios. In case of task related motion, however, corresponding systematic 
reconstruction artefacts may lead to false-positive or false-negative results. 
The purpose of the present study was to investigate whether implementation of an 
image registration (IR) method, which allows for motion-corrected attenuation correction, 
would improve accuracy of H2
15O PET activation studies. To evaluate the performance of 
this method, phantom studies as well as studies in human subjects were performed. Results 
were compared with three alternative methods: standard attenuation correction without 
motion correction, calculated attenuation correction, and no attenuation correction.  
The phantom measurements showed that, for quantitative assessment of regional 
activity concentrations, the IR method was superior to the other attenuation correction 
methods. In a single-subject study with intentional task related motion during a visual 
stimulation paradigm, false-positive results, obtained with the standard attenuation 
correction method, disappeared after attenuation correction using the IR method. Finally, a 
group analysis of 11 patients indicated that an increase in signal-to-noise ratio was obtained 
with the IR method. Therefore, in our view, the IR method should be considered as a first 
























Correction for tissue attenuation is a vital step in obtaining quantitative PET data. The most 
commonly used method to correct for tissue attenuation is by direct measurement using a 
separately acquired transmission scan. Alternatively, tissue attenuation can also be 
calculated.  In this case, not only assumptions have to be made about density of brain tissue, 
but also about density and thickness of the skull. Relative advantages and shortcomings of 
both methods have been described in detail by Huang et al.1. As measured attenuation 
correction requires fewer assumptions, it has become the accepted standard. An important 
problem with measured attenuation correction is the possibility of patient motion between 
transmission and subsequent emission scans. This motion can lead to misalignment 
between transmission and emission scans, resulting in inaccurate attenuation correction. 
This, in turn, may introduce erroneous estimations of regional activity concentrations. In 
case of H2
15O PET activation studies, motion can have two effects. If motion is random, 
transmission-emission mismatch is likely to result in a general reduction of signal-to-noise-
ratios. On the other hand, if motion co-occurs with an experimental condition (i.e. is task 
related), systematic reconstruction artefacts will occur, which may lead to both false-
positive and false-negative results. A PET activation protocol with multiple injections 
usually takes one to two hours, during which time the subject is supposed not to move. 
Whilst the use of head fixation devices restricts larger movements, it will not abolish them 
completely2;3. Although realignment of reconstructed images is an essential and standard 
step in data processing, it will only realign emission scans. The procedure cannot correct 
for possible mismatches between emission and transmission scans and, consequently, also 
not for associated attenuation correction errors. Therefore, correct alignment of emission 
and transmission scan data is important, in particular in the case of task related motion.   
For activation studies, where only changes in activity in repeat scans on the same 
subject are of interest, several options exist for dealing with motion between transmission 
and emission scans. In theory, no attenuation correction should introduce the same error in 
repeat scans and, therefore, not affect the detection of changes. Secondly, calculated 
attenuation correction can be considered. Finally, a motion corrected attenuation correction 
can be performed using a suitable image registration (IR) method4. The latter method has 
the advantage that it is also applicable to ligand studies, as described elsewhere5. However, 
application of this method for ligand studies still needs validation and the application of the 
method may not be feasible in case of poor statistical quality of dynamic PET data. In 
addition, the IR method has only been evaluated on a region of interest basis in a limited 
number of patients6. 
The purpose of the present study was to evaluate the IR method on a voxel by 
voxel basis and to assess which attenuation correction method performs best for activation 
studies. To this end, both phantom studies and studies in human subjects (single subject 
validation study and clinical group analysis) were used to compare the IR based attenuation 
correction with the following alternatives: standard attenuation correction using the 
transmission scan without motion correction, contour based calculated attenuation 
























All scans were acquired on an ECAT EXACT HR+ PET scanner (CTI/Siemens, Knoxville, 
TN), the characteristics of which are well documented 7;8. In the present study transmission 
scans of 10 min were acquired in 2D mode for all studies. Transmission scans are based on 
three rotating 68Ge rod sources, each about 150MBq for the studies described in this paper. 
All emission scans were acquired in 3D mode and data were reconstructed using FORE9 
and 2D ordered subset expectation maximisation (OSEM)10;11 applying 4 iterations with 16 
subsets12. Images were post-smoothed using a Hanning filter, resulting in an average 
resolution of about 7mm full width at half maximum (FWHM) in all directions. During 
reconstruction, a zoom of two was applied resulting in voxel sizes of 2.526 x 2.526 x 2.425 
mm3. 
 
1. Implementation of image registration method 
The IR method was first described and tested by Andersson et al.4 and subsequently used 
by Smith et al.6. We have implemented this method for this study on SUN Ultra 10 
workstations running under Solaris 2.7. As a detailed description of the method is presented 
in these papers, it will only be summarized here. The present implementation of the IR 
method consisted of the following steps13: (1) reconstruction of emission data without 
attenuation correction (AC); (2) calculation of transformation matrices between non-AC 
emission images and the first non-AC emission image; for this purpose the registration 
package AIR3.0.8, developed by Woods et al.14, was used; (3) application of the inverse 
transformation matrices to the reconstructed transmission scan image; (4) forward 
projecting the transformed, and thus aligned, transmission scan images to yield motion 
corrected attenuation correction factors (ACF’s) and; (5) finally, use of these motion 
corrected ACF’s to reconstruct the emission scan data with attenuation correction. Note that 
this alignment will provide motion corrected attenuation factors. An additional alignment of 
the reconstructed emission images is also performed within the SPM99 software, as 
explained later. Although in theory we could reuse the calculated transformation matrices 
by the IR method within the SPM program, this has not been implemented. 
The IR method is based on a number of assumptions. Firstly, it is assumed that the 
transmission scan and first emission scan, which is acquired immediately after the 
transmission scan, are well aligned. Secondly, it is assumed that transformation matrices 
can be derived accurately from non-AC emission scans. Thirdly, it is assumed that forward 
projected transmission images yield the same attenuation correction factors as those derived 
directly from transmission scans when patient motion is absent, i.e. when no transformation 
matrices need to be applied. Reconstruction and forward projection of transmission data 
might, however, reduce noise in the ACF’s. Therefore, in the present study, this step was 
also applied to the first emission scan.  
 
2. Phantom studies 
Two phantom studies were performed to determine the accuracy of several steps involved 
in the IR method: one with a solid homogeneous 20 cm diameter cylindrical phantom, the 




















For the homogeneous phantom, which was filled with 30 MBq 68Ge, a transmission scan of 
10 minutes and emission scans of 20 million true counts were acquired for 3 positions. A 
count based emission scan was applied to obtain emission data with similar statistics as 
those obtained during patient studies (20-25 million true counts). The second position was 
10 mm shifted vertically with respect to the first position and, subsequently, the third 
position was moved 10 mm laterally with respect to the second position, as indicated in 
Table 4.1. These shifts are a non-integer number of the voxel size (2.526x2.526x2.425mm3) 
and are therefore unlikely to result in truncated results within the calculated transformation 
matrices. Movements were performed including the scanner bed and using the scanner bed 
motion controller. For the first position emission data were reconstructed using attenuation 
correction factors, which were derived directly from the transmission scan data, and using 
attenuation correction factors obtained after reconstruction and forward projection of the 
transmission data, but without any transformations. The latter experiment was performed to 
evaluate the accuracy of the algorithms used for reconstruction and forward projection of 
transmission scan images. Next, for the other positions, emission scans were reconstructed 
with attenuation correction based on: (1) the transmission scan acquired at the same 
position as the emission scans and (2) the transmission scan acquired at the first position, 
but corrected for motion using the IR method as described above. Reconstructed emission 
images based on both attenuation correction factors were compared using subtraction 
analysis. In addition, agreement between transformations calculated by the IR method and 
the actual position offsets were evaluated. Since a 68Ge phantom was used for this 
experiment, emission spillover within the transmission scans is present. However, effects of 
emission spillover within the transmission scans may be ignored, since transmission scans 
at all positions must suffer from equal emission spillover due to the negligible radioactive 
decay of 68Ge during the course of the experiment. In addition, the total amount of activity 
of 30MBq within the phantom will only result in a minor spillover effects within the 
transmission scan, as shown elsewhere15.  
 
 
Table 4.1. Accuracies of the IR method for a homogeneous phantom 
 
Position Index Translation 
x, y, z (in mm) 
Detected translation 
x, y, z (in mm) 
 
Difference of pixel values after IR 
 
1 0, 0, 0   
2 0, 10, 0 0.22, 10.23, 0.41 <3% 
3 10, 10, 0 10.40, 9.62, 0.35 <3% 
 
Direction x= lateral, y= upwards, z= along scanner’s axis.  
IR= image registration based attenuation correction 
 
 
The study with the 3D brain phantom, filled with 37 MBq 18F, was performed in a similar 
way. In this case, however, four positions were used (Table 4.2). The second position was 
moved 10 mm upward from the first position, the third position was moved 10 mm in the 
axial direction with respect to the second position, and the fourth position was rotated 5 




















position also the accuracy of the method in the presence of a rotation could be determined. 
Again the scanner bed motion controller was used to carry out the movements, Rotation 
was determined using a calliper. During the evaluation of the method, manual segmentation 
was performed to exclude the bed from the transformations. 
For all positions, transmission scans and emission scans of 20 million true counts 
were acquired. Data were analysed in the same way as for the homogeneous phantom 
experiment, i.e. with subtraction analysis. To evaluate the accuracy of the IR method in 
more detail, it was used to calculate the transformations amongst non-AC emission images 
between position 1 and 2, 2 and 3, 3 and 4 and 4 and 1, respectively. Multiplying all these 
transformation matrices should result in the identity matrix, a procedure described as the 
full circle theory16. Differences of the latter matrix with the identity matrix are a measure of 
the overall accuracy of the registration performance. The main advantage of the full circle 









x, y, z (in mm) 
Detected translation 
x, y, z (in mm) 
Difference of pixel 
values after IR 
 
1 0, 0, 0   
2 0, 10, 0 0.18, 9.72, 0.36 <2.1% 
3 0, 10, 10 0.29, 9.67, 10.86 <2.0% 
4 0, 10, 10 
and 5° rotation along z-axis 
0.13, 9.81, 10.62 
and 4.3° rotation along z-axis 
<3.0% 
 
Direction x= lateral, y= upwards, z= along scanner’s axis.  
IR= image registration based attenuation correction 
 
 
3. Validation study in human brain 
This validation study comprised a simple visual cortex stimulation paradigm in a healthy 
volunteer. The transmission scan was followed by 12 emission scans (90 seconds each) 
using 445 MBq H2
15O injections. After the first 6 emission scans a controlled z-axis 
transformation of 7 mm was performed. The visual cortex stimulation paradigm consisted 
of a block design of two conditions; a baseline blind condition and a condition with visual 
cortex stimulation using high frequency binocular light flashes. Conditions were balanced 
over the scanning session. In this way 3 baseline and 3 active conditions were scanned in 
random order preceding and following the controlled transformation. Random motion of 
the subject was restricted using a head fixation strap, but as mentioned before, no complete 
immobilisation can be reached in this way.  
Image reconstruction was performed in 4 ways: (1) without attenuation correction 
(NAC), (2) using the transmission scan to reconstruct all 12 emission scans neglecting the 7 
mm z-axis transformation (Standard AC), (3) using a contour-based (CB) calculated 
attenuation correction, and (4) using the IR method. For patient studies, a radio-opaque 




















the effects of including the head holder within the IR method on the accuracy of the 
calculated attenuation factors may be ignored. Reconstructed emission images were 
realigned, normalised and re-binned to voxel sizes of 3x3x3 mm, and smoothed by 10 mm, 
using SPM99 (Wellcome Department of Cognitive Neurology, 
http://www.fil.ion.ucl.ac.uk/spm). Subtraction analysis was performed comparing visual 
cortex stimulation to the baseline blind condition. Moreover, difference maps were created 
to compare the main effect of visual cortex stimulation before and after z-axis 
transformation. 
 
4. Case-report of task related motion during H2
15O PET symptom provocation 
To illustrate the impact of inaccurate attenuation correction due to subject motion, one case 
with task related motion during a H2
15O PET symptom provocation experiment is 
presented. This case concerns a female patient with obsessive compulsive disorder during a 
H2
15O PET activation study in which contamination fear was provoked using a block design 
consisting of two conditions: baseline condition (neutral pictures) and symptom condition 
(dirty pictures). Following the transmission scan 8 emission (4 baseline, 4 symptom) scans 
were performed, following 445 MBq H2
15O injections. The order of the conditions was 
fully randomised. Ninety seconds scans were acquired whilst the subject watched the 
pictures on a screen mounted in front of her. Motion of the head was restricted by the use of 
a head fixation strap. 
Image reconstruction was performed using NAC, standard AC, CB and IR 
methods. Reconstructed images were realigned, normalised and smoothed and contrast 
images were calculated to investigate the effect of the symptom provocation. 
 
To simulate the effect of motion, the first emission scan was copied 8 times to be sure that 
the regional distribution of activity concentrations equal for all scans. Attenuation 
correction was applied to these 8 identical emission scans using transmission scans, which 
were transformed in the opposite direction to observed patients motion. In this way 
differences in reconstructed data could only be the result of the induced mismatch between 
emission and transmission data. Subtraction analysis was performed to measure the effect 
of patient motion independent of difference in brain activation.  
 
5. OCD-group analysis 
A group analysis based on 11 patients with obsessive-compulsive disorder was performed 
to evaluate the effects of different attenuation correction methods on the overall result when 
data of more patients are combined. During the H2
15O PET activation study contamination 
fear was provoked using a block design consisting of two conditions: baseline condition 
(neutral pictures) and symptom condition (dirty pictures). Image reconstruction was 
performed using NAC, standard AC, CB and IR methods. Reconstructed images were 
realigned, normalised and smoothed and contrast images were calculated to investigate the 
effect of the symptom provocation. Results obtained with the different attenuation 
correction methods were compared. A detailed treatise of paradigm and clinical results is 
























1. Phantom studies 
Results obtained for the homogeneous cylindrical phantom are shown in Table 4.1. ROI 
values of the emission images for position 1 reconstructed with attenuation correction 
derived from the transmission scan directly and with attenuation correction based on 
forward projection of a reconstructed transmission scan image agreed within 3% and with 
an average difference less than 1%, illustrating the accuracy of the algorithms used for 
reconstruction and forward projection of transmission scan data. The latter data were 
derived using several 1cm diameter ROI’s placed within the phantom, Note also the 
excellent agreement between calculated and true transformations. Differences of ROI 
values larger than 20% were observed when transmission-emission misalignments were 
neglected, while these differences reduced to within 3% when the IR method was applied. 
 
 
Figure 4.1.   Reconstructions of emission scan of 3D brain phantom at position 3 (see 
Table 4.2) using (a): transmission scan of position 3, (b): transmission 
scan at position 1, (c): motion corrected transmission scan of position 1, 
(d): difference image between image a and b, (e): difference image 




For the 3D brain phantom data are summarized in Table 4.2 and Figures 4.1 and 4.2. Use of 
the IR method resulted in emission pixel values which agreed within 3% as compared with 
the motion free attenuation correction, while differences larger than 15% were observed 
when the misaligned transmission scan was used without any motion correction. Figure 4.1 
illustrates the observed difference for emission data reconstructed using attenuation 
correction with and without motion correction. Table 4.2 also shows the accuracy of the 
calculated transformations, i.e. actual offset was calculated within 0.9 mm and rotation 




















according to the full circle theory, i.e. the product of all transformation matrices amongst all 
positions. It can be seen that residual errors after four transformations are very small, i.e. 
total translation errors smaller than 3 mm and a rotation error less than 1 degree.  
 
 





2. Validation study in human brain 
Effects of visual cortex stimulation are shown in Figure 4.3 en Table 4.3. Massive 
activation of the primary visual cortex was found, independent of the image reconstruction 
method used.  Since the two conditions were equally balanced over the two sub-sessions of 
the experiment, effects of misalignment between transmission and emission scans were 
equal for both baseline condition and active condition with visual cortex stimulation. 
Therefore, in this case of task-unrelated motion, subtraction analysis obscured the problem 
of misalignment.  
 
 
Figure 4.3. Single-subject validation experiment: main effects visual cortex 
stimulation. (a): image registration attenuation correction, (b): no 
attenuation correction, (c): contour based method, (d): standard 






















Table 4.3. Single-subject validation experiment: main effects visual cortex stimulation 
 
 Talairach coordinates 






IR 15, -87, -6 2624 5.83 <0.0001 
NAC 15, -87, -6 2770 6.17 <0.0001 
CB 6, -78, 3 1023 5.38 0.003 
standard 0, -69, 9 2120 5.68 <0.0001 
 
IR= image registration, NAC= no attenuation correction, CB= contour based method 
 
 
To compare the main effects of visual cortex stimulation before and after 7 mm z-axis 
transformation, difference maps were calculated (Table 4.4 and Figure 4.4). Using IR 
attenuation correction no effects of the 7 mm z-axis transformation were observed (i.e. 
complete correction). When no attenuation correction was used, border artefacts appeared 
bilaterally. Inferior parietal and prefrontal artefacts appeared after calculated and standard 
attenuation correction, respectively. 
 
 
Figure 4.4.  Single-subject validation experiment: difference maps before and after 
transformation. (a): image registration attenuation correction, (b): no 

























Table 4.4. Single-subject validation experiment: difference maps before vs. after 7 mm z-
axis transformation 
 
 Talairach coordinates 






IR - - - - 
NAC -69, 21, -18 







CB -27, 24, -9 







standard -33, 18, 45 
12, 60, 33 











IR= image registration, NAC= no attenuation correction, CB= contour based method 
 
 
3. Case-report of task related motion during H2
15O PET symptom provocation 
Randomisation of the conditions resulted is an unequal distribution of the conditions over 
the total study period in this patient, starting with 4 symptom conditions followed by 4 
baseline conditions. Halfway the experiment, between the fourth and fifth emission scan, 
patient motion of about 4 mm in the z-axis occurred. Before and after this z-axis 
transformation no other significant patient motion occurred. Combination of poor 
randomisation and task related motion therefore resulted in systematic misalignment 
between the initial transmission scan and the fifth to eighth emission scans, which all 
corresponded to the baseline condition. In contrast, alignment of the transmission scan to 
the first four emission scans, corresponding to the symptom condition, was much better.  
 
 
Table 4.5. Case report: main effects during provocation of contamination fear. 
Symptom condition > baseline condition  
 
 Talairach coordinates 






IR - - - - 
NAC - - - - 
CB - - - - 
standard -9, 18, 30 
51, 51, -15 
-3, -99, -15 














IR= image registration, NAC= no attenuation correction, CB= contour based method 
  
 
Figure 4.5d shows the results of the subtraction analysis, comparing symptom with baseline 




















activation was found, which could have been associated with provocation of contamination 
fear. Different results, however, were found with alternative attenuation correction 
methods. Figures 4.5a, 4.5b and 4.5c illustrate results of subtraction analyses when IR, 
NAC, and CB methods were used, respectively (see also Table 4.5). The ventromedial 
prefrontal regions disappeared completely. 
 
 
Figure 4.5.  Case report: main effects during provocation of contamination fear. 
Symptom state > baseline. (a): image registration attenuation correction, 





To simulate the effect of motion, independent of difference in brain activation, the first 
emission scan was corrected for attenuation using 8 differently transformed transmission 
scans. The result of this simulation is shown in Figure 6, where the difference map of the 
SPM analysis is projected onto a reconstructed emission scan. The highlighted 
ventromedial prefrontal cortex indicates a false-positive area, which was detected as 
significantly activated in the SPM analysis. Note that this region corresponds with the 
results shown in Figure 4.5d. 
 
 






















4. OCD-group analysis 
Table 4.6 and Figure 4.7 show the results of provoked contamination fear in 11 OCD 
patients compared with their baseline condition. Activation of the left amygdala was found 
to be more significant when using the IR method compared with standard attenuation 
correction. Moreover, when no or calculated attenuation correction was used, no significant 
difference between the conditions was found.  
 
 
Table 4.6. Group analysis (N=11 OCD patients): main effects during provocation of 
contamination fear. Symptom condition > baseline condition 
 
 Talairach coordinates 






IR 18, -6, -14 183 4.76 0.039 
NAC - - - - 
CB - - - - 
standard 18, -6, -12 137 4.75 0.049 
 
IR= image registration, NAC= no attenuation correction, CB= contour based method 
 
 
Figure 4.7.  Group analysis (N=11 OCD patients): main effects during provocation of 
contamination fear. Symptom state > baseline (a): image registration 
attenuation correction, (b): no attenuation correction, (c): contour based 

























As illustrated in this study, subject motion during PET examination may lead to 
misalignment between transmission and emission scans. When standard attenuation 
correction is used this transmission-emission mismatch can result in both underestimations 
and overestimations of regional activity concentrations. If random motion occurs, 
transmission-emission mismatch is likely to result in diminished signal-to-noise ratios. This 
effect is shown both in the single subject validation study and the clinical group analysis. In 
the case of task related motion, as clearly shown in the clinical case-report, systematic 
reconstruction artefacts occur, leading to false-positive or false-negative results. Therefore, 
possible remedies to reduce motion induced reconstruction artefacts were compared. 
 
Subtraction analysis is independent of subject motion when no attenuation correction is 
used. Results of the present study confirm that motion induced false-positive results, found 
when standard attenuation correction is used, disappear in the case of subtraction analysis 
without attenuation correction. Table 4.3 shows highest Z-values for NAC compared with 
IR, standard and CB methods. In case of no attenuation correction, however, border 
artefacts and extra-cranial activations appear, possibly due to the relatively higher pixel 
values near the border of the object. Moreover, this method is not suitable in the case of 
quantitative analyses, such as those used for ligand studies. 
 The contour-based attenuation correction methods involve image reconstruction 
without attenuation correction followed by manual geometric fitting of contours17. The 
present results show less significant results and artefacts when the CB method is used. This 
can be explained by increased noise in emission data resulting in irregular drawn contours, 
which in turn lead to increased noise and artefacts in reconstructed data. The CB methods 
neglect or only approximate density inhomogeneities within the head, thereby introducing 
inaccuracy. This drawback is of less importance in the case of H2
15O PET activation 
studies, but makes its use in ligand studies less attractive. Secondly, the method requires 
user intervention and selection of thresholds, which can easily introduce errors. To reduce 
user intervention, more automated contour-finding algorithms have been described in which 
object contours are estimated through back projection of emission sinogram borders, using 
the positions of maximum slopes in projection data, rather then from reconstructed 
images17;18. The advantage of the latter method is that no extra reconstruction is needed. 
However, the algorithm still assumes uniform skull and extra-cranial tissue thickness. 
Weinzapfel et al.19 tackled the problem of natural variations in scalp and skull thickness, by 
using the reciprocal of each emission sinogram to generate the ACF’s. The implementation 
of the CB method (CTI PET systems, ECAT software version 7.1), used in this study, 
however, might be less applicable for PET studies due to its poor performance in case of 
low count statistics in PET emission data. 
 
A third approach is the realignment of repeated brief transmission scans with an initial high 
statistics transmission scan. Repeated brief transmission scans of less than 2 minutes, prior 
or immediately after each of the subsequent emission scans, can be performed to align the 
initial high quality transmission scan to the emission scans20-22. Since such low-counts 




















transmission scan is used to obtain accurate ACF’s. However, even with this procedure, 
correct alignment between the short transmission scans and emission scans is not assured. 
The latter may be especially important in case of PET activation studies, where subject 
motion might be related with a specific condition or stimulus. In this case transmission 
scans need to be acquired while presenting the same condition to the subject as during each 
emission scan. The latter procedure, however, may confound subjects’ task related activity, 
for example by inducing habituation. 
A fourth alternative to prevent misalignment of emission and transmission data is 
simultaneous transmission and emission scan acquisition23-26. Simultaneous acquisition of 
transmission and emission scans reduces the efficiency of the technique significantly. The 
increase in noise must be weighted against the advantages of reduction in scanning time 
and the absence of misalignment between the scans. In addition, spill over from emission 
data into transmission data and vice versa might also result in less accurate attenuation 
correction and reduced quantification of PET scans.  
 
Finally, optimal alignment between transmission and emission data, thereby improving the 
accuracy of attenuation correction, can be obtained by the image registration method, as 
proposed by Andersson et al.4;5. In the present study, this method gave the best reduction of 
noise and false-positive results. In addition, the group analysis showed that this method 
provided optimal statistics. Andersson tested the method on phantoms and a very few 
patient studies. Later, Smith et al.6 tested this method on a limited number of patients. In 
the latter study, however, the effects of subject motion on attenuation correction and the 
performance of this image registration method was only evaluated for 2 regions of interest 
placed laterally in the brain. Therefore, the present study gives a more elaborate evaluation 
of the method, using phantom, single subject and group studies applying a whole-brain 
voxel based statistical analysis.  
The phantom data showed excellent accuracy of the algorithms for image 
registration, reconstruction and forward projection of transmission scan data. The average 
difference was less than 1% for a homogeneous cylindrical phantom and less than 3% for a 
3D-brain phantom. In contrast, differences larger than 15% were observed when misaligned 
transmission scans were used without any motion correction. 
The human studies showed that the IR method reduced noise for a group analysis 
and removed false positive results in the case of task related motion, while improving the 
signal from expected activated areas. This was in contrast with NAC and CB methods. By 
using no attenuation correction, reduction of noise can be achieved at the cost of extra-
cranial artefacts and loss of statistical power. The CB methods showed similar results, 
which might be due to poorly drawn (automatic) contours as a result of limited statistics in 
emission data. Despite the limitations of NAC and CB methods, they have advantages over 





For quantitative and parametric analyses of PET activations studies, the image registration 




















reconstructions using standard (i.e. no motion correction) measured attenuation correction, 
contour based calculated attenuation correction and no attenuation correction. Therefore, in 
our view, the IR method should be considered as a first choice for attenuation correction in 
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In the present study, we sought to investigate which brain structures are recruited in 
planning tasks of increasing complexity. For this purpose, a parametric self-paced pseudo-
randomised event-related functional MRI version of the Tower of London task was 
designed. We tested twenty-two healthy subjects, enabling assessment of imaging results at 
a second (random effects) level of analysis. Compared with baseline, planning activity was 
correlated with increased blood oxygenation level dependent (BOLD) signal in the 
dorsolateral prefrontal cortex, striatum, premotor cortex, supplementary motor area and the 
visuospatial system (precuneus and inferior parietal cortex). Task load was associated with 
increased activity in these same regions. In addition, increasing task complexity was 
correlated with activity in the left anterior prefrontal cortex, a region supposed to be 
























Planning, i.e. the ability to achieve a goal through a series of intermediate steps, is an 
essential component of higher-order cognitive processes, such as problem solving. Central 
in the concept of the neuronal substrate for cognitive planning is the position of the 
dorsolateral prefrontal cortex, but other brain regions, like the premotor, cingulate, and 
insular cortices and the striatum have also been implicated in cognitive planning1;2. 
Whereas until recently insight in the role of brain structures in planning processes was 
primarily based on lesion studies in patients, contemporary studies are able to employ 
human brain imaging techniques. The results of such functional neuroimaging studies have 
suggested that a distributed cortico-cortical and cortico-subcortical network is being 
activated during complex planning tasks, although there is yet no complete agreement about 
the contribution of the various components of such neuronal networks.  
A direct and very frequently used test to probe planning processes is the Tower of 
London task, originally developed by Shallice3. The Tower of London task has been 
modified in various ways to make it suitable for testing different components of cognitive 
planning in clinical and experimental psychological settings. The complexity of the task can 
range from trivial, requiring only one obvious move, to highly complex. The more complex 
versions of the task require the planning of intermediate, in many instances counter-
intuitive steps to successfully solve a problem. Individuals with decreased prefrontal 
functioning, such as those with neurosurgical lesions3, neurodegenerative diseases like 
Huntington’s or Parkinson’s disease4-6 or psychiatric disorders like obsessive-compulsive 
disorder7 and schizophrenia8 are impaired on the task, in particular when complexity 
increases.  
The Tower of London task is also very suitable to study in healthy subjects the 
patterns of brain activation in the context of planning tasks using Positron Emission 
Tomography (PET)4;9-11 or Single-Photon Emission Computer Tomography (SPECT)12;13. 
The results of these imaging studies agree on the involvement of the dorsolateral prefrontal 
cortex and parieto-occipital regions (visuospatial system) during planning. However, 
activation of other brain regions, such as the cingulate and insular cortices, and the striatum, 
has not been found across all mentioned studies. Furthermore, the results of a functional 
MRI study using the Tower of London task of Lazeron et al.14, confirmed activation of the 
dorsolateral prefrontal, parietal, cingulate and insular cortices but failed to show striatal 
activation. Several methodological differences between these studies may explain the 
inconsistencies in the results. First, different baseline conditions have been used, ranging 
from low-level conditions (watching a blank screen) to conditions involving motor activity 
(moving beads without a goal) or cognitive functioning (counting beads). Second, 
differences in the execution of the task exist: whereas in some studies subjects used a touch 
screen to perform the task4;9;11, in other designs subjects were requested to execute their 
moves mentally10;14. A third likely source of inconsistency concerns the differences in task 
load. Because in subtraction designs the specificity of active vs. baseline differences for the 
(cognitive) function under study is often questionable15;16, several researchers have used 
designs in which task load during performance of the Tower of London task was 
manipulated. For example, Baker et al.10, in comparing ‘difficult’ (4-5 moves) and ‘easy’ 




















flow (rCBF) in rostrolateral and dorsolateral prefrontal cortex, and the parietal and 
cingulate cortices. Owen et al.9 reported increased activation in striatum and thalamus, but 
not in cortical areas. Lazeron et al.14 did not find any difference between their ‘easy’ and 
‘difficult’ versions, but they used a more difficult design comparing 2-4 moves to 5-7 
moves. The only study employing a parametric approach in studying task load4, used five 
levels of planning and showed a correlation between planning complexity and increased 
rCBF in the right caudate nucleus, and prefrontal and cingulate areas. The involvement of 
visuospatial areas in the parietal lobe, however, seemed not to be related to the task load. A 
general methodological drawback in the studies performed so far, is the lack of control over 
performance differences, due to the use of blocked designs. Since performance is likely to 
deteriorate at higher complexity, this is especially relevant for parametric tasks.  
 
It must be assumed that the various cortical and subcortical brain structures that have been 
demonstrated to be involved in planning processes, execute these functions as “nodes” in 
distributed neuronal networks1. Employing a neuronal network model for planning 
processes, Dehaene and Changeux17 proposed multiple hierarchic levels with ascending and 
descending streams for execution of planning and evaluation of this behaviour, 
respectively. This model also stresses that planning behaviour cannot be related to a single 
region, but rather relies on multiple neuronal circuits coding for specialised subprocesses 
such as working memory, plan generation and internal reward. These subprocesses may 
differentially contribute to different levels of planning behaviour; some sub-processes may 
be relatively independent of task load, while other sub-processes are involved mainly at 
higher levels of planning behaviour. The main aspect in increasing planning complexity is 
the increasing amount of sub-goals and counterintuitive moves, while holding in mind the 
overall main goal. Koechlin et al.18 introduced the term “branching” for this process of 
integrating working memory with attentional resource allocation, a third order higher 
cognitive function. They found, using a multitask experiment, branching to rely on 
activation of the rostral part of the prefrontal cortex. To be able to investigate these specific 
sub processes and to differentiate between different brain regions in their contribution to 
different levels of planning behaviour, parameterisation of the task is essential. Therefore, 
the main aim of the present study was to determine the effects of task load in planning 
execution.  
 
The present study employs event-related functional MRI, as a method to study activation 
patterns on a trial-by-trial basis. This enabled us (i) to randomise items with regard to task 
complexity, and (ii) to include correct responses only. A large number of subjects (n=22) 
was included, with the aim of performing second-level or random effects analyses, allowing 
for generalisation of our results. On the basis of the considerations above,  we hypothesised 
that increased planning complexity would be associated with increased activity in 
dorsolateral prefrontal, visuospatial and striatal regions. In addition, we expected rostral 























Materials and methods 
 
Subjects 
Twenty-two healthy right-handed subjects (11 men and 11 women; mean age 29.9 years, 
range 21-49 years) performed the Tower of London task, while functional MRI data were 
collected. Subjects were recruited among university students and staff. The ethical review 




Figure 5.1. Display screen of the Tower of London task as used in the present study. 
A: planning condition. 
 
B: baseline condition. 
 
Task paradigm 
To ensure that participants were familiar with the procedure, the test was explained and 
practised outside the scanner before MR imaging was performed. The present version of the 
Tower of London task consisted of six conditions: a baseline condition and five planning 
conditions ranging from 1 to 5 moves. In the planning condition, subjects were presented, 
on a single screen, a starting configuration and a target configuration with the instruction 
“count the amount of steps” displayed at the top and two answers at the bottom (Figure 
5.1A). In both configurations, three coloured beads are placed on three vertical rods, which 
can accommodate one, two and three beads, respectively. One bead can be moved at a time 
and only when there is no other bead on top. Subjects were requested to determine the 
minimum number of moves necessary to reach the target configuration and to press the 
button corresponding to the side of the screen (left or right) where the correct answer was 
presented. In the baseline condition, subjects simply had to count the total of yellow and 
blue beads, a task which does not require any planning activity, the display being similar to 
the planning condition, but the instruction now being “count the total amount of yellow and 
blue beads” (Figure 5.1B). Moreover, the number of beads of each color in the two 
configurations, used for the baseline condition, was unequal, with the aim of preventing 
planning activity. We used a pseudo-randomised, self-paced design with a maximum 
response duration of 30 seconds for each trial. We adopted a pseudo-randomised design to 
control for any overflow effects (i.e. persevering of task related cognitive processes after a 
difficult trial). Therefore, each trial of 3 or more moves was followed by a baseline trial. No 





















Imaging was performed on a 1.5 T Sonata MR system (Siemens, Erlangen, Germany) with 
a standard circularly polarised head coil. Stimuli were generated by a Pentium PC and 
projected on a screen at the end of the scanner table, which was seen through a mirror 
mounted above the subject’s head. Two magnet-compatible four-key response boxes were 
used to record subject’s performance and reaction times (RT). To reduce motion artefacts, 
the subject’s head was immobilised using foam pads; in addition, we used automatic online 
motion correction. 
Anatomic imaging included a coronal 3D gradient-echo T1-weighted sequence (matrix 
256x160, voxel size 1x1x1.5 mm, 160 sections). For functional MR imaging, a echo planar 
imaging sequence (TR 3.045 sec., TE 45 msec., matrix 64x64, field of view 192x192 mm, 
flip angle 90o) was used, creating transversal whole-brain acquisitions (35 slices, 3x3 mm 
in-plane resolution, 2.5 mm slice thickness, 0.5 mm interslice gap). In total, 433 EPI 
volumes per subject were scanned. The distribution frequency of event types was based on 
RT data of a pilot study, so that a similar amount of scans (around 70 EPI volumes) was 
acquired per subject for each of the six conditions.  
 
Data Analysis 
Psychometric data were analysed using a standard statistical package. Imaging data were 
analysed using SPM99 (Wellcome Department of Cognitive Neurology, 
http://www.fil.ion.ucl.ac.uk/spm). After discarding the first 4 volumes, time-series were 
corrected for differences in slice acquisition times and realigned. Spatial normalisation into 
approximate Talairach and Tournoux space was performed using a standard SPM EPI 
template. Data were resliced to 2x2x2 mm voxels and spatially smoothed using a Gaussian 
kernel of 6 mm.  
Next, data were analysed in the context of the General Linear Model, using delta functions 
convolved with a canonical hemodynamic response function to model responses of varying 
length to each type of stimulus. In addition, error trials were modelled separately as a 
condition of no interest. For each subject, weighted contrasts were computed for simple 
main effects (all active conditions vs. baseline) and for task load. Contrast images 
containing parameter estimates for main effects and task load were entered into a second 
level (random effects) analysis. All results are reported at p < 0.05 (z-score > 5.00) 






Mean performance scores were 94.2 % (SD = 1.68) for baseline (mean RT = 3.7 sec, SD = 
0.88), 97.6 % (SD = 2.02) for 1 move (mean RT = 4.4 sec, SD = 1.11), 95.4% (SD = 3.99) 
for two moves (mean RT = 5.8 sec, SD = 1.27), 96.7 % (SD = 3.58) for three moves (mean 
RT = 7.4 sec, SD = 1.90), 89.9 % (SD = 7.17) for four moves (mean RT = 10.1 sec, SD = 
2.51) and 82.2 % (SD = 12.59) for five moves (mean RT = 15.0 sec, SD = 4.02). Both the 
decrease in performance (F(4,18)=12.4, p<0.0001) and the increase in RT (F(4,18)=64.3, 






















1. Planning vs. baseline 
Regions showing increased BOLD signal during planning compared with baseline (Table 
5.1 and Figure 5.2) were bilateral precuneus (Brodmann’s area (BA) 7), bilateral inferior 
parietal cortex (BA 40), bilateral premotor cortex (BA 6), right dorsolateral prefrontal 
cortex (BA 9 and 46), left supplementary motor area, left caudate nucleus, right globus 
pallidum and right insular cortex. 
 
 
Table 5.1. Maxima of regions showing significant (p<0.05 (z>5.00), corrected) BOLD 




Region of activation Left/Right Brodmann’s  
area 








































































































Caudate nucleus L  -8 8 0 8 5.01 
Globus pallidus R  12 6 6 41 5.53 
Insular cortex R  32 24 -4 23 5.59 
 
 
Figure 5.2.  Glass brain renderings showing BOLD signal increase correlating with 























2. Task load 
Increased task load (Table 5.2) was correlated with increased BOLD signal in those areas 
that already showed an increased signal compared with the baseline condition, i.e. bilateral 
precuneus (BA 7), bilateral inferior parietal cortex (BA 40), bilateral premotor cortex (BA 6 
and 8), right dorsolateral prefrontal cortex (BA 9 and 46) and left supplementary motor 
area. In addition, a number of areas showed increased BOLD signal specifically related to 
increased task load (Figures 5.3 and 5.4), i.e. left dorsolateral prefrontal cortex, left insular 
cortex, right pallidum and right caudate nucleus. The left rostral prefrontal cortex (BA 10) 
was also involved in the highest levels of planning complexity only. The reverse contrast 
(decreased BOLD signal associated with increased task load) did not show significant 
activations except for bilateral primary visual cortex. 
 
 
Table 5.2. Maxima of regions showing significant (p<0.05 (z>5.00), corrected) BOLD 




Region of activation Left/Right Brodmann’s 
area 





Anterior PFC L 10 -36 60 8 2 5.02 





















































































































































R  18 6 18 23 5.43 
Globus pallidus R  12 4 4 23 5.58 






















Figure 5.3.  
BOLD signal increase in bilateral 
dorsolateral prefrontal cortex and right 
caudate nucleus, correlating with 





BOLD signal increase in left 
Brodmann’s area 10 and right pallidum, 







In this paper we present a parametric event-related functional MRI version of the Tower of 
London task, suitable to investigate the effects of increasing complexity in planning 
processes. In agreement with the results of earlier imaging studies, the present fMRI data 
show that the process of planning, compared with baseline, was strongly correlated with 
activation of the right dorsolateral prefrontal cortex (BA 9 and 46), bilateral premotor 
cortex (BA 6 and 8), bilateral precuneus (BA 7) and inferior parietal cortex (BA 40), left 
supplementary motor area (BA 32), right insular cortex, and bilateral striatum4;9-14;19. Our 
parametric approach also shows that with increasing planning complexity a number of 
additional areas comes into play, i.e. the left dorsolateral (areas 9 and 46) and rostral 
prefrontal cortices (BA 10) as well as the right caudate nucleus. These are, at least in part, 
novel observations.  
 
Involvement of the dorsolateral and rostral prefrontal areas is in agreement with the 




















information already stored in memory, engage dorsolateral prefrontal cortex20. Rostral 
prefrontal cortex activation, on the other hand, may reflect a more complex third level of 
executive control, holding temporarily in mind an ongoing goal while first completing 
intermediate or sub-goals, although we cannot rule out the alternative explanation, i.e. that 
rostral prefrontal activation merely reflects increasing task difficulty. Burgess et al.21 
investigated the phenomenological correlates of prospective memory and found activation 
of the rostral prefrontal areas correlated with maintenance of intention. This higher-order 
supervisory cognition, specific for humans, functions beyond the manipulation in 
dorsolateral prefrontal cortex and maintenance in ventrolateral prefrontal regions20;22. 
We found dorsolateral prefrontal activation to be right lateralised in the 
comparison planning vs. baseline, but was bilaterally occurring as a function of task load. 
Lateralisation probably exists, with spatial predominance at the right hemisphere and non-
spatial predominance at the left side, but there is no consensus about the exact nature of this 
lateralisation. While Baker et al.10 found right rostral prefrontal cortex activity to be 
strongly correlated with planning complexity, in present study left lateralisation was found 
for this rostral prefrontal area (Brodmann’s area 10).  
 
In the present study, right striatal activation (head of the caudate nucleus) was correlated 
with task load. Striatal involvement in planning complexity has been described before4;9. In 
conjunction with the increased activity of dorsolateral and rostral prefrontal areas, this 
suggests a role for the frontal-striatal system in complex planning tasks. In terms of 
forebrain circuits, this indicates an involvement of particular basal ganglia-thalamocortical 
circuits23;24 which are directed at various parts of the prefrontal cortex. Interactions between 
the prefrontal cortex and the basal ganglia are thought to play a role in the selection and 
switching of behavioural components25, which are crucially important for the execution of a 
(complex) planning process. In the context of the neuronal network model of Dehaene and 
Changeux17, our finding of involvement of various cortical and subcortical regions related 
to increased planning complexity, strengthen the idea of distributed cortico-cortical and 
cortico-subcortical networks as a neuronal basis for such higher order cognitive processes. 
The involvement of the striatum might represent, at least in part, the predicted role of a 
reward system in the cognitive processes26. 
As mentioned before, most previous studies used a block design with an easy and a 
difficult planning condition, thereby restricting the investigation of task load effects to a 
subtraction analysis of both conditions. That no task load effects were found in the 
functional MRI study of Lazeron et al.14 may be explained by this operationalisation of 
“easy” and “difficult” task conditions. The main aspect of planning complexity is 
presumably the amount of sub-goals to be attained before reaching the main goal. The 
“easy” condition of Lazeron et al. consisted of 2 to 4 moves items. Part of the 3 moves 
items and all 4 moves items need the counterintuitive intermediate steps characteristic for 
planning complexity. In the “difficult” condition subjects had to solve 5 to 7 moves items, 
which are quite hard to perform. Therefore, the difference between “easy” and “difficult” 
may have been obscured by the presence of complex items in the “easy” condition and the 
occurrence of ceiling effects in the “difficult” condition.  
Our results are also at variance with Dagher et al.4, who conducted a parametric analysis 




















correlate with task complexity. Brain regions where rCBF correlated with planning 
complexity included bilateral dorsolateral prefrontal, premotor and anterior cingulate cortex 
and right caudate nucleus. In contrast with our results, Dagher et al.4 found parietal 
activation not to be correlated with task complexity. Since this PET study consisted of only 
6 subjects with 12 measurements per subject, all data were analysed using a fixed effects 
analysis, and results were presented uncorrected for multiple comparisons. Another 
important confounding factor may have been that subjects had to perform the planning task 
by touching the screen to move the beads. Motor execution is not essential for planning and 
may produce motion artefacts, confounding experimental effects. For this reason, we asked 
our subjects to execute their plan by making the moves mentally. Even without motor 
execution, massive activation of motor and visuospatial areas was found. Parietal activation 
caused by motor execution, independent of specific planning behaviour, is not correlated 
with task complexity, while visuospatial activity necessary for planning is indeed correlated 
to task complexity.  
 
Compared with previous studies, the present version of the Tower of London task has two 
advantages. First, a self-paced, parametric design allows flexible responding as well as 
comparisons between subjects/groups at each task level, providing us with the opportunity 
to investigate subjects and groups with varying levels of performance. The increased 
comparability across groups, using the same task, is important for clinical studies, for 
instance in patients with decreased functioning of the frontal-striatal system. Second, in 
addition to variation in reaction time, performance may also vary in hit percentage. Event-
related analysis enables a selective analysis of correct responses, by rejecting the false 
responses. Moreover, adequate randomisation of trials is possible in event-related designs, 
in contrast to block designs.  
In summary, frontal-striatal and visuospatial systems are strongly involved in 
planning behaviour and their level of activity is related to task complexity as demonstrated 
by the described self-paced, parametric event-related version of the Tower of London task. 
By correcting for task performance differences, it will be possible to investigate planning 
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Previous imaging studies of obsessive-compulsive symptom states have implicated frontal-
striatal and limbic regions in the pathophysiology of obsessive-compulsive disorder (OCD). 
Functional imaging studies, however, have yielded inconsistent results, presumably due to 
methodological differences (patient inclusion criteria, stimulus paradigm, imaging 
technique, and absence of control groups). In the present study, randomized presentation of 
contamination-related and neutral visual stimuli was used to investigate the 
neurophysiological correlates of contamination fear in a group of medication-free OCD 
patients with washing behaviors and healthy controls. 
Twenty-one subjects (11 OCD patients and 10 healthy controls) were scanned 
using H2
15O PET. Subjects were presented with pictures of clean and dirty surroundings 
and were requested to make indoor/outdoor decisions to control for attention differences. 
State anxiety and obsessionality were rated after each scan using visual analogue scales.  
Main effects of stimulus type (contamination vs. neutral) were found in bilateral 
occipital cortex in both groups. A significant group interaction effect was observed in the 
left amygdala reflecting enhanced activity in response to contamination stimuli in OCD 
patients. Sensitization effects were observed in the right amygdala in the OCD group; these 
paralleled an increase in levels of distress and obsessionality as well as a decrease in 
dorsolateral prefrontal activity.  
The findings of the present study are consistent with the hypothesis of decreased 
frontal-striatal control of limbic structures, specifically the amygdala, resulting in an 






















Obsessive-compulsive disorder (OCD) is a common psychiatric disorder, affecting more 
than 1% of the population1. This chronic disorder generally manifests itself first during 
adolescence and has a fluctuating course during adult life. OCD is characterized by 
recurrent intrusive thoughts (obsessions) and repetitive ritualistic behaviors (compulsions). 
These rituals can be highly time-consuming and result in considerable morbidity, whereas 
concomitant anxiety symptoms often are less prominent at clinical presentation.  
Although the pathogenesis of OCD is incompletely understood, a number of 
neuroimaging studies have reported neuro-anatomical and functional abnormalities in 
OCD, particularly involving prefrontal-striatal and limbic regions. These studies, both 
volumetric and functional, have not yielded unequivocal results, however. Structural 
abnormalities in OCD have been described in the caudate nucleus in some studies2-4, whilst 
in other studies no differences between OCD patients and normal controls were evident5;6. 
Jenike et al.7, using magnetic resonance imaging (MRI), found significantly diminished 
total white matter and increased total cerebral cortex and opercular volumes in OCD 
patients compared with controls. These results were only partially confirmed by Kim et al.8, 
who found increased gray matter (GM) density in frontal subcortical areas, but decreased 
GM density in other regions, in particular the cerebellum. In contrast, Szeszko et al.9 
reported reduced orbitofrontal and amygdala volumes (both GM and white matter), and 
lack of normal hemispheric asymmetry of the hippocampus-amygdala complex.  Although 
these inconsistencies may reflect various methodological differences such as patient 
inclusion criteria, imaging modality, and data analysis techniques, they also suggest that 
volumetric abnormalities in OCD, if present, are at best subtle. 
Early functional imaging studies in OCD have been performed using Positron 
Emission Tomography (PET), with 18fluoro-deoxyglucose (FDG) as a tracer, assessing 
resting state glucose metabolism10-13. Baxter et al.10 reported hypermetabolism of the left 
orbital gyrus and bilateral caudate nucleus. In addition, striatal hypermetabolism 
normalized after successful treatment, either pharmacotherapy14 or behavioral therapy15. 
The normalizing effect of pharmacotherapy on caudate hyperactivity has been replicated by 
many groups16-19. In a similar vein, Rauch et al.20 found that pre-treatment increased 
regional cerebral blood flow (rCBF) in orbitofrontal and posterior cingulate cortices 
predicted response to pharmacotherapy in OCD patients with prominent contamination fear.  
To our knowledge, at present six imaging studies in OCD have been published in 
which symptom provocation was employed to differentiate between state and trait aspects. 
In a H2
15O PET study, McGuire et al.21 used tactile stimuli (various contaminants sealed in 
glass tubes) in four medication-free male OCD patients. Symptom scores (and state 
anxiety) were correlated with increased activity in the right inferior frontal gyrus, basal 
ganglia, thalamus, left hippocampus and posterior cingulate cortex. Rauch et al.22, using 
C15O2 PET, similarly compared responses to individually tailored provocative versus 
neutral stimuli in a sample of 8 male OCD patients and found increased relative regional 
cerebral blood flow during OCD symptom versus resting state in bilateral orbitofrontal 
cortex, right caudate nucleus and left anterior cingulate cortex. The same group performed a 
similar study in 10 OCD patients two years later, using functional MRI, also with 





















found in the medial, right dorsolateral, and left ventrolateral prefrontal cortices (PFC), as 
well as in bilateral temporal cortex. At a lower statistical threshold, insular and anterior 
medial temporal regions were also found to be more active in the majority of patients. Since 
9 out of 10 OCD subjects in the Breiter study23 were taking medication at the time of 
scanning, Adler et al.24 replicated the study in medication-free OCD patients and reported 
increased activity in the orbitofrontal, anterior cingulate, bilateral anterior and lateral 
temporal cortices, as well as the right medial temporal cortex, during symptom provocation 
compared with baseline.  
In two studies, OCD subcategories were investigated. Cottraux et al.25 used neutral 
vs. idiosyncratic obsession-related auditory scripts during H2
15O PET in 10 OCD patients 
with checking rituals and in 10 normal controls. In both groups, orbitofrontal perfusion was 
higher during provoked vs. neutral state. In addition, regional cerebral blood flow was 
higher in basal ganglia in controls. Finally, Phillips et al.26 compared ‘checkers’ and 
‘washers’ using standardized visual stimuli during functional MR imaging. Similar to the 
results of Cottraux et al., increased frontal-striatal activity in “checkers” and normal 
controls was found. In contrast, insular activity was observed in ‘washers’, although these 
effects did not survive in an interaction analysis. A methodological drawback of the Phillips 
et al. study was that the majority of patients were using psychotropic medication.  
Taken together, these studies have implicated a number of regions in the 
pathophysiology of OCD. It has been hypothesized that frontal-striatal involvement reflects 
ritualistic behavior, even in normals25, whereas increased medial temporal activity has been 
associated with (pathological) anxiety21, and insular activity with disgust26;27.  
Similar to volumetric studies, inconsistent findings in functional imaging studies in 
OCD may result from a number of methodological issues, such as different imaging 
modalities, medication status, and small sample size. In addition, in all studies, with the 
exception of Phillips et al.26, individually tailored and therefore heterogeneous stimuli were 
used, i.e. not only contaminants, but also stimuli related to aggression/danger or sexual 
obsessions. Therefore, it cannot be ruled out that different symptoms are associated with 
different neuronal substrates. In addition, the use of idiosyncratic stimuli prohibits 
assessment of group by task interactions. Moreover, most studies used tactile stimuli, which 
may necessitate ritual behavior (hand washing), interrupting the scanning session. 
Consequently, in these studies off-on paradigms had to be used, carrying the risk of order 
effects. For example, in a recent PET study it was shown that condition-related subject 
motion might produce considerable false-positives due to transmission-emission 
mismatches28.  
 
In the present study, we aimed at investigating neurophysiological correlates of 
contamination fear. Only OCD subjects with prominent contamination fear were included, 
and presented with ‘clean’ vs. ‘dirty’ stimuli. Similar to the Phillips et al. study 26, visual 
stimuli, matched for visual complexity were used, thereby obviating the need for cleaning 
rituals. Moreover, these stimuli, although ranging in severity, are universally aversive, so 
that the same paradigm could be used both in patients and control subjects. In contrast to 
the Phillips et al. study, we included only medication-free OCD patients. Finally, H2
15O 
PET rather than fMRI was used, as the advantage of high spatial resolution (fMRI) was 




















allow return to baseline, a smaller risk of claustrophobic reactions, and the absence of 
susceptibility artifacts in regions of interest such as anterior medial temporal lobe, in 
particular in the amygdala, and orbitofrontal cortex. Each subject had 8 scans (4 active and 
4 baseline), randomized across subjects (11 medication-free OCD patients and 10 normal 
controls), which allowed examination of condition by time interactions. The specific 
experimental prediction was that contamination fear would result in recruitment of those 
circuitries hypothesized to play a role in ritualistic behavior (frontal-striatal system), 
anxiety (amygdala) and disgust (insula).  
 
 
Patients and Methods 
 
Subjects 
Eleven medication-free OCD patients (three women, eight men, age 40.5 ± 9.2 years) and 
ten normal control subjects (three women, seven men, age 36.5 ± 8.8 years) were included. 
All subjects were right-handed. Exclusion criteria were the presence of major medical 
illness, other major psychiatric disorders, and the use of psychotropic medication. 
Diagnosis was established using the Structured Clinical Interview for DSM-IV Axis I 
Disorders (SCID-I). The Yale Brown Obsessive-Compulsive Scale (Y-BOCS)29 and the 
Padua Inventory-revised (Padua-IR)30;31 were used to assess symptom characteristics and 
severity scores. Only subjects with prominent contamination fear as measured with the Y-
BOCS symptom checklist were included. Scores on Y-BOCS and Padua-IR for OCD 
patients were 23.8 ± 6.1 and 73.3 ± 22.5, for controls 0 and 12.9 ± 11.9 respectively, which 
represented significant differences (Y-BOCS: F (1,19)=179.4, p<0.001; Padua-IR: F 
(1,19)=50.0, p<0.001). Subjects were recruited from the Outpatient Department of 
Psychiatry, VU University Medical Center and the Dutch Phobia Organization. All subjects 
gave written informed consent. The protocol was approved by the Medical Ethical 
Committee of the VU University Medical Center. 
 
OCD symptom provocation paradigm 
Visual stimuli were presented to each subject to provoke contamination fear while PET data 
were obtained. A scanning session consisted of 8 randomly ordered H2
15O PET scans: 4 in 
the control condition (clean pictures) and 4 in the symptom condition (dirty pictures). 
Twenty seconds after injection of H2
15O, eleven pictures were presented sequentially on a 
high-resolution flat screen. Each picture was shown for three seconds, followed by a one 
second blank screen. To control for attention, subjects were asked to indicate for each 
picture (using a response box) whether it represented an indoor or outdoor situation. After 
each scan a resting period of eight minutes followed. During this resting phase, subjects 
were asked to rate subjective distress (ANX) and obsessionality (OBS) using 100-point 
analogue scales. In total 44 different dirty and 44 clean pictures were presented to each 
subject (examples are shown in Figure 6.1).  
 
Image acquisition and reconstruction 
PET scans were acquired on an ECAT EXACT HR+ scanner (CTI/Siemens, Knoxville, 





















cannula was inserted into the left antecubital vein and normal saline was infused. A 
transmission scan was performed first for the purpose of attenuation correction of the 
subsequent emission scans. For each emission scan 10-15 ml normal saline containing 450 
MBq of H2
15O was administered as a bolus injection using an infusion pump. Data 
acquisition lasted 90 seconds (20 seconds before, 44 seconds during and 26 seconds after 
stimulus presentation) and the interval between successive H2
15O injections was 8 minutes 
to allow for radioactive decay. In the present study, transmission scans of ten minutes were 
acquired in 2D mode for all studies. All emission scans were acquired in 3D mode. To rule 
out task related motion artifacts, data were reconstructed using an image registration 
method28 with ordered subset expectation maximization (OSEM)33;34 applying 4 iterations 
with 16 subsets35. For each subject, a T1-weighted structural MR-scan was also acquired 
using a 1.5 Tesla Sonata (Siemens, Erlangen) MR scanner (magnetization prepared-rapid 
acquisition gradient echo (MP-RAGE); inversion time = 300 ms, TR = 15 ms, TE = 7 ms, 
flip angle = 80, voxel size = 1x1x1.5 mm).  
 
 
























Behavioral data were analyzed using a standard statistical package. After reconstruction, 
PET-images were analyzed using SPM99 (Wellcome Department of Cognitive Neurology, 
http://www.fil.ion.ucl.ac.uk/spm). Spatial preprocessing consisted of realignment, 
transformation to approximate Talairach36 anatomical standard space, as defined by the 
SPM99 template, and smoothing using a 10 mm Gaussian filter instead of the customary 16 
mm for PET group studies, resulting in an overall FWHM of 12 mm. Since the human 
amygdala is about 15 mm, the present smoothing is considered to be optimal to detect 
activation changes, which are just over 12 mm in diameter37. Data were analyzed using a 
linear regression model. Weighted contrasts were computed for condition and time effects 
for each group, and for group by condition interactions. Analyses of covariance were also 
performed to assess correlations between imaging data and psychometric measurements.  In 
view of the smoothness of the data after spatial preprocessing (ca. 12 mm FWHM), a 
combined height and extent threshold was used to report main effects of p<0.001 
uncorrected with an extent threshold of 25 voxels. Interactions (group by task, and group by 
time) were masked with the appropriate main effect and are reported at p<0.001 






Among patients, OBS scores reflected increased OCD symptomatology during the active 
condition vs. baseline (paired T-test: 30.3 ± 22.4 vs. 9.3 ± 13.0, p=0.003, one-tailed). An 
increase in OBS scores was also observed in normal controls (15.9 ± 17.9 vs. 0.6 ± 1.0, p = 
0.02, two-tailed). As expected, in the OCD group, subjective distress as expressed by ANX 
scores was higher during the active condition than during baseline (32.1 ± 18.3 vs. 26.1 ± 
21.4, p=0.05, one-tailed). For control subjects, we found no significant active vs. baseline 
increase in ANX scores (7.2 ± 5.4 vs. 9.3 ± 6.9, p> 0.1, two-tailed). Comparisons between 
the two groups revealed that OBS scores were higher in the OCD group at rest (ANOVA: 
F(1,19)=4.4, p=0.05) but not during the active condition (F(1,19)=2.6, p>0.1). ANX scores 
were higher in the OCD group at baseline (F(1,19)=7.4, p=0.01) as well as during the active 
condition (F(1,19)=13.7, p=0.002). Condition by time interactions were found only in the 
OCD group during the active condition, ANX and OBS scores showing an increase from 
the first (early) to the second (late) part of the session (ANX scores: 20.5 ± 33.9, p=0.09; 
OBS scores: 24.0 ± 28.6, p=0.03). Correlations between mean ANX and OBS ratings were 
only statistically significant during the active condition in the OCD group (r=0.63, p=0.04). 
 
PET data 
Main effects of symptom compared with baseline condition are listed in Tables 6.1 and 6.2. 
Provocation of contamination fear in OCD patients was correlated with increased regional 
cerebral blood flow (rCBF) in the left amygdala, extending into left anterior temporal 
cortex, left entorhinal cortex and hypothalamus, with additional activity in bilateral 





















dorsolateral prefrontal cortex, basal forebrain extending into orbitofrontal cortex, right 
caudate nucleus, left anterior temporal cortex and bilateral extrastriatal cortex (Figure 6.3).  
 
 




Region of activation 




Left amygdala region -18 -4 -16 202  4.8** 
Left occipital cortex -44 -78 6 168 19 4.0* 
Right occipital cortex 30 -68 -14 99 19 4.2* 
 
BA= brodmann’s area 
*= p<0.001 uncorrected for multiple comparisons, **= p<0.05 corrected for multiple comparisons 
 
 





Region of activation 




Left dorsolateral prefrontal cortex -18 44 32 96 9 3.7* 








261 25 4.1* 
3.9* 
Right caudate nucleus 18 10 14 37  3.7* 
Left anterior temporal cortex -42 28 -24 82 38 3.9* 
Left occipital cortex -44 -84 0 42 19 3.7* 
Right occipital cortex 26 -80 -18 63 19 3.9* 
 
BA= brodmann’s area 
*= p<0.001 uncorrected for multiple comparisons 
 
 
Figure 6.2.  PET subtraction images of provoked minus resting conditions for 11 
OCD patients displayed on mean T1-weighted MRI show activation in 






















Figure 6.3.  PET subtraction images of provoked minus resting conditions for 10 
control subjects displayed on mean T1-weighted MRI show activation in 
left dorsolateral prefrontal cortex (Talairach coordinates x, y, z = -18, 44, 
32), basal forebrain (Talairach coordinates x, y, z = 4, 12, -14) and right 





Group by condition interactions were found in left amygdala region, reflecting relative 
enhanced activity to contamination stimuli in the OCD group with relative decreases in left 
dorsolateral prefrontal cortex and right caudate nucleus (i.e. enhanced activity in normal 
controls) (Table 6.3 and Figure 6.4). Finally, significant time by condition interactions were 
observed in the right amygdala region in the OCD group, but not in controls (group by time 
by condition ANOVA, z-score = 2.75, p = 0.003 uncorrected, see Figures 6.5a and 6.5b), 
corresponding to a decrease in rCBF in this region during the successive resting state 
conditions and an increase in rCBF during the successive active conditions. These 
differential time courses for left and right amygdala in the provocation condition were 
confirmed by a region of interest (ROI) analysis, demonstrating a statistically significant 
negative correlation between left and right amygdala signal (r= -0.35, p= 0.022). 
 
 
Figure 6.4.  
Group by condition interaction analysis, 
showing increased rCBF in left amygdala 
(Talairach coordinates x, y, z = -18, -4, -
16) during provoked versus resting 
conditions in OCD patients compared 
with control subjects and in right caudate 
nucleus (Talairach coordinates x, y, z = 
18, 8, 16) in control subjects compared 
with OCD patients (statistical 
significance was thresholded at uncorr. p 






























Region of activation 





OCD > controls 
 
      
Left amygdala region -18 -6 -18 7  3.4* 
       
Controls > OCD 
 
      
Left dorsolateral prefrontal cortex -18 44 32 96 9 3.4* 
Right caudate nucleus 18 10 14 37  3.3* 
 





PET time by condition contrast images 
for 11 OCD patients displayed on mean 
T1-weighted MRI show activation in 
right amygdala (Talairach coordinates x, 








Plot of size of effect (y-axis) in right 
amygdala for time by condition analysis 
in 11 OCD patients. Plot shows 
decreasing effect size over time during 
subsequent resting conditions (x-axis 1, 
2, 3, 4) and increasing effect size over 
time during subsequent provoked 
conditions (x-axis 5, 6, 7, 8). 
 
 
Results of correlational analyses are listed in Table 6.4. In the OCD group, OBS scores 
were correlated with increased activation of bilateral occipital cortex and decreased 




















parietal cortex. No statistically significant correlations were found between ANX scores 
and regional cerebral blood flow changes.  
 
 




Region of activation 







      












Left occipital cortex -44 -78 8 148 19 4.2* 
       
Decrease 
 
      
Right ventromedial prefrontal cortex 34 52 -14 87 11 3.7* 
Right dorsolateral prefrontal cortex 46 34 32 30 9 3.7* 
Right parietal cortex 44 -54 44 179 40 4.1* 
 
BA= brodmann’s area 





In the present study, H2
15O PET was used to investigate the neurophysiological correlates 
of contamination fear in a subgroup of obsessive-compulsive washers and healthy control 
subjects. To this end, rCBF was compared in both groups during presentation of neutral and 
contamination-related visual stimuli. Behavioral data showed that the present design was 
successful in inducing both increased subjective distress (ANX) and obsessionality (OBS). 
In the OCD group, ANX and OBS ratings were only moderately high, but showed an 
increase over time, implying that OCD patients became more sensitive, rather than 
habituated, to contamination stimuli. Nevertheless, all subjects were able to complete the 
scanning session.  
Imaging data showed that symptom provocation in OCD patients was correlated 
with increased regional cerebral blood flow in left amygdala and bilateral extrastriatal 
cortex, while control subjects showed increased activation of the basal forebrain extending 
into posterior orbitofrontal cortex, left dorsolateral prefrontal cortex, right caudate nucleus 
and bilateral extrastriatal cortex. Group by condition interactions were found in the left 
amygdala in the OCD group and in left dorsolateral prefrontal cortex and right caudate in 
controls, whereas significant time by condition interactions were only observed in the right 
amygdala in the OCD group. The finding of amygdala involvement in OCD subjects during 
symptom vs. neutral condition is in agreement with a number of studies using fear 
paradigms in normal controls27;38-44, supporting the role of the amygdala as a key structure 
in evaluating the behavioral significance of external stimuli45. Previous imaging studies in 





















lower statistical thresholds23;24, or not at all21;22;25;26. Possible explanations include statistical 
power (repeated measures vs. off-on paradigms) and stimulus type. Although the amygdala 
receives multimodal sensory information, projections from visual processing areas are 
particularly prominent46. Therefore, salient visual stimuli may give rise to amygdala 
activation more easily than tactile or auditory stimuli. In addition, the use of antidepressants 
is likely to suppress amygdala function (see Drevets47 for a review). 
 In both groups, increased activity of bilateral extrastriatal cortex in the active 
condition compared with the baseline condition was observed. It has been postulated that 
these secondary visual areas play a critical role in perceptual processing of socially and 
emotionally relevant stimuli39;48;49. Morris and colleagues39 demonstrated that activation of 
the amygdala resulted in context dependent modulatory effects in extrastriatal cortex. Lane 
et al.50 investigated the interaction between emotion and attention in visual processing and 
found the extrastriatal visual cortex as well as the anterior temporal cortex activated by 
emotional valence, arousal and attention. In the present study, increased activity in the left 
anterior temporal pole during the active condition was found in the control group. The role 
of the anterior temporal cortex, as a hierarchically higher-order cortical area involved in 
visual processing and evaluation of the significance of current stimuli, might include 
retrieval of past emotional experiences. The anterior temporal cortex has reciprocal 
connections to frontal areas, in particular orbitomedial prefrontal areas, in this way enabling 
associated behavioral responses.  
In the present study, differential effects in left and right amygdala were found. 
OCD patients showed increased activity in the left amygdala during the symptom condition, 
an effect that was stable over time. This left lateralized response is in accordance with 
results of earlier studies in normal volunteers27;38-42. However, in favor of the OCD group 
compared with healthy control subjects, a significant time by condition interaction was 
observed in the right amygdala, i.e. a signal decrease over time in the baseline condition 
compared with an increase during the symptom condition. This effect has not been 
described in previous OCD studies, but is likely to reflect the increase in ratings of 
subjective distress and obsessionality over time observed in the OCD group. In normal 
volunteers, several authors have reported habituation, not sensitization, of amygdala 
responses to alarming stimuli38;41;42;48;51. These effects have mostly been found in the right 
amygdala, but not in the left, from which it has been concluded that the right amygdala is 
involved in rapid emotional stimulus detection, whereas the left amygdala is associated 
with sustained stimulus evaluation. Alternatively, Morris et al.40 proposed that the left 
amygdala has a role in conscious stimulus processing, whilst the right amygdala is 
associated with unconscious processing. Neither hypothesis, however, fits the data from the 
present study. A possible explanation is provided by the work of Schaefer et al.52, who 
found increased amygdala activity when subjects maintained the negative emotional 
response during the delay following visual presentation of negative stimuli. This increase in 
amygdala response correlated with self-reported levels of negative affect. These findings 
suggest that maintenance of emotional responses by cognitive processes may operate, at 
least in part, by modulating neuronal activity within the amygdala. Similarly, Siegle et al.53 
reported that in subjects with major depression, processing of negative stimuli was 
associated with prolonged bilateral amygdala activity. Moreover, these responses were 




















temporal resolution of H2
15O PET, it was impossible to determine whether the sensitization 
effects observed in the OCD subjects were due to increases in amplitude or duration of 
responses to individual stimuli. 
Contrary to expectations, when contrasting symptom vs. baseline, orbitofrontal activity was 
only observed in the control group, but failed to reach significance in the OCD group. 
Moreover, group by condition interaction effects in basal ganglia and dorsolateral 
prefrontal cortex were found in favor of normal controls compared with OCD patients. 
Involvement of the basal ganglia during symptom provocation in OCD subjects has been 
reported in most21-23, but not all24, previous studies, which was attributed by Adler et al.24 to 
differences in medication status. Although in the present study only medication-free 
patients were included, this does not seem to be a plausible explanation since subjects in 
some of the above mentioned studies were off medication as well21;22. Whether paradigms 
employing tactile stimuli are generally more likely to produce basal ganglia activity is 
difficult to ascertain since most earlier studies lacked control groups. A possible 
explanation for the apparent lack of frontal-striatal involvement in OCD patients, is 
increased baseline regional perfusion, as suggested by the resting state FDG-PET studies by 
Baxter et al.10;11. To investigate this issue, we performed a post-hoc analysis comparing 
relative baseline activity between the two groups. OCD patients, compared with controls, 
showed increased activity in orbitofrontal and insular cortices; however, no differences 
were found in the basal ganglia (data not shown). These findings seem to be in agreement 
with those of Cottraux et al.25, who found increased orbitofrontal perfusion during 
provoked vs. neutral state in both OCD patients and in healthy control subjects, presumably 
reflecting ritualistic behavior. In addition, increased activity in the basal ganglia was found 
in controls, but not in OCD patients. Increased frontal-striatal involvement in controls in 
response to contamination-related stimuli was also found by Phillips et al.26. While controls 
and “checkers” recruited the frontal-striatal system, contamination-feared OCD patients 
showed increased activity in the insular cortex, important in disgust perception.  
Taken together, imaging findings from the present study indicate that presentation 
of contamination-related stimuli in normal subjects results in activation of regions assumed 
to be involved in higher order control. In contrast, in OCD subjects, condition effects were 
primarily observed in areas associated with processing of salient (i.e. threatening) stimuli. 
This interpretation receives some support from our finding that OBS ratings increased in 
both groups, but ANX ratings only in the OCD group. Moreover, ANX and OBS ratings 
showed significant correlations only during the symptom condition in the OCD group. 
However, we recognize that the specificity of visual analogue scales used in the present 
study as well as in others is debatable22; in particular, OBS ratings may reflect not only urge 
to ritualize, but also disgust.  
With regard to these two emotional states, Phillips et al.27 showed that separate 
regions were associated with fear and disgust. Whereas perception of fearful faces was 
correlated with activation of the left amygdala, perception of facial expressions of disgust 
was correlated with activation in right medial frontal and insular cortices. Very strong 
disgust also activated right putamen and thalamus, structures associated with the cortico-
striatal-thalamic circuit54. Sprengelmeyer et al.55 also reported right putamen and left 
insular cortex during presentation of disgusted, but not fearful, facial expressions, in 





















and disgust. However, the issue whether the neuronal representation of emotion involves 
separate systems for individual emotions, or an integrated system able to code all emotions 
is still unresolved56. Although several studies support the category-based model, indicating 
that the neuronal mechanisms underlying fear and disgust might be at least separate in 
part27;55, some studies also show amygdala involvement in perception of disgust, supporting 
a dimensional model57. Impaired recognition of disgust from facial expressions has been 
reported in patients with OCD58, Huntington’s disease59 and brain injury in the area of basal 
ganglia and insular cortex60. In contrast to the results of Phillips et al.26;27 and 
Sprengelmeyer et al.55, in the present study no task related insular activity was found in the 
OCD group, although our post-hoc results indicate that this may have been due to increased 
activity in insular cortex at baseline in OCD patients compared with controls.  
Finally, an explanation for the differential frontal-striatal involvement in the two 
groups in the present study is suggested by our finding that OBS ratings in OCD patients 
were inversely coupled to both ventromedial and dorsolateral prefrontal activity. An inverse 
correlation between OCD scores and prefrontal activity (albeit in the orbitofrontal cortex) 
was also reported by Rauch et al.22 and Adler et al.24. This finding was attributed to a loss 
of inhibitory input from frontal structures. Similarly, negative correlations between 
amygdala and dorsolateral prefrontal activity were demonstrated in depressed subjects in 
the study of Siegle et al.53. Therefore, we suggest that the observed differences between 
OCD patients and controls reflect a failure of frontal-striatal circuitry in OCD patients to 
control the processing of negative (contamination-related) stimuli, resulting in an 
inadequate fear response, involving bilateral amygdala. The present data also indicate that 
repeated stimulation may lead to sensitization in OCD subjects. However, because we 
studied only OCD subjects with prominent contamination fear, these findings cannot be 
generalized to other OCD subtypes. Different OCD symptom dimensions might be 
associated with differential patterns of activation in ventral prefrontal, limbic and dorsal 
prefrontal regions61. Future research will need to investigate temporal characteristics of 
amygdala responses in OCD patients, to compare contamination and general threat stimuli 
in medication-free OCD patients and normal controls, and to compare OCD subgroups, by 
including subjects with prominent checking rituals. To investigate the specificity of the 
neurophysiological abnormalities found in OCD, comparison with results in other anxiety 
disorders, like hypochondriasis and panic disorder, or with mood disorders is important. 
Pre-post treatment studies, in case of pharmacotherapy as well as psychotherapy, may result 
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Dysfunction of frontal-striatal, in particular orbitofrontal-striatal, circuitry has been 
implicated in the pathophysiology of obsessive-compulsive disorder (OCD), characterized 
by obsessions, ritualistic behavior, anxiety and specific cognitive impairments. In addition, 
neuropsychological studies in OCD have reported impairments in visuospatial tasks and 
executive functions, such as planning. The aim of the present study was to determine 
whether dorsal frontal-striatal dysfunction mediates planning impairment in OCD patients. 
 A parametric self-paced pseudo-randomized event-related functional MRI version 
of the Tower of London task was used in 22 medication-free patients with OCD and 22 
healthy control subjects. This paradigm, allowing flexible responding and post hoc 
classification of correct responses, was developed to compare groups likely to differ in 
performance.  
 Behavioral results showed significant planning impairments in OCD patients when 
compared with control subjects. During planning, decreased frontal-striatal responsiveness 
was found in OCD patients, mainly in dorsolateral prefrontal cortex and caudate nucleus. In 
addition, OCD patients showed increased - presumably compensatory - involvement of 
brain areas such as the anterior cingulate, ventrolateral prefrontal and parahippocampal 
cortices, known to play a role in performance monitoring and short-term memory 
processing, respectively.  
 These findings support the hypothesis that decreased dorsal frontal-striatal 
responsiveness is associated with impaired planning capacity in OCD patients. Since 
described frontal-striatal dysfunction in OCD is independent of state anxiety and disease 
























Clinical, neurosurgical and functional neuroimaging studies have provided evidence that 
dysfunctional prefrontal cortex-basal ganglia circuits are involved in the pathogenesis of 
obsessive-compulsive disorder (OCD). The high co-occurrence between obsessive-
compulsive disorder (OCD) and other basal ganglia disorders strongly supports the so-
called frontal-striatal hypothesis1;2. In addition, recent neuropsychological studies have 
shown cognitive impairments in OCD, particularly with regard to visuospatial processing, 
executive functioning, and motor speed3;4. Other cognitive domains appear to remain intact, 
indicating a specific, rather than a general, cognitive deficit.  
 Executive functioning implies different subdomains of higher order cognitive 
functioning. Planning, i.e. the ability to achieve a goal through a series of intermediate 
steps, is an essential component of higher-order cognitive processing, such as problem 
solving. Employing a neuronal network model, Dehaene and Changeux5 proposed multiple 
hierarchic levels coding for specialized subprocesses of planning such as plan generation, 
working memory, and internal evaluation and reward. Some subprocesses seem to be 
relatively independent of task load, i.e. increasing planning complexity, while other 
subprocesses are mainly involved at higher levels of planning behavior.  
 A frequently used test to probe planning processes is the Tower of London task 
(ToL)6, adapted by Shallice et al. from the Tower of Hanoi7. The ToL has been used to 
investigate planning in healthy control subjects using positron emission tomography 
(PET)8-12, single-photon emission computed tomography (SPECT)13;14 and functional 
magnetic resonance imaging (fMRI)12;15-20. The results of these imaging studies agree on 
the involvement of (dorsolateral) prefrontal cortex and parietal-occipital regions during 
planning. However, activation of other brain regions, such as cingulate9;10;12;16;17;19 and 
insular cortices9;10;17, striatum8;10;12;16;17;20 and rostral prefrontal cortex9;10;17, has not been 
found across all mentioned studies. These inconsistencies are likely to be explained by 
methodological differences between these studies, such as group size, scanning modality, 
analysis technique (regions of interest versus whole brain analysis), and details of task 
paradigm. For example, baseline conditions have not been uniform (low-level vs. matched 
for visual complexity and motor demands); also, some paradigms require mental execution, 
whereas in others a touch screen is used. Berg and Byrd21 have emphasized the potential 
impact of such modifications, providing recommendations for constructing e.g. 
computerized versions of the ToL, to increase comparability across studies. 
Neuropsychological studies of planning ability, as a measure of executive 
functioning, in OCD patients have not provided wholly consistent results. Veale et al.22, 
using a computerized version of the ToL, found no difference in accuracy between OCD 
patients and healthy control subjects. However, when OCD patients made a mistake, they 
spent more time than controls in generating alternative solutions or in checking next 
responses. Normal accuracy in planning execution in OCD was also found by Schmidtke et 
al.23, using the Tower of Hanoi; however, in this study no reaction time data were collected. 
Results of the study of Purcell et al.24, comparing neuropsychological profiles of patients 
with OCD, panic disorder, and major depression, highlight the importance of task 
implementation. Although motor speed was decreased, OCD patients showed a normal 




















using a touch screen, providing external validation of ongoing performance. In contrast, 
when the task had to be executed mentally, OCD patients were significantly impaired. 
Whether impaired executive functioning is a trait feature of OCD, i.e. not secondary to 
present mood or anxiety symptoms, is not yet clear. In one study25 impaired performance 
relative to controls was found in subclinical obsessive-compulsive subjects. However, in 
this study it was also found that performance was inversely correlated with symptom 
severity, in particular severity of checking behavior.  
 Although these neuropsychological studies, together with functional imaging 
studies in healthy subjects, suggest that the executive impairment found in OCD patients 
reflects dorsal prefrontal-striatal dysfunction, so far no imaging study has been published in 
which this hypothesis has been investigated. Functional imaging studies using executive 
tasks have been performed in schizophrenia26 and major depression27, whereas in OCD 
most studies have used symptom provocation paradigms. However, evidence of striatal 
dysfunction in OCD has been provided in a PET-study employing an implicit learning 
task28;29. In this study, OCD patients showed increased activity of posterior (temporal and 
parietal) cortical regions relative to controls, explained as compensatory mechanisms.   
The aim of the present study was to investigate dorsal prefrontal-striatal function 
during performance of a planning task in OCD patients compared with healthy controls. To 
this end, we developed a parametric self-paced pseudo-randomized event-related version of 
the Tower of London task17, suitable for fMRI. A self-paced parametric design allows 
flexible responding as well as comparisons between subjects or groups at each task level, 
resulting in increased comparability across groups with varying levels of performance. In 
addition, an event-related design enables post hoc classification of events based on 
subjects’ responses, so that correct responses and errors can be analyzed separately. Based 
on previous studies, we expected task performance in OCD subjects to be impaired; in 
addition, we hypothesized this planning deficit to be reflected in decreased responsiveness 






Twenty-two OCD patients (7 males; age 34.4 (range 21-49) years) and 22 healthy control 
subjects (11 males; age 29.9 (range 23-51) years) performed the Tower of London task, 
while functional MRI data were collected. All subjects were right-handed, as assessed 
during a medical interview. Exclusion criteria were the presence of major medical illness, 
other major psychiatric disorders, and the use of psychotropic medication. Subjects had to 
be off medication for at least 4 weeks. Diagnoses were established using the Structured 
Clinical Interview for DSM-IV Axis I Disorders (SCID-I/P30). The Yale Brown Obsessive-
Compulsive Scale (Y-BOCS)31 and the Padua Inventory-revised (Padua-IR)32;33 were used 
to assess symptom characteristics and severity scores (cf. Table 1). Patients were recruited 
from the outpatient clinic for anxiety disorders of GGZ Buitenamstel/VU University 
Medical Center (VUMC) and the Netherlands Anxiety, OCD and Phobia Foundation. The 
ethical review board of the VUMC approved the study and all participants provided written 





















A pseudo-randomized, self-paced version of the ToL was used, discussed in detail 
previously17. This version consisted of six conditions: a baseline condition and five 
planning conditions, ranging from one to five moves. In the planning conditions, subjects 
saw a starting configuration together with a target configuration with the instruction “count 
the number of steps”. Two possible answers were shown, from which the correct one had to 
be selected (see Figure 5.1A). In both configurations, three colored beads were placed on 
three vertical rods, which could accommodate one, two and three beads, respectively. One 
bead could be moved at a time, and only when there was no other bead on top. Subjects 
were requested to determine the minimum number of moves necessary to reach the target 
configuration and to press the button corresponding to the side of the screen (left or right) 
where the correct answer was presented. In the baseline condition, subjects simply had to 
count the total amount of yellow and blue beads (see Figure 5.1B). A pseudo-randomized 
design was adopted to control for any overflow effects (i.e. perseverance of task related 
cognitive processes after a difficult trial). Therefore, each trial of three or more moves was 
followed by a baseline trial. No feedback regarding the answers was provided during the 
task. A maximum response duration of 30 seconds for each trial was applied. After 
performing the task, subjects were asked to rate subjective distress using 100-point 
analogue scales. To ensure that participants were familiar with the procedure, the test was 
explained and practiced outside the scanner before MR imaging was performed. 
 
Data acquisition 
Imaging was performed on a 1.5 T Sonata MR system (Siemens, Erlangen, Germany) with 
a standard circularly polarized head coil. Stimuli were generated by a Pentium PC and 
projected on a screen at the end of the scanner table, which was seen through a mirror 
mounted above the subject’s head. Two magnet-compatible four-key response boxes were 
used to record subject’s performance and response times (RT). To reduce motion artifacts, 
the subject’s head was immobilized using foam pads. 
Anatomic imaging included a coronal 3D gradient-echo T1-weighted sequence 
(matrix 256x160, voxel size 1x1x1.5mm, 160 sections). For functional MR imaging, an 
echo planar imaging sequence (TR 3.045s, TE 45 ms, matrix 64x64, field of view 
192x192mm, flip angle 90o) was used, creating transversal whole-brain acquisitions (35 
slices, 3x3mm in-plane resolution, 2.5mm slice thickness, 0.5mm inter-slice gap). In total, 
433 EPI volumes per subject were scanned. The distribution frequency of event types was 
based on RT data of a pilot study, so that a similar amount of scans (around 70 EPI 
volumes) was acquired per subject for each of the six conditions.  
 
Data Analysis 
Demographic and behavioral data were analyzed using SPSS software (version 11.0). 
Imaging data were analyzed using SPM99 (Wellcome Department of Cognitive Neurology, 
http://www.fil.ion.ucl.ac.uk/spm). After discarding the first 4 volumes, time-series were 
corrected for differences in slice acquisition times and realigned. Spatial normalization into 
approximate Talairach and Tournoux space was performed using a standard SPM EPI 
template. Data were resliced to 2x2x2mm voxels and spatially smoothed using a 6mm 




















Next, data were analyzed in the context of the General Linear Model, using delta functions 
convolved with a canonical hemodynamic response function to model responses of varying 
length to each type of stimulus. In addition, error trials were modeled separately as a 
regressor of no interest. For each subject, weighted contrasts were computed for main 
effects, i.e. all active conditions vs. baseline. In addition, specific linear contrasts for task 
load were computed34. Contrast images containing parameter estimates for main effects and 
task load were entered into a second level (random effects) analysis. Main effects for each 
group are reported at p<0.05 significance level corrected for multiple comparisons; group 
interaction effects (masked with the appropriate main effect) are reported at an uncorrected 





Demographic and behavioral data 
The groups did not differ significantly with respect to age and gender. Education level, 
however, was higher in control subjects. OCD symptom severity, as measured with the Y-
BOCS and Padua questionnaires, was significantly higher in patients (Table 7.1). Analysis 
of behavioral data (ANOVA) showed significant differences in performance between OCD 
patients and controls at all task levels, whereas RTs were longer in OCD patients compared 
with controls only in the two easiest planning conditions (Table 7.2). Subjective distress 
scores were significantly higher in the OCD group compared with the control group 
(42+25.5 vs. 21+11.8, F(1,42)=12.4, p<0.001). Within groups, performance was not 
significantly correlated with trait- or state measures (all p’s>0.1).  
 
 
Table 7.1. Demographic characteristics 
 
 22 healthy control subjects 
 
22 OCD patients 
 Mean (SD) Mean (SD) 
   
Age, yr 29.9 (7.4) 34.4 (8.6) 
Sex (M/F) 11/11 7/15 
Education (1-8) 7.36 5.67 * 
Y-BOCS 0 22.2 (6.5) ** 
Padua-IR 9.9 (10.4) 61.3 (21.9) ** 
 























Table 7.2. Response times (RT, in seconds) and performance scores (PS, in %) 
 
 22 healthy control subjects 
 
22 OCD patients 
Condition RT (SD) PS (SD) RT (SD) PS (SD) 
 
Baseline 3.71 (0.88) 94.2 (1.66) 4.23 (1.07) 88.3 (3.66)*** 
1 move 4.44 (1.10) 97.6 (2.04) 5.46 (1.39)** 78.5 (9.0)*** 
2 moves 5.79 (1.26) 95.4 (3.98) 6.66 (1.49)* 79.3 (15.99)*** 
3 moves 7.40 (1.89) 96.7 (3.58) 8.51 (2.08) 72.0 (15.7)*** 
4 moves 10.06 (2.48) 89.9 (7.11) 10.72 (3.41) 68.1 (14.3)*** 
5 moves 14.99 (3.99) 82.2 (12.6) 14.99 (5.54) 63.6 (21.3)*** 
 





1. Main effects of task  
In controls, regions showing increased BOLD signal during planning compared with 
baseline (Table 7.3) were found bilaterally in dorsolateral prefrontal (Brodmann area (BA) 
9 and 46), motor and premotor (BA 4, 6 and 8), inferior parietal (BA 40), insular and 
superior occipital (BA 19) cortices, as well as bilateral precuneus (BA 7), right caudate 
nucleus and left globus pallidus. OCD patients showed increased BOLD signal in most of 
these regions as well. However, in contrast to control subjects, in OCD patients, no 
activation was found in the striatum during planning. In addition, activation was found in 
right cingulate cortex (BA 32). Group by task interaction analyses (Table 7.4) showed 
increased activation in controls compared with OCD patients in right dorsolateral prefrontal 
cortex (BA 9/46), right premotor cortex (BA 6), left cingulate cortex (BA 32), bilateral 
precuneus (BA 7), left inferior parietal cortex (BA 40), right caudate nucleus (Figure 7.1) 
and left putamen. No significant group by task interactions were found in OCD patients 
compared with controls. 
 
 
Figure 7.1.  
Increased BOLD signal in right caudate 
nucleus during planning compared with 
baseline in healthy control subjects 





















Table 7.3. Brain regions showing significant (p<0.05 corrected) BOLD signal increase 
during planning compared with baseline. 
 
   22 healthy control subjects 
 






Region of activation L/R BA 
x y z 
z-value 




L 9/46 -40 30 28 4.46     
L 9     -44 38 30 3.78 
R 9 48 34 34 4.05     
Dorsolateral prefrontal 
cortex 
R 9/46     48 38 30 3.63 
 
Cingulate cortex R 32     10 24 42 3.78 
 
L 4/6 -20 -6 50 4.50     
R 4 24 -12 52 4.31     
L 6 -22 10 58 4.67 -24 12 52 5.69 
R 6 22 16 50 4.83 24 6 54 4.54 
L 8 -22 20 48 3.48     
(Pre)motor cortex 
R 8 8 24 48 3.67     
 
L 7 -6 -54 48 5.05     
L 7 -12 -62 22 4.90 -2 -56 54 4.84 
Precuneus 
R 7 10 -58 48 5.59 8 -58 52 4.41 
 
L 40 -26 -44 48 4.52 -30 -48 46 4.03 Inferior parietal cortex 
R 40 52 -40 46 3.82 38 -42 44 3.53 
 
L  -28 18 -2 4.91 -32 22 -4 3.65 Insular cortex 
R  28 26 0 4.36     
 
Caudate nucleus R  12 12 0 4.23     
 
Globus pallidus L  -10 8 -2 4.04     
 
L 19 -42 -76 30 5.05 -38 -78 32 4.60 Superior occipital cortex 























Table 7.4. Brain regions showing significant (p<0.001 uncorrected) BOLD signal increase 




Region of activation L/R BA 
x y z 
z-value 
Healthy control subjects > OCD patients 
 
Dorsolateral prefrontal cortex               R 9/46 32 42 14 3.37 
(Pre)motor cortex R 4/6 24 -14 54 3.76 
Cingulate cortex L 32 -14 20 34 3.73 
L 7 -10 -64 22 3.66 Precuneus 
R 7 10 -78 44 3.30 
Inferior parietal cortex L 40 -52 -28 32 3.21 
Caudate nucleus R  8 16 6 3.73 
Putamen L  -26 16 -6 3.74 
 
OCD patients > healthy control subjects 
 
No significant regions 
 
 
2. Task load 
In controls, increased task load (Table 7.5) was correlated with increased BOLD signal 
bilaterally in anterior prefrontal (BA 10), dorsolateral prefrontal (BA 9 and 46), cingulate 
(BA 32), premotor (BA 6 and 8) and insular cortices and the precuneus (BA 7). 
Furthermore, increases were observed in right inferior parietal cortex (BA 40), left superior 
occipital cortex (BA 19) and left caudate nucleus. OCD patients, in contrast, did not show 
increased activity in the caudate nucleus correlating with task load. Instead, task load was 
correlated with increased activation bilaterally in supplementary motor area, as well as left 
posterior globus pallidus, left parahippocampal gyrus, thalamus and dorsal brainstem, and 
right ventrolateral prefrontal cortex (BA 44).  
 
 
Table 7.5. Brain regions showing significant (p<0.05 corrected) BOLD signal increase 
correlating with increased task load. 
 
   22 healthy control subjects 
 





Regions L/R BA 
x y z 
z-value 




L 10 -24 52 2 3.29 -36 52 8 4.14 
R 10 38 50 -4 3.66     
R 10 34 62 4 3.69     
Anterior prefrontal cortex 
R 10/46 32 52 6 3.49 38 54 8 5.03 




















Table 7.5 (continue) 
   22 healthy control subjects 
 





Regions L/R BA 
x y z 
z-value 




L 9     -44 32 34 4.62 
L 9/46 -44 38 24 4.86 -42 32 28 4.51 
L 46 -30 42 4 3.95     
R 9 44 32 32 4.73 38 40 34 5.17 
L 8 -40 28 44 3.91 -30 36 46 5.30 
Dorsolateral prefrontal 
cortex 




R 44     58 16 6 4.63 
 
L 32 -10 22 34 3.82 -6 34 28 4.50 Cingulate cortex 
R 32 6 22 40 4.01 6 34 24 3.88 
 
L 6     -6 28 36 4.82 Supplementary motor 
area R 6     6 20 44 5.55 
 
R 4/6 18 -10 58 4.46 26 -2 50 4.33 
L 6 -22 6 58 5.55 -34 16 56 4.48 
R 6 26 8 50 4.98 28 4 52 5.20 
(Pre)motor cortex 
L 6/8     -24 16 50 4.58 
 
L 7 -10 -54 48 4.98 -2 -62 52 4.40 Precuneus 
R 7 8 -60 52 5.29 2 -54 52 4.52 
 
L 40     -50 -42 40 4.74 Inferior parietal cortex 
R 40 50 -42 54 4.55 56 -40 40 4.66 
 
L  -32 20 -4 4.08 -32 20 -4 5.00 Insular cortex 
R  34 22 -4 4.84 34 20 -6 4.33 
 
Caudate nucleus L  -18 4 16 3.78     
 
Globus pallidus posterior L      -16 -6 4 4.36 
 
Parahippocampal gyrus L      -26 -24 -22 3.56 
 
Thalamus L      -14 -4 -4 3.42 
 
Brainstem L      -8 -22 -26 3.71 
 
Occipital cortex L 19 -42 -70 36 3.71 -40 -72 38 4.50 
 
 
Group by task load interaction analyses (Table 7.6 and Figures 7.2 and 7.3a-c) showed 




















cortex (BA 46). In contrast, OCD patients, compared with controls, showed increased 
activation bilaterally in cingulate (BA 32), ventrolateral prefrontal (BA 47 and 45) and 
parahippocampal cortices, as well as left anterior temporal cortex and dorsal brainstem. 
 
 
Table 7.6. Brain regions showing significant (p<0.001 uncorrected) BOLD signal increase 




Region of activation L/R BA 
x y z 
z-value 
Healthy control subjects > OCD patients 
 
Dorsolateral prefrontal cortex L 46 -32 40 4 3.38 
 
OCD patients > healthy control subjects 
 
L 32 -2 18 32 3.40 Cingulate cortex 
R 32 9 26 26 3.49 
L 47 -50 24 -10 3.68 
L 47 -46 24 0 3.51 
R 47 50 24 -2 3.84 
Ventrolateral prefrontal cortex 
R 45 58 20 8 3.63 
Anterior temporal cortex L  -44 0 -32 3.54 
L  -24 -24 -24 3.62 Parahippocampal gyrus 
R  24 -18 -26 3.54 





Increased BOLD signal in left 
dorsolateral prefrontal cortex (BA 46) in 
healthy control subjects compared with 

























Figure 7.3. Increased BOLD signal correlating with task load in OCD patients 
compared with control subjects, in a): parahippocampal gyrus and 
brainstem, b): bilateral ventrolateral prefrontal cortex (BA 47 and 45), 





Analyses of covariance 
In OCD subjects, neither main effects for task nor task load effects were associated with 
symptom severity scores (Y-BOCS and Padua-IR), except for a small region in left 
ventrolateral prefrontal cortex (BA 44, z-value = 3.24). Additional analyses of covariance 
were performed to investigate whether the observed between-group differences could be 
explained by differences in demographic variables or levels of subjective distress. 
However, the above-described group by task interaction effects in favor of control subjects 





In the present study, a parametric self-paced pseudo-randomized event-related fMRI 
version of the Tower of London task was used to investigate the neuronal substrate of 
planning in medication-free OCD patients compared with healthy control subjects. This 
paradigm allowed flexible responding as well as post hoc selection of correct trials, so that 
analyses of imaging data were not confounded by performance differences35. The present 
results not only confirm previous findings with regard to impaired planning capacity in 
OCD, but also clearly demonstrate decreased responsiveness of dorsal frontal-striatal 
circuits in OCD patients.  
Behavioral data showed increased RTs in OCD patients only during the two 
easiest task levels, whereas performance scores were significantly lower compared with 
control subjects across all levels. These behavioral findings are in agreement with some, but 
not all, previous findings with regard to planning performance in OCD. While some studies 
have reported decreased response speed24 or performance scores25, other studies found 
unaffected planning capacity in OCD patients compared with healthy control subjects22;23. 




















in task implementation, such as mental performance vs. the use of a touch screen, or 
providing feedback vs. no feedback21;24.  
Imaging results showed increased task-associated activation in controls compared 
with OCD patients in several regions previously found to be involved in planning, in 
particular dorsolateral prefrontal cortex, basal ganglia, and parietal cortex. Task load 
correlated activity was found in left dorsolateral prefrontal cortex in control subjects 
compared with OCD patients. In contrast, OCD patients showed increased activation in 
bilateral cingulate, ventrolateral prefrontal and parahippocampal cortices, left anterior 
temporal cortex and dorsal brainstem, correlated with increased task load. Our finding of 
decreased responsiveness of dorsal frontal-striatal circuits during planning in OCD patients 
is in accordance with previous findings with regard to basal ganglia dysfunction in OCD in 
implicit learning28;29. However, in the Rauch et al. study28, OCD subjects showed impaired 
performance during motor skill acquisition, suggesting basal ganglia-motor cortical rather 
than striatal-dorsal prefrontal dysfunction, as found in the present study. In addition, several 
functional imaging studies using symptom provocation designs have reported abnormalities 
in orbitofrontal-striatal function in OCD, thought to reflect its role in ritualistic behavior36-
40. Most of these studies, however, lacked adequate control groups, or failed to find 
significant group by task interactions in subcortical areas36;37;40. Increased prefrontal-
subcortical glucose uptake in OCD patients relative to controls, resolving after successful 
therapy, has also been reported in a number of resting-state imaging studies41-45. Although 
apparently in one investigation dorsal prefrontal abnormalities were found43, the majority of 
these studies have reported increased orbitofrontal-striatal metabolism. Moreover, although 
dorsal and ventral PFC are known to project to dorsal and ventral parts of the striatum, 
spatial resolution of FDG-PET may have been insufficient to detect differences based on 
topographical organization within the basal ganglia. Therefore, the evidence for 
pathologically increased baseline activity in dorsal prefrontal-striatal, as opposed to ventral 
frontal-striatal, loops in OCD is still inconclusive. However, although the present functional 
MRI data do not allow baseline comparisons, our finding of decreased or absent prefrontal-
striatal responsiveness is compatible with existing pathophysiological models of OCD 
hypothesizing basal ganglia disinhibition due to an altered balance between indirect, 
inhibitory and direct, excitatory cortico-striatal-thalamico-cortical circuits46;47. Whether the 
failure of OCD patients to recruit dorsal striatal-prefrontal regions in comparison with 
controls, as found in the present study, is specific for planning tasks is also not yet clear. In 
a recent fMRI study, van der Wee et al.48 found decreased performance only at the highest 
task level in OCD patients compared with controls during performance of a spatial n-back 
task. Imaging results showed similar activity in bilateral dorsolateral prefrontal and parietal 
cortex in both groups, from which the authors concluded that (spatial) working memory in 
OCD was not abnormal. The findings of the present study provide support for this 
conclusion. Whereas it might be argued that in our paradigm not only planning complexity 
but also working memory load was (linearly) increased, our results reveal impaired 
planning at all levels, which is difficult to explain by differences in working memory 
capacity.  
In the present study, OCD patients, compared with control subjects, showed 
increased activation of bilateral ventrolateral prefrontal, anterior cingulate and 




















load. These interaction effects may reflect both compensatory processes and increased 
arousal. Functional neuroanatomical subdivisions of the lateral prefrontal cortex (i.e. 
ventrolateral and dorsolateral PFC) have been proposed based on stimulus type (verbal vs. 
object/spatial49)50 and process type (maintenance/manipulation), recent evidence favoring 
the latter hypothesis51;52. Thus, the VLPFC region (BA 44, 45 and 47) supports processes 
that transfer, maintain and match information in working memory. In contrast, the 
dorsolateral prefrontal cortex (BA 9 and 46) supports complex processes operating on 
information (spatial as well as non-spatial) that is currently maintained in working memory, 
such as monitoring, manipulation and higher-level planning. Beyond maintenance in 
VLPFC and manipulation in DLPFC, the anterior prefrontal cortex (BA 8 and 10) is 
associated with processes of a third level of executive control53. Increased VLPFC activity 
may reflect not only working memory load, i.e. the number of items kept ‘on line’, but also 
retrieval and maintenance of abstract rules used for problem solving54. In addition, it has 
been shown that VLPFC activity is selectively increased during arithmetic computations, in 
particular when subjects attempt to resolve a conflict between externally presented answers 
and internally computed solutions55. Such a mechanism may explain the increased activity 
of bilateral VLPFC associated with task load in OCD patients compared with control 
subjects observed in the present study.   
 Compared with control subjects, OCD patients also showed increased activity of 
anterior cingulate cortex (BA 32) correlated with task load. Anterior cingulate involvement 
in OCD has been observed at rest, during symptom provocation, and after having 
committed errors during cognitive tasks37;40. The ACC has been implicated in performance 
monitoring, error detection, conflict monitoring, response selection, and reward 
expectation56. ACC activity has been found prior to a response during correct trials and 
immediately following error trials, reflecting its role in error prevention and detection57. 
Ursu et al.58 reported increased activation of the ACC in OCD patients, compared with 
control subjects, during both incorrect and correct trials, indicative of an overactive 
performance monitoring system in OCD, independent of the actual occurrence of errors. 
These results were replicated in a subclinical group of obsessive-compulsive 
undergraduates59. In addition to the ACC, the supplementary motor area (SMA) may also 
have a role in performance monitoring60. Increased activity in ACC and SMA was also 
observed during performance of a spatial n-back task in OCD patients, thought to reflect 
increased effort to develop an efficient strategy or increased error monitoring48. A 
functional neuroanatomical dissociation between these areas has been proposed, with error 
processing associated with the anterior cingulate region and response competition with 
SMA61. Increased performance monitoring during correct task performance, as well as 
during errors, may be characteristic of the critical self-evaluation of performance in OCD, 
leading to inappropriate need for correction and, consequently, repetitive behavior.  
Increased activity correlated with task load was also observed in bilateral 
parahippocampal gyrus (PHG) in OCD patients relative to controls. Similar results were 
obtained by Rauch et al.28 in OCD patients during a motor sequence learning paradigm. The 
authors hypothesized that dysfunction of corticostriatal systems in OCD resulted in 
compensatory recruitment of ‘explicit networks’ to perform the task. However, debriefing 
data from their study showed that OCD patients did not differ from controls in explicit 




















intermediate-term memory for spatial information, in addition to working memory, 
supported by parietal and lateral prefrontal cortex as discussed above, and long-term 
memory (more than about 2 minutes) provided by the hippocampal formation62. Increased 
activity of both PHG and VLPFC may therefore be secondary to OCD patients’ failure to 
develop an adequate strategy, so that they need to rely on short- and intermediate term 
memory capacity to perform the task3. Connections exist between the rostral anterior 
cingulate cortex (BA 32) and parahippocampal gyrus63. Faw64 described this system of 
ACC and adjacent dorsal medial prefrontal cortex, with extensions to the hippocampal 
stream, as a key player in spatiotemporal processing and attention, supporting executive 
functions located in dorsolateral prefrontal cortex. 
Finally, we found an area of increased activation in left dorsal brain stem 
associated with task load in OCD patients compared with control subjects. This region was 
located within the reticular formation, extending rostrally into the periaquaeductal grey, and 
may therefore reflect increased arousal at higher task loads in our OCD group65;66. Arousal 
responses implicate activation of the hypothalamic-pituitary-adrenal (HPA) axis and the 
reticular activating system (RAS). The RAS is composed of cholinergic neurons from the 
pedunculopontine nucleus, stimulating the noradrenergic system of the locus coeruleus 
(LC), which in turn inhibits cholinergic output of the pedunculopontine nucleus65. Evidence 
from non-stress experiments suggests that phasic LC activity is associated with increased 
attention and task related performance66-68, whereas tonically increased tonic activity of the 
LC results in attentional instability, decreased performance, and increased emotional 
reactivity66;68. Chronic stress, on the other hand, may lead to locus coeruleus damage, 
resulting in reduced output from the LC69 and disinhibition of the pedunculopontine 
nucleus70. In the present study, our finding that increased dorsal brain stem activity in OCD 
was associated with task load suggests increased effort rather than increased subjective 
distress, although we cannot rule out the latter possibility. 
To our knowledge, this study is the first to demonstrate impaired planning 
associated with decreased dorsal frontal-striatal responsiveness in OCD. Strengths of the 
study are the inclusion of medication-free subjects, a large group size permitting random 
effects analyses, and the use of a parametric self-paced event-related design. The present 
study is not without limitations, however. First, education level was higher in control 
subjects, although we controlled for performance differences by selecting correct responses 
only. In addition, post hoc analyses of covariance with regard to education level, sex ratio, 
and age were performed. Moreover, it has been shown that planning performance (both 
error rates and RTs) is not correlated with intelligence measures71. Second, although in the 
present study no clear correlations were found between symptom severity ratings and 
outcome measures, in accordance with previous studies3;48, we did not specifically 
investigate OCD subgroups, e.g. with prominent washing or checking symptoms. Although 
little is known with regard to the generalisability of neuropsychological deficits across 
clinical subtypes, a dimensional model of OCD has been proposed, in which various 
symptom dimensions are associated with differential patterns of functional neuroanatomical 
abnormalities72;73. Recent data showed activation of VLPFC and caudate nucleus correlated 
with washing characteristics and dorsal regions (DLPFC, thalamus and putamen/globus 
pallidus) with checking symptoms73. Based on these subtype differences in provocation 




















of dorsal prefrontal-striatal circuits as found in present study, mainly concerns OCD 
patients with predominant checking symptoms. Another issue for future research is whether 
the dorsal frontal-striatal dysfunction observed in this study is specific for OCD or extends 
to other neuropsychiatric disorders. These include not only anxiety disorders, but also basal 
ganglia disorders such as Tourette’s syndrome, and major depressive disorder (MDD). 
MDD is characterized by impairments in various executive functions, such as verbal 
fluency, and attentional set shifting74. However, in MDD, dorsal prefrontal baseline 
perfusion is decreased, rather than increased75. Moreover, MDD is not associated with 
striatal pathology76. Whereas depressive symptoms frequently co-occur in OCD, cognitive 
deficits in OCD are not associated with comorbid depression3, suggesting different 
pathophysiological mechanisms in OCD compared with MDD. Future studies should also 
investigate whether the executive deficits in OCD are specific for the present paradigm, or 
can be replicated during other ‘strategic’ tasks, such as set-shifting tasks. Finally, to further 
elucidate the pathophysiology of OCD, the ‘state-trait’ issue needs to be addressed by using 
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Attentional bias to disease relevant emotional cues is considered to be important in the 
causation and maintenance of affective symptoms in anxiety disorders. However, 
neuropsychological studies have reported conflicting results concerning the disease-
specificity of attentional bias. Moreover, although frontal-striatal and limbic circuits have 
been implicated in attentional bias and emotion processing, neuroanatomical correlates of 
emotional interference across different anxiety disorders have not yet been investigated. 
 A functional MRI version of a cognitive and emotional Stroop task was used in 16 
patients with obsessive-compulsive disorder (OCD), 15 patients with panic disorder (PD), 
13 patients with hypochondriasis and 19 healthy control subjects. All subjects were 
medication-free. The paradigm consisted of congruent color words, incongruent color 
words, OCD related negative words, panic related negative words and neutral words.  
 During incongruent versus congruent color naming, all patient groups recruited 
additional posterior brain regions relative to controls, but only in OCD patients 
performance was impaired. In OCD, color naming of OCD related, but not panic related 
words, was associated with increased activation of frontal-striatal and temporal regions, 
although performance was not abnormal. In contrast, in PD patients, increased frontal-
striatal involvement was found during color naming of both OCD and panic related words. 
In PD, color naming of panic related words was significantly slowed and was associated 
with increased activation of right amygdala and hippocampus. Hypochondriasis patients 
showed a similar activation pattern to PD patients. 
 The present results support the hypothesis of increased distractibility for irrelevant 
information in patients with OCD, PD and hypochondriasis compared with healthy control 
subjects, associated with frontal-striatal and limbic involvement. Clear differences between 
OCD patients on the one hand and PD and hypochondriasis patients on the other were 
found. Increased cognitive interference was observed only in OCD. Although OCD patients 
did not display an attentional bias in behavior relative to healthy controls, there was a clear 
and specific neuronal response during color naming of OCD related words, involving 
mainly ventral brain regions. In contrast, generalized emotional interference effects were 
found in PD and hypochondriasis, involving both ventral and widespread dorsal brain 

























Difficulty inhibiting irrelevant information, for instance obsessive thoughts and impulses, is 
a key feature of obsessive-compulsive disorder (OCD)1;2. Because most of their attentional 
resources are allocated to threat cues related to their concerns, OCD patients are limited in 
their ability to selectively attend to relevant information, while simultaneously ignoring 
irrelevant competing information1. Similar cognitive dysfunctions have been described for 
panic disorder (PD)3. Attentional bias in anxiety disorders is presumably not simply a by-
product of emotional state, but may play a major role in symptom causation and 
maintenance4-6. The critical process of gating, i.e. inhibiting irrelevant information, has 
been linked to frontal-striatal function7;8. Impaired frontal-striatal function is considered to 
be of etiological importance in the affective, behavioral, as well as cognitive characteristics 
of OCD9. In contrast, the brainstem and limbic regions, such as the amygdala and 
(para)hippocampal region, are mainly implicated in the symptomatology of PD10-13. 
 
Cognitive interference occurs when processing one stimulus impedes simultaneous 
processing of another stimulus, as in Stroop‘s color-word task14. This task requires the 
ability to actively inhibit a fast automatic response (word reading) in favor of a slower 
voluntary response (color naming), resulting in increased response latencies and error rates 
during the interference condition (e.g. “red” printed in blue ink) compared with the 
facilitation (or baseline) condition (e.g. “red” printed in red (or black) ink).  
Frontal involvement in interference processes was first demonstrated in lesion 
studies, showing impaired Stroop performance in patients with lesions in left15 and right16 
lateral prefrontal cortex. More extensive investigation of the neuronal correlates of 
interference in healthy subjects was undertaken with the advent of positron emission 
tomography (PET)17-21, functional magnetic resonance imaging (fMRI)22-31 and 
magnetoencephalography32. In many17-20;22;24;25;27;28;30;31, but not all18;21;26;29;32 studies 
interference was associated with increased activation of anterior cingulate cortex (ACC). 
Prefrontal involvement in interference was reported in dorsolateral (DLPFC)19;22;23;26-29;31;32, 
anterior (aPFC)18;20;29;32 and ventrolateral (VLPFC)21;25;26;28;29 prefrontal subregions. Recent 
imaging studies have shown that ACC is primarily involved in response-related processes, 
such as performance monitoring, response conflict and error detection24;27;28;31;33;34. In 
contrast, various prefrontal regions seem to be primarily responsible for the implementation 
of top-down attentional control (i.e. higher order regulation of hierarchically lower 
attentional processes) per se, although the relative contribution of specific prefrontal 
subregions is insufficiently clear24;27;28;31. Other regions associated with interference were 
(pre)motor17;22;25;32, temporal17;22;23;25;29;31, parietal18-20;22;23;28;29;32, extrastriate17;19-21;23;26;31 
and insular19;20;25 cortices, thalamus19;20;23 and striatum17;19;23;25.  
In OCD patients, neuropsychological studies using the word-color Stroop task 
have provided mixed evidence for impaired selective attention compared with control 
subjects1;35-40. Some studies showed that OCD patients performed slower than control 
subjects1;35 and made significantly more errors and had slower reaction times during the 
interference condition of the Stroop task1;37.  This interference effect in OCD patients was 
augmented when situational anxiety was high1. Moreover, decreased Stroop performance in 




















metabolism rates in lateral prefrontal cortex35, in agreement with the notion of prefrontal 
involvement in the pathophysiology of OCD. 
 
A potentially more powerful and specific way to investigate selective attention and 
response inhibition in anxiety disorders is based on an emotional analogue of the Stroop 
task5. When anxious patients are presented with colored words relevant to their concerns, 
automatic semantic processing will delay voluntary color naming. This interference effect, 
however, is not restricted to patients; control subjects, after priming to an anxious state, also 
show interference during color naming of threat words41;42. Whalen et al43, using a counting 
version of the emotional Stroop task during functional MR imaging in healthy subjects, 
reported significant activation in the affective (rostral) subdivision of the ACC during 
emotional interference in the absence of a behavioral interference effect. In contrast, the 
traditional Stroop task was correlated with increased activation of the dorsal anterior 
cingulate cortex (cognitive subdivision of the cingulate cortex)22. The authors suggested 
that rostral ACC activation reflected a regulatory response during successful suppression of 
task-irrelevant emotional information.  
Neuropsychological studies using the emotional Stroop task in various anxiety disorders, 
such as generalized anxiety disorder (GAD)44-46, PD47-53, OCD53-56, posttraumatic stress 
disorder (PTSD)57-59, social phobia46;60-64 and spider phobia65;66, all (but one53) showed 
robust interference effects in patients during color naming of threat related words. It is not 
yet clear, however, whether this effect is specific to disease related threat words or extends 
to general threat domains (or even positive emotional material), although some anxiety 
disorders seem to be more specific in their attentional bias than others. Whereas patients 
with OCD54-56;67 and social phobia46;63;64 showed a predominantly disease-specific 
attentional bias, threat word interference in GAD46 and PD49 was found to be more 
generalized51;52. A second issue of consideration in emotional interference is the explicit 
versus implicit nature of the attentional bias. Most studies using subliminal stimulus 
presentation support the assumption that interference is not dependent on conscious 
strategies5;52;68;69.  
To summarize, evidence from imaging data in healthy subjects as well as from 
neuropsychological studies in anxiety disorder subjects appear to be in agreement with the 
hypothesis of frontal involvement in emotional Stroop interference. However, direct 
evidence for the underlying neuronal substrate in anxiety disorders is lacking, with a single 
exception70. Shin and colleagues70 found activation of the rostral ACC in non-PTSD 
Vietnam veterans during trauma-related emotional interference, similar to the results of 
Whalen et al43 in healthy volunteers, but not in veterans with PTSD. Shin et al suggested 
that the absence of rostral ACC activation in PTSD patients reflected the inability of this 
region to inhibit amygdalar hyperresponsivity, although no amygdala activation was found 
during threat-related emotional processing in their PTSD patients. They did not include 
additional experimental groups, so that the specificity of their findings remains to be 
confirmed.  
 The aim of the present study was to investigate the neuronal substrate of both 
cognitive and emotional Stroop interference across anxiety disorders, by addressing the 
following questions. First, is increased cognitive interference, as found in OCD, syndrome-




















relevant to their concerns? Third, is the neuronal substrate of emotional interference 
different across anxiety disorders? To answer these questions, functional MRI data of 
patients with OCD, PD and hypochondriasis were compared with data of healthy control 
subjects, during performance of a Stroop task containing color-congruent color words, 
color-incongruent color words, OCD related negative words, panic related negative words 
and neutral words. Although emotional Stroop interference at a behavioral level can be 
demonstrated using either supra- or subliminal stimuli, we chose to present overt 
(supraliminal) stimuli based on observations that covert stimuli are not very effective in 
eliciting regional cerebral blood flow changes in the amygdalar region71;72, unless in an 
aversive conditioning paradigm73. In agreement with the results of previous studies, we 
hypothesized that OCD patients would show increased interference effects for incongruent 
versus congruent color words. In addition, we expected significant interference effects in 
OCD for disease-specific threat words only, compared with generalized interference effects 
(i.e. for PD and OCD related words) in PD. To investigate whether any increased 
responsiveness to PD and OCD related words is specific to OCD and/or PD, we included a 
third experimental group of patients with hypochondriasis. In hypochondriasis, obsessions 
or compulsions are by definition restricted to illness concerns. However, compared with 
PD, in hypochondriasis patients these worries typically do not spiral into panic74. We 
expected to find frontal-striatal as well as limbic (including amygdala) regions correlated 






Eighteen OCD patients (6 males, age 33.4±2.4 yrs (mean±SE)), 15 PD patients (8 males, 
age 33.7±2.5 yrs), 14 hypochondriasis patients (12 males, age 40.6±3.2 yrs) and 19 healthy 
control subjects (10 males, age 30.3±1.9 yrs) performed the Stroop task, while functional 
MRI data were collected. Mean age (p=0.04) and M/F ratio (p=0.04) were both higher in 
the hypochondriasis group compared with other groups. All subjects were right-handed. 
Patients were recruited from the outpatient clinic for anxiety disorders of GGZ 
Buitenamstel/VU University Medical Center (VUMC) and the Netherlands Anxiety, OCD 
and Phobia Foundation. The medical ethical review board of the VUMC approved of the 
study and all participants provided written informed consent.  
Exclusion criteria were the presence of major internal and/or neurological illness, 
other psychiatric disorders and the use of psychotropic medication. Subjects had to be off 
medication for at least 4 weeks. One OCD patient had comorbid hypochondriasis, one 
hypochondriasis patient had comorbid PD and one OCD patient was found to have a 
vascular malformation near the ACC. These three patients were excluded from further 
analysis.  
Diagnoses were established using the Structured Clinical Interview for DSM-IV 
Axis I Disorders (SCID-I/P)75. To assess symptom characteristics and severity scores, the 
Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)76, the Padua Inventory-revised 




















BOCSH)76 and the Whitley Index (WI)79 were used. In addition, the Body Sensations 
Questionnaire (BSQ)80 was administered to PD patients.  
 
Task paradigm 
The Stroop paradigm used in the present study consisted of 6 conditions: congruent color-
words (e.g. “red” printed in red), incongruent color-words (e.g. “red” printed in blue), OCD 
related negative words (e.g. dirty, mess, uncertain), panic related negative words (e.g. heart 
attack, crowd, faint) and two baseline conditions with neutral words (e.g. percent, month, 
oval). OCD related words were selected based on studies of Lavy et al55;66; panic related 
words were derived from earlier research of attentional bias in PD48.  
Stimuli were presented in a block design, consisting of eighteen randomized blocks (three 
blocks of each condition), each containing sixteen words. Each word was presented during 
2 seconds, followed by a 200ms blank screen. Subjects were asked to respond as fast as 
possible by pressing the button corresponding to the color of the ink (yellow, green, red, 
blue), irrespective of the meaning of the word. After performing the task, subjects were 
asked to rate subjective distress using a 100-point analogue scale.  
  
Functional MRI data acquisition  
Imaging was performed on a 1.5T Sonata MR system (Siemens, Erlangen, Germany) with a 
standard circularly polarized head coil. Stimuli were projected on a screen at the end of the 
scanner table, which was seen through a mirror mounted above the subject’s head. Two 
magnet-compatible four-key response boxes were used to record subject’s performance and 
response times (RT). To reduce motion artifacts, the subject’s head was immobilized using 
foam pads. 
  For functional MR imaging, an axial echo planar sequence (TR 1.99sec., TE 
45ms., matrix 64x64, field of view 192x192mm, flip angle 90°) was used (28 slices, 
3x3mm in-plane resolution, 3.6mm between-plane resolution ), which was selected based 
on its sensitivity to signal changes in (orbital) prefrontal cortex. In total 296 EPI volumes 
per subject were scanned, 48 EPI volumes in each condition. In addition, a coronal T1-
weighted MR was acquired (matrix 256x160, voxel size 1x1x1.5 mm, 160 sections). 
 
Imaging data analysis 
Imaging data were analyzed using SPM99 (Wellcome Department of Cognitive Neurology, 
http:www.fil.ion.ucl.ac.uk/spm). After discarding the first 6 volumes, time-series were 
corrected for differences in slice acquisition times and realigned. Spatial normalization into 
approximate Talairach and Tournoux space was performed using a standard SPM EPI 
template. Data were resliced to 2x2x2mm voxels and spatially smoothed using a 6mm 
Gaussian kernel. Subsequently, data were band pass filtered, and analyzed in the context of 
the General Linear Model, using boxcar regressors convolved with the canonical 
hemodynamic response to model responses during each condition.  
 For each subject, weighted contrasts were computed for cognitive color-word 
interference (incongruent versus congruent color words), for OCD related emotional 
interference (OCD related negative words versus neutral words) and for panic related 
emotional interference (panic related negative words versus neutral words). These contrast 




















(random effects) analysis, using one-way ANOVA’s for each contrast. Main effects and 
group by task interaction effects are reported at p<0.05 significance level corrected for 






OCD patients had significantly higher scores on the Y-BOCS (23.4±1.7) and Padua-IR 
(63.2±5.6) than subjects of other groups (ANOVA: F(3,53)=144, p<0.001 and F(3,52)=22, 
p<0.001), respectively). Hypochondriasis patients scored significantly higher on the Y-
BOCSH (25.9±3.6) and the WI (24.4±2.4) than subjects of other groups (ANOVA: 
F(3,55)=60, p<0.001 and F(3,55)=34, p<0.001, respectively). Mean BSQ scores in PD 
patients were 38.1±3.3, in agreement with previous findings82. 
 
Task performance 
Behavioral data of one hypochondriasis patient were lost due to technical problems. Mean 
response times (RTs) and performance rates for each group are listed in Tables 8.1a and 
8.1b. Across groups, RTs showed a significant increase for incongruent versus congruent 
color words (ANOVA: F(1,61)=129.8, p<0.001) and panic related words versus neutral 
words (F(1,61)=34.7, p<0.001), but not for OCD words versus neutral words (F(1,61)=0.7, 
p=0.40). Between-group comparisons revealed that the increase for panic related words 
versus neutral words was greater in PD and hypochondriasis patients compared with both 
OCD patients (ANOVA: F(1,30)=6.5, p=0.016 and F(1,27)=4.8, p=0.037 respectively) and 
controls (F(1,33)=9.1, p=0.007 and F(1,30)=10.4, p=0.003 respectively). RTs for color 
naming of neutral words were also longer in PD patients (F(1,33)=6.9, p=0.013) and 
hypochondriasis patients (F(1,30)=6.7, p=0.015) compared with controls. The increase in 
RTs for incongruent versus congruent color words in OCD subjects was greater than in PD 
patients (F(1,30)=4.2, p=0.049) and marginally greater than in control subjects 
(F(1,34)=3.4, p=0.076). Correlation analyses showed significant associations between 
subjective distress scores and increased RTs for color naming of panic related in PD 
patients (Pearson’s r=0.56, p=0.047) and for color naming of OCD words in OCD patients 
(r=0.63, p=0.011).  
 
 
Table 8.1a. Response times, averaged within each condition for each subject (mean (± SE), 
in milliseconds)  
 
 Controls PD OCD Hypochondriasis 
 
Congruent color 831 (± 31) 891 (± 33) 834 (± 32) 873 (± 34) 
Incongruent color 985 (± 25) 1027 (± 28) 1062 (± 45) 1073 (± 34) 
OCD related 874 (± 25) 949 (± 27) 943 (± 43) 953 (± 36) 
Panic related 898 (± 20) 1057 (± 29) 986 (± 46) 1022 (± 34) 
Neutral 1 870 (± 25) 967 (± 27) 934 (± 39) 984 (± 39) 




















Table 8.1b. Performance scores, expressed as percentage of the total number of responses 
within each condition for each subject (mean (± SE), in %) 
 
 Controls PD OCD Hypochondriasis 
 
Congruent color 83 (± 4.6) 87 (± 2.5) 85 (± 5.4) 79 (± 7.5) 
Incongruent color 84 (± 4.5) 82 (± 5.2) 74 (± 7.4) 75 (± 7.3) 
OCD related 86 (± 4.9) 93 (± 2.5) 89 (± 5.3) 86 (± 8.2) 
Panic related 87 (± 4.9) 90 (± 3.2) 87 (± 6.2) 82 (± 8.0) 
Neutral 1 84 (± 4.6) 88 (± 3.2) 85 (± 5.2) 80 (± 7.9) 
Neutral 2 87 (± 4.9) 90 (± 3.8) 88 (± 6.4) 83 (± 7.9) 
 
 
Analysis of performance scores across all groups (Table 1b) showed a significant increase 
in error rates during incongruent versus congruent color naming (F(1,61)=5.6, p=0.021), 
but not during color naming of panic related words versus neutral words (F(1,61)=0.3, 
p=0.57). The increase in error rates was greater in OCD subjects compared with controls 
(F(1,34)=4.1, p=0.050), whereas compared with controls performance was unimpaired in 
PD and hypochondriasis patients. Paradoxically, error rates decreased across groups during 
color naming of OCD related words versus neutral words (F(1,61)=36.1, p<0.001). Paired 
comparisons showed that this decrease was greater in hypochondriasis patients 
(F(1,30)=5.8, p=0.022) and marginally greater in PD patients (F(1,33)=2.9, p=0.097) 
compared with controls. Correlation analyses showed a significant negative association 
between subjective distress scores and performance during color naming of panic related 




1. Incongruent versus congruent  
Across all groups, regions showing increased Blood Oxygenation Level Dependent 
(BOLD) signal during color naming of incongruent versus congruent color words (see 
Figure 8.1) were present in right aPFC, bilateral DLPFC, VLPFC, dorsal ACC, motor, 
premotor, supplementary motor, insular, inferior parietal, superior and middle temporal, 
temporal-occipital and peristriate cortices, striatum, thalamus, hypothalamus, rostral 
brainstem and cerebellar cortex, and in left fusiform gyrus. Group by task interaction 
effects are shown in Table 8.2. Compared with control subjects, increased activation was 
found in OCD patients in right precuneus, left parahippocampal gyrus and left brainstem, in 
PD patients in right fusiform gyrus and in hypochondriasis patients in bilateral inferior 
parietal cortex, precuneus, left insular cortex and left rostral brainstem. No regions of 
significantly increased activation were found in control subjects compared with patients. 
 
2. OCD related versus neutral 
Color naming of OCD related words compared with neutral words, across all groups (see 
Figure 8.1) was correlated with increased BOLD signal in bilateral VLPFC, left OFC, right 
middle temporal cortex, bilateral superior temporal cortex, right parietal-occipital cortex 




















Figure 8.1.  ‘Glass brain’ renderings showing main effects for the contrasts of interest 
(incongruent versus congruent color words, OCD related versus neutral 

















































































control subjects, anxious patients showed widespread increased involvement of frontal-
striatal regions. Whereas OCD patients, compared with control subjects, showed 
significantly increased activation of bilateral amygdala and left hypothalamus during color 
naming of OCD related words, PD and hypochondriasis patients did not (see Figure 2). In 
OCD patients, increased activation of right amygdala was found compared with PD 
patients, and of right VLPFC, temporal and supplementary motor cortex compared with 
hypochondriasis patients. 
 
Figure 8.2. Increased BOLD signal in left and right amygdala during OCD related 
emotional interference in OCD patients compared with control subjects 





3. Panic related versus neutral 
Across all groups, color naming of panic related words compared with neutral words (see 
Figure 8.1) was correlated with increased BOLD signal in bilateral frontal-striatal regions, 
temporal-parietal cortices, fusiform gyrus and thalamus, right hippocampus, right amygdala 
and left rostral brainstem. Group by task interactions are shown in Table 8.4. Compared 
with control subjects, PD patients showed increased activation bilaterally in the aPFC, ACC 
and inferior parietal cortex and right-sided in the DLPFC, VLPFC, OFC, thalamus, middle 
temporal cortex, amygdala (see Figure 3a) and hippocampus (see Figure 3b). Similar 
regions were identified when comparing PD with OCD; in addition, OCD versus control 




















showed a similar activation pattern as PD patients, although no activation was found in 
amygdala and ACC. 
 
 
Figure 8.3. Increased BOLD signal during panic related emotional interference in PD 
patients compared with control subjects in (a) right amygdala and (b) 




4. Effect of disease severity 
No specific brain regions were found when correlations were investigated between OCD-
interference related BOLD-responses and symptom severity in OCD as measured by the Y-
BOCS and Padua-IR. Similarly, no correlation was found between panic-interference 
related activation patterns in PD patients and BSQ-scores. State anxiety was correlated with 
increased activation of right VLPFC (z =4.67) and left extrastriate cortex (z-=4.78) in OCD 
subjects during presentation of OCD related versus neutral words. No such state anxiety 





In the present study a cognitive and emotional Stroop task was used to investigate the 
neuroanatomical correlates of attentional bias across different anxiety disorders. The 




















in patients with OCD, PD and hypochondriasis compared with healthy control subjects, 
associated with frontal-striatal and limbic involvement. Moreover, we found clear 
differences between OCD patients on the one hand and PD and hypochondriasis patients on 
the other. In particular, OCD patients displayed increased cognitive interference compared 
with healthy control subjects, which was accompanied by activation of posterior brain 
regions. Although OCD patients did not display an attentional bias in behavior during color 
naming of OCD related words relative to control subjects, there was a clear and specific 
neuronal response in mainly ventral and limbic brain regions. In contrast, patients with PD 
and hypochondriasis displayed no interference for incongruent versus congruent words, but 
showed an attentional bias for both panic and OCD related information, involving both 
ventral and dorsal brain regions.  
 
In agreement with previous studies using the traditional color-word Stroop task, the present 
results showed the recruitment of prefrontal-striatal regions during cognitive interference. 
Prefrontal involvement implies the activation of various hierarchic subregions, known to 
subserve different executive subprocesses necessary to perform the task83. While activation 
of VLPFC may reflect lexical processing (word generation)84 and working memory 
(maintenance of information)85, activation of DLPFC and aPFC is associated with 
manipulation processes and complex executive control, respectively85. In addition to these 
prefrontal top-down control processes, the ACC is presumably involved in performance 
monitoring, response conflict and error-detection24;27;28;31;33;34. PD and hypochondriasis 
patients performed similarly during incongruent versus congruent color naming compared 
with control subjects, but performance in OCD patients was impaired. This finding is in 
agreement with Hartston & Swerdlow37, who reported increased color-word interference in 
OCD patients compared with control subjects, but not with Moritz et al38. Increased 
regional brain activity associated with cognitive interference, in patients compared with 
controls, was observed in posterior regions only. This may reflect increased effort, i.e. 
enhanced visual processing (fusiform and parahippocampal gyrus), heightened arousal 
(insular cortex and brainstem) and attention (precuneus and parietal cortex). Compensation 
by recruitment of posterior regions has been found in OCD patients before86. Moreover, 
altered frontal-striatal functioning in OCD is not restricted to attentional bias, but has 
recently also been demonstrated during executive tasks 87.  
 
Interestingly, our behavioral data showed improved performance for color naming of OCD 
related words compared with neutral words. This effect was found in all groups, but 
particularly in PD and hypochondriasis patients. It is inconsistent with the results of most, 
but not all53, previous studies, reporting increased response times and error rates due to 
emotional interference5. Possibly, the use of supraliminal stimuli in a block design may 
have enabled subjects to devise strategies to facilitate task performance. Alternatively, 
anxiety disorder patients may engage in more extensive processing of threat stimuli 
compared with normal controls88. 
Across all groups, color naming of OCD related versus neutral words was 
correlated with activation of VLPFC, OFC and posterior (temporal and parieto-occipital) 
regions. As expected, all three patient groups showed increased involvement of these 




















emotional interference was not restricted to OCD patients but also present in patients with 
PD and hypochondriasis, important differences were also found between the patient groups. 
First, in OCD patients VLPFC was activated, whereas patients with PD and 
hypochondriasis mainly showed DLPFC, aPFC and medial prefrontal activation. Second, in 
OCD patients bilateral amygdala activation was found during color naming of OCD related 
words, while no amygdala involvement was found in the other patient groups, as shown in 
Figure 2. The role of the amygdala in the evaluation of the behavioral significance of 
external stimuli and affective responses89;90 has been addressed in a number of studies using 
fear paradigms in normal controls73;91-95. Most previous imaging studies in OCD have 
observed amygdala involvement only in small samples and/or at lower statistical 
thresholds96;97, or not at all98-101, which may have been due to various methodological 
issues102. Strong reciprocal connections exist between the amygdala and widespread regions 
of frontal, insular, temporal and occipital cortices103. Although at present our understanding 
of the neuronal circuits underlying human emotion perception is limited, two interacting 
systems have been hypothesized to subserve the different subprocesses of emotional 
appraisal and behavior90. First, a ventral system, including the amygdala, insula, ventral 
striatum and ventral prefrontal regions (rostral ACC, VLPFC, OFC), is mainly important 
for the identification of the emotional significance of a stimulus and the generation of an 
autonomic, unconscious emotional response. Second, a dorsal system, consisting of the 
parahippocampal gyrus and dorsal regions of the frontal cortex (dorsal ACC, aPFC, DLPFC 
and medial PFC), is engaged in additional regulation of the initial emotional response by 
combining cognitive and emotional input. The present results in OCD patients are likely to 
reflect automatic processing of disease-specific emotional cues by the ventral system. 
Additional cognitive regulation seems to be reflected in the role of the dorsal ACC. 
Involvement of the dorsal ACC is consistent with the results of Shin et al70. They found 
dorsal ACC activation during emotional interference in their Vietnam veterans with PTSD, 
while rostral ACC activity was found in the non-PTSD group. Although OCD patients were 
capable of normal task performance, our behavioral data also showed that RTs as well as 
disease-specific neuronal responses in OCD subjects were correlated to subjective distress 
ratings. This suggests that cognitive function in OCD is vulnerable to high levels of state 
anxiety.  
 
In contrast to OCD related words, color naming of panic related words was not associated 
with differences in error rate, either across groups or between groups. However, RTs were 
significantly longer in PD and hypochondriasis patients compared with OCD patients and 
normal controls. Our imaging data parallel these behavioral results. Compared with control 
subjects and OCD patients, PD patients showed increased activation of prefrontal areas 
(mainly right sided), right rostral ACC, amygdala, hippocampus, rostral brainstem and 
thalamus. When comparing hypochondriasis patients to OCD patients and controls, a 
similar pattern was observed, but without the involvement of the amygdala and rostral 
brainstem as was found in PD. However, contrasting PD and hypochondriasis subjects did 
not yield significant interaction effects. Structural104;105 as well as functional (resting 
state106;107 and challenge108) neuroimaging studies in PD, have repeatedly demonstrated the 
role of the amygdala and hippocampal region in the symptomatology of panic disorder. In 




















panic attacks10. So far, only two functional MRI studies were performed in PD. In these 
studies, PD patients showed increased activation of prefrontal, anterior cingulate and 
(para)hippocampal cortices in response to threat related words88 or imagery exposure109. 
The widespread dorsal prefrontal involvement in PD and, to a lesser extent, 
hypochondriasis again suggests (cognitive) modulation of emotional responses. However, 
in contrast to OCD subjects during color naming of OCD related words, this seems to 
intervene with task demands. Whether this is due to stimulus characteristics (e.g. greater 
salience of panic related words relative to OCD related words) or reflects differences in 
processing of emotional material between OCD and PD/hypochondriasis is not yet clear. A 
post hoc comparison between neuronal activation patterns during color naming of disease-
specific words in OCD and PD showed increased recruitment of the dorsal system in PD 
patients compared with OCD patients (data not shown). This might reflect increased 
cognitive modulation elicited by the initial emotional response in PD, and intervening with 
performance.  
 
Concerning the issue of disease-specificity, our data indicate a clear distinction between 
OCD on the one hand and PD and hypochondriasis on the other hand, but not between PD 
and hypochondriasis. First, during incongruent versus congruent color naming, all patient 
groups recruited additional posterior brain areas relative to controls, but only in OCD 
performance was significantly impaired. Second, in OCD we observed increased 
recruitment of anterior cingulate and limbic regions only during color naming of OCD 
related versus neutral words, whereas in PD and hypochondriasis patients widespread 
activity in prefrontal, striatal and temporal regions was found during color naming of both 
OCD and panic related words. This is consistent with the hypothesis of a more generalized 
attentional bias to threat cues in PD. However, both in OCD and PD, amygdala activation 
was found to be disease-specific. Moreover, in OCD, state anxiety was correlated with 
longer RTs only during the disease-specific interference condition. Based on similarities 
between hypochondriasis and OCD, inclusion of hypochondriasis in the spectrum of 
obsessive-compulsive disorders has been suggested110;111. However, other distinctive 
features provide support for the association between hypochondriasis and PD74. While 
hypochondriasis and PD co-occur and overlap phenomenologically112, this overlap is by no 
means complete113. The results from the present study apparently support the association 
between PD and hypochondriasis. We did, however, not include an extra category of 
disease-specific words for hypochondriasis, unrelated to panic and OCD.  
 
To our knowledge, this study is the first to elucidate the neuronal correlates of color-word 
interference and attentional bias in three distinct, but related, disorders, i.e. OCD, PD and 
hypochondriasis. Strengths of the study are the inclusion of medication-free subjects, a 
large sample size permitting random effects analysis and the comparison across different 
patient groups. A limitation of the present study is that the hypochondriasis patients were 
significantly older than the other participants, although a post-hoc analysis of covariance 
with age as nuisance variable showed that the interaction effects, described in the present 
paper, persisted after regressing out age. Second, we did not specifically investigate 
diagnose subgroups, e.g. OCD patients with prominent washing or checking symptoms, or 




















investigated, is the possible role of strategic differences in task performance, by comparing 
overt (supraliminal presented) versus covert (subliminal presented) stimuli. For example, 
decreased involvement of dorsal brain regions in OCD compared with PD, as observed in 
the present study, may reflect predominantly unconscious emotional stimulus processing in 
OCD90. Alternatively, it can be argued that condition effects in OCD may have been 
obscured by ongoing top-down control processes irrespective of stimulus type, reflecting 
the difference between tonic and phasic symptomatology in OCD and PD. Finally, future 
research is warranted to explore whether the behavioral and neuropsychological 
abnormalities observed in the present study are trait- or state dependent, for example 
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Working in the field of neuroimaging is just like looking for a flower in a meadow.  
 
The objectives of this work were to investigate the frontal-striatal and limbic circuits during 
emotional and cognitive processes in patients with obsessive-compulsive and related 
disorders and to determine the specificity of possible abnormalities for these disorders. To 
address these issues, task related changes in regional cerebral blood blow (rCBF) and blood 
oxygenation level dependent (BOLD) signal were measured, using both positron emission 
tomography (PET) and functional magnetic resonance imaging (fMRI). The neuroimaging 
studies described in this thesis started in 2000. As can be seen from a review of this field 
(part I), almost half of the relevant studies have been published after 2000. This illustrates 
the tremendous developments within the field and stimulates to further innovation of 
imaging techniques and neuropsychological paradigms (part II). In this last chapter of the 
thesis, significance and limitations of the results of this thesis (part III) will be discussed. 





Other people have traveled the meadow of neuroimaging before. They made maps of their 
routes and they described the flowers they picked on their way. Some of their paths appear 
to have a dead-end; others seem to promise infinite views. Before starting your walk, it is 
important to study the maps of your predecessors. Which paths look most promising? And 
are there any hidden paths that have never been walked before?  
 
Part I of this thesis critically reviewed the results of neuroimaging studies in obsessive-
compulsive disorder (OCD) and panic disorder (PD), and illustrated some of the strengths 
and limitations of the various imaging techniques available. 
 Chapter two reviewed two decades of neuroimaging research in OCD, ranging 
from morphological measurements to functional experiments at baseline, after symptom 
provocation, and during neuropsychological performance. The overview clearly shows a 
shift in thinking about OCD over time. Theoretical models were first based on the idea of 
an exclusive, or at least prominent, role of the striatum. Subsequent theories emphasized the 
functional significance of the frontal-striatal circuits1, and the differentiation (mainly dorsal 
versus ventral) within these circuits. Recently, limbic structures, mainly the amygdala, have 
been implicated as well2.  
To date, imaging findings in OCD may be summarized as follows: 1) resting state 
in OCD patients is associated with increased activity of the ventral parts of frontal-striatal 
circuits - probably reflecting ongoing emotional and cognitive processing related to tonic 
symptomatology - and decreased activity in the dorsal parts of the prefrontal cortex, 2) 
during symptom provocation, activation of limbic structures (mainly the amygdala) and 
additional recruitment of ventral frontal-striatal regions may reflect the processing of salient 
information and emotional responses, and 3) exaggerated responses (anxiety and/or 
distress) may, at least in part, be the result of insufficient suppression or top-down control 
by the dorsal frontal-striatal circuit. The results of the present thesis provide a major 




















simplification of the complex mechanisms underlying the disorder and that it does not fully 
answer the question about the disorder-specificity of the assumed pathophysiological 
processes.  
 
In order to investigate the issue of disorder-specificity, comparisons between OCD and 
related disorders are warranted. The comparison with PD enables the differentiation 
between aspecific distress or anxiety related characteristics and OCD specific deficits. 
Chapter three illustrated the impact of neuroimaging experiments on the understanding of 
PD. Neuroimaging studies in PD, compared with those in OCD, originate from a different 
tradition. So far, the work in PD largely consists of pharmacological challenge studies in 
order to induce panic attacks, and receptor ligand studies, most of which have addressed the 
functioning of the GABA-benzodiazepine complex. Theoretical models of PD are based on 
the assumption that the main components of the illness – anticipatory anxiety, panic attacks 
and phobic avoidance - are linked to distinct neuroanatomical systems in the brain: the 
temporal lobe structures (mainly the amygdala, hippocampus and parahippocampal gyrus), 
the brainstem, and the prefrontal cortex, respectively3;4. Results of imaging studies in PD 
only partly support this hypothesis. As in most imaging studies a clear description of the 
emotional state at the time of data acquisition is lacking, proper neuroanatomical 
differentiation between panic attacks, anticipatory anxiety and other related symptoms is 





Working in the field of neuroimaging is like looking for a rare flower in a meadow. The 
flower of interest is often overgrown by weeds. And the colorful spot seen in the distance 
might just as well be a plastic bag.  
 
Noise and artifacts are the weeds and plastic bags of neuroimaging. It requires a critical 
attitude towards the experimental data acquired in order to improve signal-to-noise ratios 
and to differentiate between true and artificial findings. Only this attitude will lead to 
further innovation of imaging techniques. In Part II, two methodological aspects were 
investigated. 
 In chapter four an important methodological aspect of PET imaging has been 
investigated in detail, namely the effect of subject motion on the quality of the attenuation 
correction. Correction for tissue attenuation is a vital step in obtaining quantitative PET 
data. The most commonly used method to correct for tissue attenuation is by direct 
measurement using a separately acquired transmission scan. However, subject motion 
between transmission and emission scans may result in misalignment and, therefore, in 
erroneous attenuation correction. When standard attenuation correction is used, this 
mismatch can result in either underestimation or overestimation of regional activity 
concentrations. In case of random motion, transmission-emission mismatch will result in 
diminished signal-to-noise ratios and false-negative findings (type-II errors). On the other 
hand, as illustrated by a clinical case report, task related motion will result in systematic 




















symptom provocation experiments in psychiatric patients task related motion may easily 
occur when the presented emotional stimuli elicit muscle contractions accompanying 
emotions of fear, disgust or discomfort. For that reason, head positions may differ between 
the provoked and neutral state.  
It was investigated whether the implementation of an image registration (IR) 
method, which allows for motion-corrected attenuation correction, improved the accuracy 
of H2
15O PET analyses. The IR method, first described by Andersson et al.5, is based on 3 
assumptions: 1) the transmission scan and the first emission scan are well-aligned, 2) 
transformation matrices can be derived accurately from non-attenuation corrected emission 
scans, and 3) forward projected transmission scans result in the same attenuation correction 
factors as those derived directly from transmission scans when patient motion is absent. 
The implementation of the IR method consisted of the following five steps: 1) 
reconstruction of emission scans without attenuation correction, 2) calculation of 
transformation matrices between the first and the subsequent emission scans, 3) application 
of inverse transformation matrices to the reconstructed transmission scan, 4) forward 
projection of the transformed transmission scans to yield motion-corrected attenuation 
correction factors, and 5) application of these factors in the reconstruction of the emission 
scans. To evaluate the accuracy of this method, phantom studies (using a solid 
homogeneous 20-cm-diameter cylindrical phantom and a 3D brain Hoffman phantom) as 
well as studies in human subjects were performed. The results were compared with three 
alternative methods: 1) standard measured attenuation correction without motion 
correction, 2) calculated contour-based attenuation correction, and 3) no attenuation 
correction. 
In case of subtraction rather than quantitative analyses, attenuation correction 
might not be necessary, thereby bypassing the problem of subject motion. Indeed, results of 
the clinical case report and human validation study confirmed that motion induced false-
positive results, as obtained with standard attenuation correction, greatly reduced in case of 
subtraction analyses without attenuation correction. This method, however, is likely to 
generate extracranial (or border) artifacts, and is not suitable in the case of quantitative 
analysis (e.g. such as required in ligand studies). In addition, the calculated contour based 
method proved to be suboptimal, probably due to difficulties in accurately defining 
contours.  
The elaborate evaluation of the IR method showed that this method reduces noise 
for the group subtraction analysis and removes type-I errors in case of task related motion, 
while improving the signal from expected activated areas. The phantom data showed 
excellent accuracy of the algorithms for image registration, reconstruction, and forward 
projection of the transmission scan data. Therefore, the IR method should be considered as 
the first choice for attenuation correction in PET activation studies. Although promising, 
the application of this method for dynamic ligand studies still needs validation. 
 
Another domain of methodological consideration in neuroimaging research is the 
experimental paradigm used to visualize a specific cognitive and/or emotional state. An 
almost infinite battery of neuropsychological tasks can be used to investigate various 
neuropsychiatric disorders. To prevent contamination with aspecific findings, it is 




















related neuronal correlates between different groups requires a sensitive paradigm that 
specifically addresses the function of interest and incorporates a correction for potential 
differences in task performance.  
In chapter five the design of a parametric self-paced pseudo-randomized event-
related fMRI-version of the Tower of London task has been described. This planning task, 
originally developed by Shallice6, is supposed to address the flexibility of the frontal-
striatal and visuo-spatial circuits. A self-paced, parametric design allows for flexibility in 
response as well as for comparisons between subjects and/or groups at each task level, 
providing the opportunity to investigate groups with varying levels of performance. As 
performance is likely to deteriorate at higher complexity, control for performance 
differences is especially relevant for parametric designs. In addition to variation in reaction 
times, performance may also vary in hit frequency. Event-related analysis enables a 
selective analysis of correct responses, by separate modelling of the false events. Moreover, 
adequate randomization of trials is possible using an event-related design. 
 To evaluate this version of the Tower of London task, 22 healthy control subjects 
were investigated. Compared with baseline, planning activity was correlated with increased 
blood oxygenation level dependent (BOLD) signal in the dorsolateral prefrontal cortex 
(DLPFC), striatum, pallidum, (pre)motor cortex, supplementary motor area (SMA), and 
visuo-spatial system (precuneus and inferior parietal and parietal-occipital cortex). Task 
load was associated with increased activity in the same regions, and additional recruitment 
of the left anterior prefrontal cortex, a region supposed to be specifically involved in 3rd 
order executive functioning. 
 Two different aspects need to be considered when interpreting these results. First, 
compared with the main effects (i.e. planning versus baseline contrast), task load effects are 
more specific, although less sensitive, in their measurement of planning related changes in 
BOLD response. Second, while increasing task load, other processes, not specific for 
planning, might also increase (e.g. working memory). Therefore, the investigation of the 
neuronal correlates of planning might be best visualized by the combination of main and 
task load effects. 
 
Another methodological issue in neuroimaging of psychiatric conditions is the 
experimentally induced state of interest.  Although not addressed in part II, probably the 
most important questions remain: in which state is the patient at the moment of data 
acquisition and to what extent do researchers succeed in inducing and maintaining a desired 
emotional and/or cognitive state in subjects within an experimental setting? It is 
questionable whether the usual subtraction designs really succeed in isolating only the 
neuropsychological function of interest, even with a carefully matched baseline condition 
(e.g. for stimulus complexity and motor demands). Moreover, aspecific factors, such as 
arousal or distress, may disturb the visualization of the task related neuronal correlates. 
 Being aware of the difficulty of capturing the mental state of interest, an attempt 
was made to develop proper paradigms in order to investigate three different mental states: 
1) emotional perception during provoked contamination fear, 2) higher-order cognitive 
function during executive performance, and 3) the interaction between emotional and 























We started our walk. And how lucky we were! We found beautiful flowers on our way. 
  
Chapter six described the neurophysiological correlates of experimentally induced 
symptoms of contamination fear in OCD patients. This was not the first study to investigate 
the symptomatic state in OCD patients. Inconsistencies in earlier experimental results due 
to various methodological concerns (lack of control groups, medicated subjects, 
idiosyncratic tactile stimuli, off-on designs, limited sample size), however, asked for 
replication of the findings in 1) a homogeneous group, 2) of medication-free OCD patients, 
3) in comparison with healthy control subjects, 4) during a randomized design, 5) with 
standardized visual stimuli. To this end, a symptom provocation experiment was performed 
in 11 medication-free OCD patients with contamination fear and 10 healthy control 
subjects. Using oxygen-15 water (H2
15O) PET, task related changes in rCBF were measured 
during a randomized block design containing visual presentations of ‘dirty’ and ‘clean’ 
surroundings. To prevent type-I errors due to task related, subject motion induced 
transmission-emission mismatches, the IR method (as described in chapter 4) was used to 
reconstruct images.  
 Behavioral data showed that the provocation design was successful in inducing 
both subjective distress and obsessionality. Whereas obsessionality scores increased in 
OCD patients as well as in healthy control subjects, subjective distress scores only 
increased in the patient group. In other words, subjects in both groups experienced 
‘ritualism’, but only OCD patients also became anxious. Moreover, OCD patients became 
sensitised rather than habituated as a result of the contamination related stimuli. Imaging 
findings corresponded with these behavioral results. Healthy control subjects showed 
provocation induced increased rCBF in the left DLPFC and right caudate nucleus. The 
recruitment of frontal-striatal regions in controls in response to emotional stimuli seems to 
reflect ‘normal ritualism’ or top-down control of the emotional response. In contrast, in 
OCD patients the provoked symptomatic state was correlated with increased rCBF in the 
left amygdala. Moreover, in this group a time by condition interaction effect was found in 
the right amygdala, reflecting sensitization. The involvement of the amygdala in OCD 
during the symptomatic state is in agreement with the literature on the central role of the 
amygdala in evaluating the emotional significance of external stimuli and fear responses7;8. 
In OCD research, however, the role of the limbic system, mainly the amygdala, in the 
pathophysiology of the symptomatic state has been underestimated so far. Based on these 
results, it is suggested that the observed differences between OCD patients and controls 
reflect a failure of the frontal-striatal circuitry in OCD patients to control the processing of 
negative disease-relevant stimuli, resulting in an inadequate fear response, involving both 
amygdalae. 
 
The flexibility of the frontal-striatal system in OCD during an emotionally neutral state was 
investigated using an fMRI version of the Tower of London task, as described in chapter 
seven. To control for differences in performance between OCD patients and healthy control 
subjects, and to increase the specificity of the experimental effect of interest, a parametric 




















Twenty-two medication-free OCD patients and 22 healthy control subjects were included. 
Behavioral data showed decreased performance scores across all levels in OCD patients 
compared with control subjects, whereas reaction times (RTs) were significantly longer in 
OCD patients only during the two easiest task levels. Within groups, performance was not 
significantly correlated with symptom severity and subjective distress. Compared with 
controls, imaging results showed decreased task-associated activation in OCD patients in 
several regions previously found to be involved in planning, in particular DLPFC, basal 
ganglia and parietal cortex. Task load correlated with increased activity in the left DLPFC 
in control subjects compared with OCD patients. In contrast, the OCD group showed 
increased - presumably compensatory and/or stress-related - involvement of bilateral 
cingulate, ventrolateral prefrontal and parahippocampal cortices, left anterior temporal 
cortex and dorsal brain stem. The decreased responsiveness of the frontal-striatal system, 
described in OCD patients, was not correlated with ratings for symptom severity and 
subjective distress.  
 The results further support the involvement of a frontal-striatal dysfunction in the 
pathophysiology of OCD. Some alternative explanations might, however, be postulated in 
relation to the present differences between OCD patients and healthy control subjects, and 
some important concerns remain.  First, it might be argued that only the parametric task 
load contrast represents a valid and specific comparison between different groups, since the 
main effects for task might have been confounded by differences in baseline activity. 
Baseline differences may result from both resting state differences between patients and 
controls, and dissimilar cognitive or emotional processes during the baseline task in patients 
compared with controls. Second, the finding of decreased frontal-striatal responsiveness 
during planning performance might be at least partly explained by poor matching for 
intelligence. Although only correct responses were selected to control for performance 
differences, and in spite of the fact that post-hoc analyses of covariance with regard to 
educational level were performed (showing that the crucial fMRI task by group interaction 
effects in the striatum and DLPFC persisted after correcting for differences in education), 
the present findings need replication in an appropriately matched sample. Third, the 
question remains whether the frontal-striatal dysfunction during planning is specific for 
OCD, or whether it reflects an aspecific characteristic of anxiety or even neuropsychiatric 
disorders in general. This issue can be addressed by comparing the task related activation 
patterns across different patient groups. The present data set enables a comparison between 
OCD, PD and hypochondriasis, and this analysis will be performed in the near future. If 
patients with PD and hypochondriasis show normal frontal-striatal recruitment during 
planning, similar to controls, it might be concluded that the observed frontal-striatal 
dysfunction in OCD is specific for the pathophysiology of OCD. In contrast, if patients 
with PD and/or hypochondriasis also have decreased frontal-striatal responsiveness during 
planning performance, in common with OCD patients, a closer look at the shared features 
will contribute to a better understanding of common characteristics across disorders and /or 
aspecific factors confounding the task related activation patterns.  
   
In chapter eight, addressing attentional bias, emotional and cognitive processes are 
strongly interwoven. Difficulty in inhibiting irrelevant information is a key feature of OCD. 




















concerns, OCD patients are limited in their ability to selectively attend to relevant stimuli, 
whilst simultaneously ignoring irrelevant competing stimuli. As the critical process of 
gating, i.e. inhibiting irrelevant information, has been linked to frontal-striatal function and 
the evaluation of emotional stimuli to limbic function, the investigation of attentional bias 
to disease-relevant emotional cues might contribute to the understanding of the altered 
function of both frontal-striatal and limbic circuits in OCD. Moreover, comparisons across 
related disorders are needed to address the specificity of the dysfunction. 
 To investigate the neuronal correlates of attentional bias across related anxiety 
disorders, cognitive and emotional Stroop task related BOLD responses were measured in 
medication-free patients with OCD (N=16), PD (N=15), and hypochondriasis (N=13), and 
the behavioral and imaging results of these patient groups were compared with those of 19 
healthy control subjects. Contrasts of interest were the cognitive interference effect 
(incongruent versus congruent color words), the OCD related emotional interference effect 
(OCD related negative words versus neutral words) and the panic related emotional 
interference effect (panic related negative words versus neutral words).  
 Cognitive interference in all patient groups relative to controls was correlated with 
recruitment of additional posterior brain regions, but performance was impaired only in 
OCD patients. In OCD, color naming of disorder specific (OCD related) words only was 
associated with increased activation of ventral frontal-striatal and limbic regions, including 
bilateral amygdala, although performance was not abnormal. In contrast, patients with PD 
and hypochondriasis showed increased activation of ventral and widespread dorsal frontal-
striatal regions during both OCD and panic related words. In addition, in PD patients, the 
speed of color naming panic related words was significantly reduced, which was associated 
with increased activation of the right amygdala and hippocampus.  
 These results imply clear differences between OCD patients on the one hand and 
PD and hypochondriasis patients on the other. The disorder specific neuronal response in 
OCD mainly involves ventral brain regions, which are assumed to be implicated in 
emotional appraisal of emotional cues and unconscious fear responses. Attentional bias was 
found to be more generalized in patients with PD and hypochondriasis, involving both 
ventral and dorsal brain regions, which reflects not only unconscious emotional stimulus 
processing, but also increased cognitive elaboration of the initial emotional response. 
 
 
Where we are now? 
 
Now that we’ve returned from our journey the time has come to ask ourselves what we 
actually found. Did we really pick the specific beautiful flowers we were looking for, or 
have we been seduced by the painted flowers of van Gogh?  
 
Taking together the results described in part III, it can be hypothesized that altered dorsal 
frontal-striatal function in OCD patients is responsible for 1) decreased inhibition of ventral 
frontal-striatal and limbic recruitment in response to disease-relevant emotional cues and 2) 
decreased executive performance. This hypothesis, if confirmed, leaves several questions to 




















First, the term frontal-striatal appears to be too broad to capture the subtle alterations of 
brain functioning in OCD during the various emotional and/or cognitive conditions of 
interest. A distinction between dorsal and ventral frontal-striatal circuits is generally 
accepted in both the neuroanatomical and neuropsychiatric literature. However, the results 
of the present study do not allow us to unequivocally associate any of the studied OCD 
emotional and cognitive deficits to a specific striatal region or a particular prefrontal 
cortical circuit. A key issue seems to be how cognitive and emotional functions interact or, 
in other words, dorsal and ventral frontal-striatal circuits might influence each other. 
Moreover, there appear to be differences in interpretation as to connectional 
characterization of the dorsal and ventral striatum in the neuroanatomical and the 
neuropsychiatric literature. Whereas in neuroanatomical models the limbic (or ventral) 
striatum is defined as the area that receives hippocampal and amygdaloid input and is 
associated with emotional and motivational functions9, in psychiatric models the 
hippocampus belongs to the dorsal circuit8. Close collaboration between psychiatrists and 
anatomists is required in developing future theoretical models of psychiatric conditions. 
 Second, it is questioned whether anxiety is the key feature of OCD, leading to the 
repetitive behaviors, or whether OCD is a primary ‘cognitive’ disorder and anxiety just the 
spin-off. In other words, which level of emotional processing is most abnormal: the 
appraisal of the emotional significance of a stimulus, the subsequent fast and unconscious 
behavioral response, or the higher-order evaluation and modification of this initial 
response? This issue is hard to investigate and longitudinal designs are needed to 
differentiate between cause and effect. The present working hypothesis implies a primary 
failure (hypofunction) in the dorsal frontal-striatal circuit rather than a primary deficit 
(hypersensitivity) of the limbic or ventral frontal-striatal circuits. Support for a primary 
deficit in the DLPFC stems from imaging studies in children, showing altered maturation of 
the DLPFC in pediatric OCD10. Although replication is needed, this suggests a primary 
‘cognitive deficit’. To date, however, it has not been possible to prove this theory and the 
opposite hypothesis still cannot be rejected. As stated by Damasio11 and LeDoux7, trying to 
disentangle the issue might lead to a Cartesian error. Separation of emotion and cognition 
implicitly involves an artificial divorce of two closely interacting partners. Interactions 
between the different functional neuronal circuits subserving emotional and cognitive 
processes and the effects of the various neurotransmitters, from early development to the 
mature adult brain, are poorly understood and need further elaboration. 
 Third, the hypothesis suggests a direct top-down control mechanism from the 
DLPFC to the limbic circuit (mainly the amygdala). Although this sounds attractive, 
neuroanatomical evidence for projections descending directly from the DLPFC to the 
amygdala is rather weak. Whereas connections of the amygdala with orbitofrontal and 
medial prefrontal areas are robust and bi-directional, connections with lateral prefrontal 
areas are sparse, uni-directional and primarily ascending12;13. One possible way in which 
diverse streams of information could guide behavior would be through the rich 
interconnections between prefrontal areas9, involving cortico-cortical and cortico-thalamo-
cortical connections. Whereas the latter have long been thought to be organized in a strict 
reciprocal manner, recent evidence indicates that different cortical areas might be 
interconnected via the thalamus14. However, little is known about the complex direct and 




















important problem with the interpretation of neuroanatomical tracing studies is that these 
are at best carried out in non-human primates necessitating the extrapolation of the results 
to the more complex human brain. It is assumed that humans differ from animals in the way 
cognition is used to modify instinct-driven behavior. Possibly, humans differ from non-
human primates in the complexity of the neuroanatomical connections between dorsolateral 
prefrontal areas and limbic structures (e.g. the amygdala). The same reasoning applies to 
the opposite direction of the reciprocal interactions between emotion and cognition. 
Although psychiatrists and psychologists are easily inclined to assign a role for anxiety in 
executive impairment in patients, it is unclear in which way the amygdala might influence 
dorsolateral prefrontal functioning. 
Fourth, OCD is not the first or only psychiatric disorder in which a frontal-striatal 
dysfunction has been implicated. Not only anxiety disorders, but also psychotic disorders 
(e.g. schizophrenia), movement disorders (e.g. Tourette’s Syndrome) and mood disorders 
(e.g. major depressive disorder) have been attributed to an imbalance of the frontal-striatal 
circuits. This phenomenon might be explained in two different ways. On the one hand, 
different subregions of the frontal-striatal circuits, subserving different emotional and/or 
cognitive processes, might be involved in different neuropsychiatric disorders. Even in the 
case of a disorder specific dysfunction, the question remains whether the 
neurophysiological alterations reflect either state or trait characteristics of the disorder. 
Longitudinal follow-up measurements, for instance before and after treatment, may 
contribute to a better understanding of this issue. On the other hand, various 
neuropsychiatric disorders might share a common feature. These features might be related 
to the illness (e.g. feelings of stress and hopelessness) or to aspecific demographic and 
behavioral characteristics (e.g. educational level, unemployment, and smoking). Another 
common feature might be temperament, i.e. the inborn psychological profile. Schwartz et 
al.15;16 showed that adults who, in the second year of their life, had been categorized as 
inhibited, display amygdala hyperresponsiveness to novel versus familiar faces in 
comparison with those previously categorized as uninhibited.  
 
 
Where are we going?  
 
To date, almost all neuroimaging results in OCD have been based on comparisons between 
OCD patients and healthy control subjects. There are two questions with respect to the issue 
of disorder-specificity: 1) is a neurophysiological differentiation possible between OCD 
subcategories, and 2) are the frontal-striatal and limbic activation patterns found in OCD 
specific for this disorder or is there overlap with other anxiety, mood and even psychotic 
disorders? To answer these questions, two opposite approaches are needed: ‘splitting’, i.e. 
contrasting subcategories within OCD, and ‘lumping‘, or grouping together of OCD 
patients with patients suffering from other neuropsychiatric disorders, thereby focusing on 
functional dimensions rather than on DSM-categories. The latter approach appears to be the 
most promising one. Similarities between anxiety disorders seem to be more pronounced 
than differences. In addition, reported dysfunctional neuronal circuits are implicated in 
general aspects of human, and even non-human, behavior. First, it is necessary to 




















and fear responses and inhibition. Only then, will it be possible to interpret, sometimes 
subtle, neurophysiological differences between related disorders.  
Using the strategy of ‘lumping’, an important methodological question remains to 
be addressed: how to select patients and control subjects independent of the DSM-based 
criteria? The answer to this question depends on the aspect of the disorder to be 
investigated. A first step in the dimensional approach is to combine different related 
disorders as compared with healthy control subjects. Another possibility for subject 
inclusion, both in patients and in controls, is the use of a cut-off score on a scale developed 
to measure a specific dimension, for instance state anxiety, compulsiveness, inhibition, 
uncertainty, disgust, etc. The between-subject variance in the dimensional scores might be 
used to perform analyses of covariance with the BOLD response of interest. It will be 
interesting to use this approach to reanalyze the data presented in chapters seven and eight. 
Instead of grouping patients by diagnosis (OCD, PD and hypochondriasis), the score on the 
Padua Inventory Revised17;18 or a visual anxiety scale may be used to investigate the role of 
a possible common feature on the task related BOLD response. Moreover, the score on the 
Whitely Index19, a measure for obsessionality to diseases, might be used to further 
investigate similarities and differences in neuronal response to OCD and panic related 
negative words across the different patient groups. 
As proposed by Phillips et al.8, in a model on emotional perception, altered 
behavioral responses to emotional information might be investigated at roughly three 
different levels. The first level concerns the identification of the emotional significance of a 
stimulus. It might be possible that perceptual processing of emotional stimuli is impaired in 
anxiety disorders due to altered amygdala function. Vuilleumier et al.20 have shown that 
emotion can directly affect sensory processing at an early stage of perception. If so, anxious 
people may not only have a different interpretation of what they see, but may also literally 
perceive these stimuli as abnormal themselves21. The second and third levels of emotional 
perception relate to the production and regulation of an affective response to this emotional 
information. When focusing on anxiety disorders, these processes might best be 
investigated by studies on fear responses, fear extension learning and higher-order 
modulation of behavior. Whereas almost nothing is known about the role of the DLPFC in 
the modulation of fear responses, studies in extinction learning, both in animals and in 
humans, have contributed to the understanding of the role of the ventromedial PFC in the 
inhibition of learned fear. Direct interconnections between the ventromedial PFC (or 
subgenual anterior cingulate cortex) and the amygdala have been implicated in fear 
extinction, which is not simply a process of ‘unlearning’, but rather one of ‘new learning’22-
24. Understanding how learned fears are diminished and how extinction learning is changed 
in patients with anxiety disorders might be an important step in translating neurobiological 
research to diagnosis and treatment of these patients. 
 As mentioned above, there is a lack of understanding of the modulation of 
emotional responses by higher-order cognitive processes. Therefore, probably one of the 
key issues for the coming years is to integrate research on emotion and cognition. With 
regard to the complex interactions between emotion and cognition, there appear to be two 
important questions: 1) which direct and indirect descending connections from the DLPFC 
to the amygdala play a role in the presumed top-down control of the amygdala response, 




















executive functioning? More insight in the functional neuronal circuits connecting emotion 
and cognition, underlying normal and pathological behavior, necessitates a 
multidisciplinary approach, combining lesion studies, structural measurements, and 
functional imaging paradigms in human and non-human primates. Useful comparisons 
between human and non-human experiments require neuropsychological paradigms that are 
applicable across various species. 
Finally, future research in this field may benefit most from a longitudinal and 
multimodal approach. Probably the most interesting cohort consists of young children, with 
and without obsessive-compulsive and related disorders. Longitudinal follow-up of these 
children into adolescence and adulthood enables visualization of natural history as well as 
the evaluation of long-term effects of environmental influences and treatment strategies. 
Multimodal designs can also contribute to a better differentiation between cause and effect. 
For instance, altered morphology may be related to an imbalance of interacting 
neurotransmitter systems, and differences in task related BOLD responses may be 
confounded by early maturation deficits. If we succeed in mapping neurophysiological 
profiles relevant for the symptomatology of patients, these profiles might be used as 





OCD is an interesting neuropsychiatric disorder, particularly because of the simultaneous 
presence of cognitive and emotional processes underlying the characteristic, pathological 
behavior. The specificity of research findings and the sensitivity of experimental 
paradigms, however, seem to be limited. This may be explained by the congeniality with 
other neuropsychiatric disorders, and the lack of a strict dividing line between normal and 
pathological obsessive-compulsive behavior (or between adequate and inadequate fear 
responses). At presence it is not clear, which research approach will be superior in its 
attempt to understand the specific underlying mechanisms of the symptomatology. In view 
of the heterogeneity of the clinical phenomena in OCD, the main challenge for 
neuroimaging researchers is to define and map the clinically most relevant and specific 
psychopathological features of the disorder. The findings described in this thesis contribute 
to the knowledge about the underlying mechanisms of some of the psychopathological 
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Beeldvormend hersenonderzoek bij  
obsessieve-compulsieve en aanverwante stoornissen 























De dwangneurose (ook wel obsessieve-compulsieve stoornis of OCS genoemd) wordt 
gekenmerkt door dwanggedachten (obsessies) en/of dwanghandelingen (compulsies). 
Obsessies zijn hardnekkige, hinderlijke repetitieve gedachten of beelden die angst of 
spanning veroorzaken. Vaak hebben deze gedachten te maken met de angst besmet te 
worden, met een extreme twijfel over de juistheid van het eigen handelen of de overtuiging 
iets belangrijks te hebben nagelaten en daardoor verantwoordelijk te zijn voor mogelijke 
rampzalige gevolgen. Gedachten kunnen ook voortkomen uit de behoefte tot symmetrie of 
perfectionisme of een vastomlijnd gevoel over ‘hoe het moet zijn’. Karakteristieke thema’s 
zijn verder seksualiteit en agressie. Compulsies zijn rituele gedragingen (soms uiterlijk 
waarneembaar, soms slechts mentaal aanwezig) die steeds op stereotiepe wijze worden 
uitgevoerd om de angst of de spanning, ontstaan door de obsessies, te doen afnemen. Vaak 
voorkomende dwanghandelingen zijn wassen, controleren, ordenen, tellen, herhalen en 
verzamelen.  
OCS is een ‘verscholen’ chronische psychiatrische ziekte: mensen met zelfs 
ernstige dwangklachten vertonen in contact met anderen vaak weinig afwijkend gedrag en 
zij blijven meestal jarenlang buiten het zicht van hulpverleners. Dit ondanks de vaak 
ernstige beperkingen in dagelijks, sociaal en beroepsmatig functioneren. Uit 
epidemiologisch onderzoek blijkt dat OCS een niet-zeldzame stoornis is, met vaak een 
chronisch recidiverend beloop. OCS wordt sinds de introductie van de derde editie van de 
Diagnostic and Statistic Manual (DSM-III) van de American Psychiatric Association in 
1980 geclassificeerd als een angststoornis. Andere angststoornissen zijn onder meer de 
paniekstoornis, de posttraumatische stressstoornis, de sociale fobie, de specifieke fobie (b.v. 
hoogtevrees, vliegangst, angst voor spinnen) en de generaliseerde angststoornis. Het 
klinisch beeld van OCS vertoont ook overeenkomsten met andere, niet binnen het 
angstcluster geclassificeerde stoornissen. Zo zijn obsessieve-compulsieve klachten frequent 
aanwezig bij mensen met het syndroom van Gilles de la Tourette en neurologische 
aandoeningen zoals Sydenham’s chorea en morbus Huntington. Ook vertoont het klinisch 
beeld overeenkomsten met de somatoforme stoornis hypochondrie, ofwel de preoccupatie 
met de vrees een ernstige ziekte onder de leden te hebben.  
 Hoewel uitgebreide behandelingmogelijkheden bestaan om dwangklachten te doen 
afnemen, is over de werking van de hersenen bij deze aandoening nog relatief weinig 
bekend. Inzicht in de neurobiologische achtergrond van OCS zou op termijn kunnen 
bijdragen aan nieuwe behandelstrategieën voor therapieresistente dwangklachten. De 
verwantschap met de neurologische ziektebeelden Sydenham’s chorea en morbus 
Huntington brachten het onderzoek naar de neurobiologische achtergrond van OCS op de 
betrokkenheid van specifieke prefrontale en subcorticale (= onder de hersenschors gelegen) 
gebieden van de hersenen (zie Fig. 1). Deze samenwerkende hersengebieden worden ook 
wel aangeduid met de term fronto-striatale circuits. Tevens werd een verstoorde functie van 
limbische structuren (met name de amandelkern of amygdala) vermoed, gezien diens rol in 
normale angstreacties bij dieren.  Het onderzoek naar de betrokkenheid van de fronto-
striatale en limbische circuits bij de etiologie van OCS is de laatste decennia in een 
stroomversnelling geraakt met de komst van nieuwe technieken voor beeldvormend 
onderzoek, met name positron emissie tomografie (PET) en magnetic resonance imaging 

























wijze in vivo afbeeldingen van zowel structuur als functie van de hersenen te verkrijgen. 
Dergelijke technieken maken gebruik van subtiele regionale veranderingen in 
bloeddoorstroming, welke gepaard gaan met de taak-gerelateerde veranderde neuronale 





Het doel van het onderzoek, zoals beschreven in dit proefschrift, was het verkrijgen van 
inzicht in de rol van verschillende neuronale circuits, met name de fronto-striatale en 
limbische circuits, bij cognitieve en emotionele processen die ten grondslag liggen aan de 
symptomen van OCS. Met andere woorden, is er sprake van aantoonbare afwijkingen in de 
activiteit van deze neuronale circuits bij OCS-patiënten in vergelijking met gezonde 
mensen? Een bijkomend doel was om te onderzoeken in hoeverre deze eventuele  
afwijkingen specifiek zijn voor OCS-patiënten of dat deze op ook optreden bij mensen met 





















Beeldvormend hersenonderzoek is een relatief nieuwe tak van onderzoek die zich 
razendsnel ontwikkelt. De studie is van start gegaan in het jaar 2000. Zoals ook blijkt uit 
het literatuuroverzicht (deel I van het proefschrift), is ongeveer de helft van de relevante 
studies in dit veld gepubliceerd na het jaar 2000. Dit geeft aan hoe belangrijk de 
ontwikkeling en innovatie van scantechnieken en neuropsychologische experimenten is 
geweest tijdens de periode waarin deze studie is uitgevoerd (deel II van het proefschrift). 
De resultaten van het onderzoek naar de rol van de fronto-striatale en limbische circuits 
tijdens verschillende cognitieve en emotionele processen in OCS (deel III van het 
proefschrift) bevestigen in belangrijke mate de hypothese van een verstoorde functie van 
deze circuits bij OCS en dragen bij aan verder inzicht in de overeenkomsten en verschillen 
tussen aanverwante stoornissen. 
 
 
De opbouw van het proefschrift 
 
Het proefschrift bestaat uit drie delen. Deel I bevat een uitgebreid literatuuroverzicht: de 
resultaten van twee decennia beeldvormend onderzoek in OCS en paniekstoornis. De 
literatuur is ingedeeld naar type experiment en/of gebruikte techniek. In het overzicht zijn 
ook de eigen bevindingen opgenomen om ze zo te plaatsen binnen de grotere context. 
 Deel II van het proefschrift beschrijft de bijdrage die binnen deze promotiestudie 
is geleverd aan de methodologie van beeldvormend hersenonderzoek in het algemeen. Dit 
betreft 1) het onderzoek naar het effect van ongewenste hoofdbeweging van de 
proefpersoon op de kwaliteit van PET-scans en, 2) het geschikt maken van een 
neuropsychologische taak voor gebruik bij onderzoekspopulaties met ongelijk 
prestatievermogen. 
 Deel III van het proefschrift beschrijft de achtergrond en de resultaten van drie 
patiëntgebonden experimenten. De resultaten bevestigen de hypothese van een verstoorde 
functie van de fronto-striatale en limbische circuits bij OCS. De resultaten dragen ook bij 




De samenvatting van de resultaten 
 
Deel I: literatuuroverzicht (hoofdstukken 2 en 3) 
 
Het literatuuroverzicht van beeldvormend onderzoek in OCS, zoals beschreven in 
hoofdstuk 2, laat duidelijk een verschuiving zien in het denken over deze aandoening. 
Theoretische modellen waren in eerste instantie gebaseerd op een exclusieve, of op zijn 
minst prominente, rol van het striatum (met name de staartkern of nucleus caudatus). Latere 
theorieën benadrukten de functionele betekenis van de fronto-striatale circuits en de verdere 
ventrale versus dorsale differentiatie binnen deze circuits. Recent is ook de rol van het 
limbische systeem (met name de amygdala) in de modellen opgenomen.  
Onderzoek naar structurele afwijkingen bij OCS heeft veel inconsistente resultaten 




















dorsale prefrontale schorsgebieden, suggestief voor OCS als neuronale 
ontwikkelingsstoornis. Functioneel beeldvormend onderzoek heeft daarentegen meer 
eenduidig afwijkingen in de fronto-striatale en limbische gebieden laten zien en zou als 
volgt kunnen worden samengevat: 1) in rust is met name verhoogde ventrale en verlaagde 
dorsale fronto-striatale activiteit kenmerkend voor OCS, 2) gedurende symptoomprovocatie 
neemt de activiteit toe in de limbische structuren (waaronder de amygdala) en – in 
wisselende mate – de ventrale fronto-striatale gebieden, 3) toegenomen respons (angst en 
spanning) op emotionele stimuli zou deels verklaard kunnen worden door verminderde 
onderdrukking van de limbische activiteit vanuit de dorsale fronto-striatale gebieden, en 4) 
bij cognitieve taken gaat verminderde activering van de dorsale fronto-striatale circuits 
samen met verhoogde activiteit van de anterieure cingulaire schors en posterieure 
schorsgebieden (zoals de parahippocampale schors). Beeldvormend onderzoek naar de 
neurochemische veranderingen bij OCS laat verder betrokkenheid zien van diverse 
interacterende neurotransmitter systemen, waaronder serotonine, dopamine, glutamaat en 
acetylcholine.  
 Onderzoek naar de ziektespecificiteit van de beschreven afwijkingen bij OCS is 
mogelijk door middel van vergelijking met aanverwante stoornissen. De vergelijking met 
de paniekstoornis maakt het mogelijk te differentiëren tussen aspecifieke stress- en/of 
angstgerelateerde karakteristieken en voor OCS specifieke afwijkingen. Hoofdstuk 3 
belicht de bijdrage van beeldvormend onderzoek aan de kennis over de paniekstoornis. 
Beeldvormend onderzoek naar de paniekstoornis kent een andere geschiedenis dan die in 
OCS. Vooralsnog werd deze vooral bepaald door farmacologische provocatiestudies en 
ligandstudies naar de werking van het GABA-benzodiazepinecomplex. Theoretische 
modellen waren gebaseerd op de veronderstelling dat de verschillende componenten van de 
ziekte (anticipatieangst, paniekaanvallen en fobische vermijding) geassocieerd zijn met 
verschillende neuronale systemen in de hersenen (respectievelijk amygdala, hersenstam en 
prefrontale schors). Deze hypothese wordt slechts deels gedragen door de bevindingen van 
beeldvormend onderzoek, mogelijk door de beperkte mogelijkheid de precieze emotionele 
toestand van de proefpersoon op het moment van dataverzameling te bepalen of te 
beïnvloeden.  
 
Deel II: bijdragen aan de methodologie van beeldvormend hersenonderzoek (hoofdstukken 
4 en 5) 
 
Het gebruik van beeldvormende technieken is te vergelijken met het zoeken van een 
zeldzame bloem in een veld: de gezochte bloem is vaak overwoekerd met onkruid en een 
kleurige stip gezien in de verte zou voor hetzelfde geld een rondslingerende plastic zak 
kunnen zijn. Ruis en artefacten zijn het onkruid en de plastic zakken van beeldvormend 
hersenonderzoek. Het vereist een kritische houding bij het bewerken en interpreteren van de 
experimentele data. In hoofdstuk 4 wordt een belangrijk methodologisch aspect, het effect 
van ongewenste beweging van het hoofd van de proefpersoon tijdens het experiment, in 
detail uitgewerkt. Gedurende de analyses van de PET data werd duidelijk dat beweging van 
de proefpersonen geleid zou kunnen hebben tot artefacten. Bij nadere bestudering bleken 
deze te maken te hebben met een onjuiste correctie voor attenuatie (verzwakking van het 





















verkrijgen van kwantitatieve data. De bekendste methode (de zogenaamde gemeten 
attenuatiecorrectie) maakt gebruik van directe meting via een transmissiescan, welke wordt 
gemaakt direct voorafgaand aan de experimentele emissiescans.  Beweging van het hoofd 
tussen de afzonderlijke emissiescans door leidt tot ten opzichte van elkaar verschoven 
posities van de transmissie en emissiescans. Wanneer de beweging willekeurig is, zal de 
verschuiving leiden tot een afgenomen signaal-ruis-verhoudingen en vals-negatieve 
bevindingen. Wanneer de beweging echter taak-gerelateerd plaatsvindt, bijvoorbeeld door 
toegenomen spanning in het lichaam tijdens het kijken naar angstprovocerende stimuli, zal 
de verschuiving leiden tot systematische reconstructieartefacten en daardoor vals-positieve 
resultaten. Onderzocht werd of de implementatie van een alternatieve methode voor 
attenuatiecorrectie, de zogenaamde ‘image registration method’ of IR-methode, zou leiden 
tot toegenomen kwaliteit van de PET beelden. Gebruik makend van zowel fantoomstudies 
als humane experimenten, werd de IR-methode vergeleken met de gemeten 
attenuatiecorrectie en twee andere benaderingen (geen correctie voor weefselverzwakking 
en berekende of ‘contour-based’ attenuatiecorrectie). De resultaten lieten zien dat de IR-
methode superieur is ten opzichte van de andere methoden, door een toegenomen signaal-
ruis-verhouding en een reductie van vals-positieve bevindingen. Gebruik van deze methode 
kan daarom gezien worden als 1ste keus bij PET activatiestudies. 
 Een ander methodologisch aspect van belang is de aanpassing van het 
neuropsychologische paradigma voor gebruik in de scanner bij onderzoekspopulaties met 
een variabel niveau van prestatie.  Hoofdstuk 5 beschrijft een fMRI-versie van de Tower of 
London, een planningstaak. De Tower of London bestaat uit een plankje met 3 stokjes van 
respectievelijk 1, 2 en 3 bal-lengten en drie verschillend gekleurde ballen. In beeld worden 
twee configuraties getoond, de beginconfiguratie en de doelconfiguratie. Aan de 
proefpersonen wordt gevraagd om het minimaal aantal stappen te tellen dat nodig is om van 
begin- naar doelconfiguratie te komen. Men mag daarbij slechts 1 bal tegelijkertijd van 
plaats veranderen en een bal kan alleen verplaatst worden als er geen bal bovenop ligt. In de 
controleconditie moeten proefpersonen het totaal aantal blauwe en gele ballen tellen. De 
fMRI-versie van deze taak bestond uit de volgende elementen: parametrische condities 
(variërend van 1 tot 5 stappen) in pseudo-gerandomiseerde aanbieding, flexibele 
responssnelheid en separate analyse van goede en foute antwoorden. Voorafgaand aan 
toepassing in patiënten werd het paradigma getest bij 22 gezonde controles. Iedere 3 
seconden werden MRI-beelden vervaardigd (433 scans/proefpersoon in totaal). Vergeleken 
met de controleconditie ging planning gepaard met verhoogde activiteit in de dorsolaterale 
prefrontale schors, motorische schors, visuospatiële gebieden (pariëtale en occipitale 
schorsgebieden) en het striatum en pallidum. Toename in complexiteit van de taak 
correleerde met extra activering van dezelfde gebieden en additionele activiteit in de linker 
anterieure prefrontale schors, een gebied dat een speciale rol toegekend heeft gekregen in 
3de-orde executieve functies. Op basis van deze resultaten kan geconcludeerd worden dat de 
taak zeer geschikt is voor het bestuderen van het executief vermogen in OCS-patiënten: de 
taak brengt specifiek het dorsale fronto-striatale systeem in beeld en maakt het mogelijk te 





















Deel III: resultaten van drie patiëntgebonden experimenten (hoofdstukken 6, 7 en 8) 
 
Dit deel van het proefschrift bevat de achtergrond en de resultaten van drie patiëntgebonden 
experimenten. Het beschrijft de neuronale correlaten van normale en pathologische 
emotionele en/of cognitieve processen in patiënten met OCS in vergelijking met zowel 
gezonde controleproefpersonen als patiënten met aanverwante aandoeningen (namelijk  
paniekstoornis en hypochondrie). Drie experimenteel geïnduceerde mentale condities 
worden achtereenvolgens beschreven: 1) informatieverwerking van emotionele stimuli 
tijdens de provocatie van smetvrees, 2) executief cognitief functioneren tijdens de 
uitvoering van een planningstaak en 3) de interactie tussen emotionele en cognitieve 
processen gedurende een aandachtstaak met ziekte-specifieke woorden.  
 Wij waren niet de eersten die de smetvreesprovocatie gebruikten om de bij OCS 
betrokken neuronale circuits te bestuderen. Echter, de studie beschreven in hoofdstuk 6 
verschilt van voorgaande studies door enkele methodologische verbeteringen: de selectie 
van een homogene groep medicatievrije smetvreespatiënten, de inclusie van een 
controlegroep, en het gebruik van gestandaardiseerde visuele stimuli die gerandomiseerd 
aan de proefpersonen is aangeboden. Met behulp van licht radioactief gelabeld water 
werden PET-scans gemaakt in een actieve conditie (vieze plaatjes) en een rustconditie 
(schone plaatjes). In de controlegroep was een toegenomen activiteit zichtbaar in de linker 
dorsolaterale prefrontale schors, basale voorhersenen en de rechter nucleus caudatus tijdens 
het kijken naar de vieze plaatjes (zie Fig. 2a). Bij deze groep lijkt de bijsturing van de 
emotionele reactie vanuit het dorsolaterale circuit verantwoordelijk voor het voorkómen 







Bij de OCS-patiënten daarentegen, was de actieve conditie gecorreleerd met verhoogde 
activiteit in de linker amygdala. Bovendien was een in de tijd toenemende activiteit 
zichtbaar in de rechter amygdala gedurende de actieve conditie (ook wel sensitisatie-effect 
genoemd, zie Fig. 2b). De amygdala staat bekend om haar rol in emotionele 





















reactie op de aangeboden plaatjes (de patiënten reageren met een significante toename in 
angst, de controles niet) is te verklaren door een bij OCS verminderde controle op het 
alarmsysteem (amygdala) vanuit het dorsale fronto-striatale circuit, resulterend in een 
inadequate angstreactie en sterke activering van beide amygdalae.  
 
 




De bevinding van het tekortschieten van het dorsale fronto-striatale systeem in OCS 
gedurende emotioneel beladen condities, doet vermoeden dat ditzelfde circuit 
verantwoordelijk is voor verstoring van bepaalde denkfuncties (bijvoorbeeld het 
leervermogen, planning, aandacht en besluitvorming). De bestudering van de flexibiliteit 
van het dorsale fronto-striatale systeem in OCS gedurende de uitvoering van een 
planningstaak (Tower of London) wordt beschreven in hoofdstuk 7. In totaal deden 22 
medicatievrije patiënten met OCS en 22 gezonde controles mee aan de studie.  Vergeleken 
met gezonde controles maakten patiënten met OCS significant meer fouten tijdens de 
uitvoering van de taak. Tijdens het plannen worden verschillende gebieden van het fronto-
striatale systeem geactiveerd, zowel bij gezonde controles als bij patiënten met OCS. 
Echter, vergeleken bij controles is dit fronto-striatale systeem bij mensen met OCS minder 
actief. De verminderde reactiviteit van deze hersengebieden lijkt gecompenseerd te worden 
met verhoogde activiteit in andere gebieden (waaronder de cingulaire en parahippocampale 
schors). Tevens is in de OCS-groep verhoogde activiteit zichtbaar in stressgerelateerde 
gebieden (zie Fig. 3). Samengevat laat deze studie zien dat een verminderd 
planningsvermogen in OCS samen gaat met verminderde reactiviteit van het dorsale fronto-


























In het experiment van hoofdstuk 8 zijn emotie en cognitie sterk met elkaar verweven. Het 
is bekend dat angstige mensen minder goed in staat zijn irrelevante informatie te negeren, 
onder meer doordat zij de neiging hebben de aandacht te richten op elementen die te maken 
hebben met hun angsten. Met behulp van de Stroop, een aandachtstaak, wordt gekeken in 
hoeverre het een proefpersoon lukt de aandacht te richten op de kleur van de inkt van 
getoonde woorden, onafhankelijk van de inhoud van die woorden. Bij deze taak is het de 
bedoeling zo snel mogelijk de knop in te drukken die correspondeert met de kleur van de 
inkt. Wanneer het antwoord beïnvloed wordt door de betekenis van het woord (zowel in 
reactietijd als in juistheid van het antwoord) is er sprake van interferentie. De taak bestond 
uit een zuiver cognitief deel en een ziekte-gerelateerd, emotioneel deel. De cognitieve 
condities bestonden uit congruente (bijvoorbeeld het woord ‘rood’ in rode inkt geschreven) 
en incongruente (bijvoorbeeld het woord ‘rood’ in blauwe inkt geschreven) woorden. 
Tijdens de emotionele condities werden woorden getoond die betrekking hebben op OCS 
(bijvoorbeeld de woorden ‘twijfel’ en ‘vies’) en paniekstoornis (bijvoorbeeld de woorden 
‘menigte’ en ‘hartaanval’). Prestatie op deze ziekte-gerelateerde woorden werd vergeleken 
met die tijdens neutrale woorden (bijvoorbeeld de woorden ‘tafel’ en ‘ovaal’). Met het doel 
de fronto-striatale en limbische circuits te bestuderen tijdens de uitvoering van deze 
aandachtstaak, en bijkomend de specificiteit van de mogelijke afwijkingen te onderzoeken, 
werden met behulp van fMRI 4 onderzoekspopulaties vergeleken: medicatievrije patiënten 
met OCS (N=16), paniek (N=15) en hypochondrie, en een gezonde controlegroep (N=19). 
Vergeleken met controles en patiënten met paniek en hypochondrie, hadden OCS-patiënten 
slechtere scores op het cognitieve deel van de taak, maar de uitvoering van dit deel ging bij 
alle patiëntengroepen (vergeleken met gezonde controles) gepaard met verhoogde activiteit 
in compensatiegerelateerde hersengebieden. Tijdens de uitvoering van het emotionele deel 
van de Stroop was een duidelijk verschil zichtbaar tussen OCS-patiënten enerzijds en 
patiënten met een paniekstoornis en hypochondrie anderzijds. Patiënten met OCS hadden 





















met verhoogde activiteit in het ventrale fronto-striatale systeem en beide amygdalae (zie 






Patiënten met een paniekstoornis hadden slechtere scores op de paniek-woorden. Terwijl 
OCS-patiënten heel specifiek reageerden op OCS-woorden en niet op paniek-woorden, 
vertoonden patiënten met een paniekstoornis zowel op OCS-woorden als op paniek-
woorden een verhoogde activiteit in het fronto-striatale systeem. Echter, alleen tijdens de 
paniek-woorden was ook de verhoogde amygdala-activiteit zichtbaar. Tevens waren de 
geactiveerde fronto-striatale gebieden in patiënten met een paniekstoornis uitgebreider dan 
bij OCS-patiënten. Patiënten met hypochondrie vertoonden een beeld dat sterk leek op die 





Op basis van de bevindingen beschreven in deel III kan de volgende hypothese 
geformuleerd worden: verstoord dorsaal fronto-striataal functioneren in OCS-patiënten ligt 
ten grondslag aan 1) de verminderde remming op de ventrale fronto-striatale en limbische 
activiteit als reactie op ziekte-specifieke emotionele stimuli en 2) een verminderd cognitief 
functioneren, welke deels kan worden gecompenseerd door het aanspreken van alternatieve 




















Toekomstig onderzoek zal zich moeten richten op het in kaart brengen van de interacties 
tussen de verschillende fronto-striatale en limbische circuits om zo antwoord te kunnen 
geven op de volgende vragen: 1) welke directe en indirecte connecties vanuit de dorsale 
fronto-striatale gebieden op het limbische circuit spelen een rol in de bijsturing van de 
emotionele respons en 2) op welke manier beïnvloedt activiteit in de amygdala direct of 
indirect het hoger cognitief functioneren? Het vergt een multidisciplinaire aanpak, waarbij 
laesiestudies, structurele metingen en functionele beeldvorming worden gecombineerd in 
mens en dier. Tevens is een grote winst te verwachten van longitudinaal patiëntgebonden 
onderzoek, zodat meer inzicht ontstaat in de vroege kenmerken, het natuurlijk beloop en het 





















Bloed, zweet en tranen 
 
of de emotie achter de cognitie 





















Dank ben ik verschuldigd aan alle proefpersonen, met of zonder angst, die zich lieten 
overhalen mee te werken aan de soms belastende experimenten. Dank dat ik een kijkje kon 
nemen in uw denkende en voelende brein. Zonder uw onbaatzuchtige bijdrage aan de 
wetenschap was het onderzoek onmogelijk geweest. 
  
Dit boekje is een kind van gemengde afkomst. Met een stevig neuronaal fundament 
(vakgroep anatomie) en groot gebracht in een fysisch milieu (PET-centrum en MRI-
afdeling), is het gedreven door een levendige nieuwsgierigheid in de angstige geest 
(angstpolikliniek). Het heeft vele vaders, enkele moeders en een groot aantal ooms en 
tantes. Ik dank allen die op welke wijze dan ook hebben bijgedragen.  
 
Een aantal mensen wil ik graag nog persoonlijk bedanken. 
 
Allereerst mijn promotoren, Richard van Dyck en Adriaan Lammertsma, en copromotoren, 
Dick Veltman en Henk Groenewegen. Hen wil ik bedanken voor de superviserende rol 
gedurende de afgelopen jaren.  
Beste Richard, jij hebt een belangrijke rol gespeeld als supervisor op ‘nabije 
afstand’: nabij door je persoonlijke interesse in mijn ontwikkeling als jonge onderzoeker en 
op afstand door de inhoudelijke vrijheid die je me gaf. Jij zag de soms lastige 
wisselwerking tussen emotie en cognitie en hebt als meester in de cognitieve en 
diplomatieke bijsturing, en met de nodige humor en relativering, menig emotioneel moment 
helpen overwinnen. Ik heb jouw vaardigheden afgekeken en ik hoop deze in de toekomst, 
wanneer ik het zonder jouw supervisie moet doen, nog vaak te gebruiken. 
Beste Dick, jij begon niet aan een makkelijke taak toen je jouw eerste 
promovendus eind 1999 de hand schudde. De intensieve begeleiding die vanaf dat moment 
vorm kreeg laat zich niet in drie zinnen samenvatten. We hebben allebei een zeer 
verschillende stijl, maar het doel en de gedrevenheid dat doel te bereiken was altijd gelijk. 
Ik heb veel geleerd van jouw technische kennis en jouw perfectionisme bij het verkopen 
van de oogst. Toen je in de vorm van twaalf vrijwillige injecties radioactief gelabeld water, 
twee uur met flitsbril op je neus, meeging in mijn behoefte tot het uitroeien van 
bewegingsartefacten, wist ik dat je me steunde. Straks, als eerste Nederlandse professor in 
de psychiatrische beeldvorming, wacht jou de uitdagende taak gedachte en gevoel steeds 
verder te integreren.  
Beste Adriaan, jouw bereidheid asiel te verlenen aan de psychiatrie heeft 
inmiddels ernstige vormen aan genomen. Eerst was een enkele verdwaalde geest nog 
makkelijk weg te stoppen in een stralingsgevaarlijke telkamer. Nu, vele gigabytes 
neurodata verder, wacht familie ‘psycho-1’ een uitzettingsprocedure. Maar de fysica en de 
psychiatrie zijn inmiddels te zeer met elkaar verstrengeld om het ooit nog zonder elkaar te 
moeten stellen.  
Beste Henk, jij hebt als geen ander de deur altijd open staan. Zelfs als jouw agenda 
overvol was, was je bereid mee te denken over de betekenis van de vlekjes op het scherm 
en had je conceptmanuscripten steeds binnen korte tijd van grondig commentaar voorzien. 
Ik hoop in de toekomst nog vaak bij je binnen te kunnen vallen, want de functionele 
modellen die gangbaar zijn in de psychiatrie missen al te vaak neuroanatomische evidentie. 




















pleegadres. Vanaf het allereerste begin, toen de J-vleugel nog dun bevolkt was, hebben 
jullie me opgenomen in de anatomische familie. Zo hebben jullie me ongemerkt wegwijs 
gemaakt over de neuronale paden. En we zijn nog lang niet uitgewandeld. 
 
Een belangrijke stuwende kracht achter het onderzoek was de onderzoeksgeest van de 
angstpolikliniek, waar geen patiënt onopgemerkt aan een protocol kan ontsnappen. Ik wil 
Daniëlle Cath bedanken voor haar voortdurende enthousiaste inbreng. Daniëlle, ik waardeer 
jouw gedrevenheid je stem te laten horen in het sterk masculien georiënteerde academische 
gezelschap. Richard vergeleek ons wel eens met twee hanen, maar ik denk dat de term 
moederkloeken beter recht doet aan onze sterke emotionele betrokkenheid bij het reilen en 
zeilen van het onderzoek. Daarnaast heb jij samen met Ton van Balkom, Patricia van 
Oppen, Noor Tromp en alle behandelaren van de polikliniek ervoor gezorgd dat de 
instroom van medicatievrije proefpersonen vlot verliep. 
Het vinden van gemotiveerde patiënten voor deelname aan het onderzoek werd 
verder gestimuleerd door de actieve patiëntenverenigingen onder de bezielende leiding van 
Josine van Hamersveld (Angst, dwang en fobie stichting) en Hans Eijsackers (Nederlandse 
Tourette vereniging). Jille Merkelbach kan ik helaas niet meer persoonlijk bedanken voor 
zijn geleverde strijd bij het vinden van patiënten met hypochondrie. Zo vaak kreeg ik 
optimistische emailtjes van je als het je weer was gelukt iemand bereid te vinden voor 
deelname aan het onderzoek. Jille, ik betreur het zeer dat jij het einde van onze 
gezamenlijke onderneming niet meer mee hebt kunnen maken. Julie van Hartskamp dank ik 
voor haar grote inzet bij de afronding van de dataverzameling in de periode dat ik weer 
fulltime in de kliniek werkte. Marjan Nielen bleek een grote aanwinst voor de 
‘angst&depressie-imaging’-groep door haar neuropsychologische kennis van OCD-zaken. 
Marijke van ter Tholen bedank ik voor haar hulp bij het vergaren van oude en recente 
literatuur.  
 
Het boekje bestaat voor een belangrijk deel uit water, waarvan de bron ligt onder de 
parkeerplaats van het VU medisch centrum. Met de symptoomprovocatiestudie werd voor 
het eerst in Nederland de productie van H2
15O voor patiëntgebonden onderzoek in werking 
gezet. Ondanks de onvoorspelbare grillen van het cyclotron en de extreem korte levensduur 
van het gelabelde water (t½ = 2 min) was het met vereende krachten mogelijk een tamelijk 
ingewikkeld protocol uit te voeren. Ik dank hen die dit kostbare, radioactieve vocht 
maakten (Gert Luurtsema, Henri Greuter, Joke Eyndhoven, Patricia Ophemert) en zij die 
als trouwe waterdragers (Suzette van Balen, Bas Hoving, Rob Koopman, Annemarie de 
Wildt) de proefpersonen begeleidden tijdens de vaak spannende en belastende scansessies.  
Ronald Boellaard en Catalina Mesina dank ik voor de prettige samenwerking bij het 
optimaliseren van de technische aspecten van de dataverwerking. Pieper *391 (Remi 
Schmeits) was steeds als baken in het duister op te roepen wanneer het digitale huis ineen 
leek te storten (eenmaal was het kwaad al geschied). Secretariële ondersteuning (inclusief 
vrijwillige onderwerping aan het MRI experiment) kwam van Amanda Kalwij en Jaap van 
der Kuij. 
 Iets toegankelijker was de techniek van de magnetische resonantie. Dankbaar heb 
ik gebruik gemaakt van de kennis en ervaring van Serge Rombouts en de adviserende 





















Kuijer, Sander Daselaar en Richard Lazeron. Het ‘fMRI-eetclubje’ (helaas een vroege dood 
gestorven door de transatlantische gang van de topkoks Ysbrand en Sander) zorgde voor de 
nodige bijvoeding.  
 
Knowledge from oversee came from Ray Dolan (Wellcome Department of Cognitive 
Neuroscience, London, UK) and Scott Rauch (Massachusetts General Hospital, Harvard, 
Charlestown, USA). Dear Ray, I would like to thank you for your contribution to our work. 
I hope we will once continue the stimulating discussion about what the big thing is in OCD. 
Dear Scott Rauch, most of the studies described in this thesis are largely inspired by your 
work in OCD. I am very honored that you reviewed my thesis and that you will participate 
in the opposition during the graduation ceremony. I am looking forward to meet you in 
May.  
Gedeelde smart is halve smart. Mocht voorheen de AGIKO een zeldzame soort zijn en 
slechts zelden in staat te overleven, inmiddels vormen we een waar elftal (Peter, Marijke, 
Christel, Daniel, Arne, Gerben, Eric, Ritsaert, Saskia en Neeltje). Dé plaats om de twijfels, 
frustraties en cirkelredenaties teruggespiegeld te krijgen was aan de eettafel tijdens de 6-
wekelijkse intervisies. De rector gaat niet akkoord met 11 paranimfen, maar ik weet me 
gesteund door jullie allemaal. Peter, jouw boek volgt. Ik voel me 12 mei gesterkt met de 
wetenschap dat jij de verdediging in geval van nood kan overnemen. 
 
Na gedane arbeid is het fijn thuiskomen. Lieve papa en mama, ik bedank jullie voor alle 
liefde en steun gedurende de afgelopen tropenjaren. Jullie stonden het toe dat ik vlak voor 
het kerstdiner, met een vertrouwd “j’arrive”, nog even snel een laatste paragraaf ging 
afmaken. Als ware duizendpoten hielpen jullie bij ‘het leven naast het boek’: van 
bruidskleed tot babyslofjes, 3000 kilo eikenhout, 45 meter gordijn, en Tarzan altijd 
tevreden ronkend voor de deur. “Een druppeltje olie doet wonderen”. Jullie waren de olie 
die de raderen draaiende hield. 
Schoonpapa, ouwe reus, ik verleng hierbij voor het leven mijn abonnement op de 
exclusieve psychiatrie&wetenschap-knipselkrant. 
Harold, liefste para-elf, de geest van de kunstenaar blijkt nauw verwant met die 
van de wetenschapper. Met jouw brede interesse, ijzersterk geheugen en wetenschappelijke 
geest, verruilde jij de geologie voor de gitaar. Maar onderzoeker ben je in hart en nieren. Jij 
hebt als onzichtbare coauteur een groot deel van het manuscript van kritisch commentaar 
voorzien en met al jouw zorgzaamheid en levenslust steeds weer mijn accu opgeladen. Nu 
is de beurt aan jou jouw geesteskind op de wereld te zetten.  
Tot slot, Ada, lieve kleine meid, jij hebt me de belangrijkste titel gegeven die er 
bestaat. Jouw vrolijke nieuwsgierigheid is aanstekelijk en ik hoop dat je die eigenschap 
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